Development and Validation of the Wheelchair Seating Discomfort Assessment Tool (WcS-DAT). by Crane, Barbara Anne
DEVELOPMENT AND VALIDATION OF THE WHEELCHAIR SEATING DISCOMFORT
ASSESSMENT TOOL (WcS-DAT)
by
Barbara Anne Crane
BS, University of Connecticut, 1989
MA, Saint Joseph College, 1997
Submitted to the Graduate Faculty of
The School of Health and Rehabilitation Sciences in partial fulfillment
of the requirements for the degree of
Doctor of Philosophy
University of Pittsburgh
2004
ii
UNIVERSITY OF PITTSBURGH
FACULTY OF ARTS AND SCIENCES
This dissertation was presented
by
Barbara Anne Crane
It was defended on
January 14, 2004
and approved by
Douglas A. Hobson, Ph.D.
Margo B. Holm, Ph.D., OTR/L,
FAOTA, ABDA
Steve Stadelmeier, M.Sc.
Matthew P. Reed, Ph.D.
Rory A. Cooper, Ph.D
Dissertation Director
iii
Copyright by Barbara A. Crane
2004
iv
DEVELOPMENT AND VALIDATION OF THE WHEELCHAIR SEATING DISCOMFORT
ASSESSMENT TOOL (WcS-DAT)
Barbara Anne Crane, PhD, PT
University of Pittsburgh, 2004
Wheelchair seating discomfort is an important but poorly understood negative outcome for long
duration wheelchair users.  A major impediment to the study of this problem is the lack of a validated tool
for quantification of wheelchair seating discomfort.  The goal of this dissertation research was to develop
and validate an assessment tool appropriate for the quantification of wheelchair seating discomfort among
long duration (> 8 hours per day) wheelchair users.  This was accomplished through the completion of
three research phases, each described within the body of this dissertation.  Phase I consisted of a
qualitative research study involving in-depth interviews with experienced wheelchair users.  Data from
these interviews resulted in the development of the Wheelchair Seating Discomfort Assessment Tool
(WcS-DAT), a three-part tool to allow wheelchair users to quantify their level of seating discomfort.
Phase II of the research assessed the reliability and concurrent validity of this assessment tool through a
test/re-test reliability study.  Intra class correlation (ICC) coefficient scores ranged from 0.83 to 0.97,
indicating adequate reliability of the two discomfort scores in the WcS-DAT.  Internal item consistency,
assessed using Cronbach’s alpha, indicated that all items were consistent and not redundant, with scores
ranging from 0.82 to 0.92.  Pearson product-moment correlations were used to assess the concurrent
validity of the WcS-DAT and all of these correlations were significant at a minimum of p < 0.05 level,
with many significant results at the 0.01 and 0.001 levels.  These results indicated good concurrent
validity of the WcS-DAT.  In Phase III, the WcS-DAT was evaluated for its ability to show changes in
discomfort over time and with the introduction of novel, user adjustable wheelchair seating.  Both the
General Discomfort Assessment score (GDA) and the Discomfort Intensity Score (DIS) were sensitive to
changes in seating discomfort level and were adequate for use in detecting differences associated with
changes in duration of sitting as well as those associated with use of different seating equipment.  Results
of this final phase indicated that the WcS-DAT is a useful tool for evaluation of wheelchair seating
discomfort in a research or clinical environment.
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1.0 INTRODUCTION
1.1 THE PROBLEM
Wheelchair-seating discomfort has not been extensively investigated in the field of wheelchair
seating research.  In fact, there currently exists no validated tool for use in quantifying seating
discomfort for persons who use wheelchairs.  This lack of a tool has greatly impeded progress in
researching this important issue.  While it is true that wheelchair seating discomfort is subjective
in nature, this does not preclude the ability to quantify and study this important wheelchair
seating outcome.  Discomfort is a frequent and prevalent problem among wheelchair users.
Bardsley (1984) surveyed multiple populations of wheelchair users and found discomfort was
one of the wheelchair seating problems commonly identified by individuals with muscular
dystrophy, multiple sclerosis, rheumatoid arthritis and spinal cord lesions.  In a 1991 study of
individuals in skilled nursing facilities, discomfort and impaired mobility were the most
frequently reported problems associated with wheelchair use (Shaw & Taylor, 1991).  Similarly,
two studies of seating needs of elderly nursing home residents found that discomfort was a
significant and highly prevalent problem (Shaw, 1993; Shaw, 1992).  Furthermore, discomfort
has been shown to reach such levels as to cause the wheelchair user to spend more time in bed
(Herzberg, 1993).  This may lead to decreased quality of life, impaired ability to participate in
functional activities and increased incidence of problems associated with being bedfast including
decubitus ulcers and pneumonia (Herzberg, 1993).  Weiss-Lambrou (1999) studied consumer
satisfaction with wheelchair devices and found that the most important consumer criterion for
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satisfaction with a wheelchair was comfort, but that it was evaluated by many as the least
satisfying feature of their wheelchair (Weiss-Lambrou, Tremblay, LeBlanc, Lacoste, &
Dansereau, 1999).  Scherer (1996a) has identified discomfort as a contributing factor in what she
describes as partial or reluctant equipment use. Partial equipment use is characterized by (1) use
of a device for less than the optimal length of time or (2) reluctant use of the device (Scherer,
1996a).  Partial use is an important concept because it is closely related to equipment
abandonment, but individuals who rely on wheelchairs for primary mobility are unable to
completely abandon their wheelchairs without sacrificing all mobility.  Due to the prevalence of
discomfort among wheelchair users and all of these possible negative outcomes, seating
discomfort is an important problem related to use of wheelchairs and warrants further
investigation.
1.2 GOALS AND HYPOTHESES
The purpose of the research presented in this dissertation was to develop and test a Wheelchair
Seating Discomfort Assessment Tool (WcS-DAT) using a prototype dynamic seating system
(PTS2) to elicit the comfort-discomfort continuum in sensate wheelchair users.  This research is
presented in three phases.  Phase I is a descriptive study using ethnographic research techniques
to investigate “wheelchair seating discomfort” in the target population and to determine how
wheelchair users define this construct and other associated factors.  This phase is used to guide
the development of the WcS-DAT, which is then evaluated for reliability, validity and efficacy in
phases II and III.  Phase II is a test-retest reliability study of the WcS-DAT to determine the
basic reliability and validity of this assessment tool when used by representatives of the target
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population.  Phase III involves testing of a user adjustable wheelchair seating system prototype
(PTS2) to investigate the efficacy of the WcS-DAT in quantifying discomfort over time and with
the introduction of a novel seating environment.
Phase I is not associated with any specific research hypotheses, but does have a research
objective.  This objective is development of the WcS-DAT – a clinical and research evaluation
tool effective for quantifying the level of seating discomfort in a wheelchair-seated individual.
Phase II has one associated hypothesis:  (1) Participants with severe motor impairment and intact
sensation, using the WcS-DAT will be able to reliably quantify the level of discomfort they feel
after a minimum of 2-hours using a wheelchair.  Phase III also has one associated hypothesis:
(2) Persons who use wheelchairs and have intact sensation will demonstrate a difference in
discomfort when provided with the capacity to self-adjust their seated posture and their support
surface characteristics with a dynamic seating device compared to their regular wheelchair.
1.3 CONSIDERATIONS GUIDING THIS RESEARCH
To develop the WcS-DAT, more information about seating discomfort experienced by
wheelchair users was necessary. While the constructs of comfort and discomfort have been
extensively evaluated in the office environment by Helander (1997) and Zhang (1996), the only
exploration of them among wheelchair users was done in a preliminary study by Monette, et al.
(1999).  In Monette’s study, a focus group research format was used with wheelchair users to
differentiate the discomfort factors already identified in other populations (e.g. office workers)
from those specific to wheelchair users.  Although this provided valuable information regarding
some of these differences, more investigation of this topic is warranted.  Phase I of this study
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utilizes a semi-structured interview-based qualitative research design using ethnographic
techniques (Bailey, 1991).  The topic of investigation was wheelchair seating discomfort.  The
informants selected to participate are all experts as they all sit for more than 8 hours per day in
wheelchair seating systems and they all have experienced wheelchair seating discomfort.
For Phase II and hypotheses 1 testing, a test-retest single group research design is used
for reliability testing.  This phase involved the use of 30 subjects.  Subjects complete the WcS-
DAT four times during the course of one week.  This allowed verification of test/re-test
reliability.  In addition to the use of the newly developed WCS-DAT, similar concurrent
measures of discomfort (developed for use in other populations) and a commonly used pain
assessment tool were used for cross validation.  These measures are tools already validated in the
literature for use with other populations.
Phase III of this research followed a single subject ABCA/ACBA multiple baseline,
alternating conditions design (Ottenbacher, 1986). Six subjects participated in this phase.  Two
alternating treatment designs were used – ABCA and ACBA.  This phase of research was
designed for hypothesis two and three testing.  During the course of this research, the WcS-DAT
was also evaluated for its performance and sensitivity to detecting changes in wheelchair
discomfort over time and with the introduction of a wheelchair seating intervention.  In order for
the WcS-DAT to be a valuable research or clinical outcomes measurement tool, it must not only
be reliable, but also be sensitive to actual changes in wheelchair seating discomfort.  This phase
of research provided valuable information on the performance of this tool in a longitudinal
context in which seating discomfort was expected to change.
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1.4 ORGANIZATION OF THIS DISSERTATION
The body of this dissertation includes three research papers (chapters 4, 5 and 6), each presenting
one of the phases of research mentioned above.  Chapter 2 of this dissertation is an extensive
review of the relevant literature, too lengthy for inclusion within the structure of the individual
research papers, but containing important background information.  Chapter 3 reports the
methods and results of two preliminary research studies that were done to investigate the
problem of wheelchair seating discomfort in the target population, to initiate the development of
the WcS-DAT tool and to guide the development of the user adjustable seating system for the
PTS2 test wheelchair used in Phase III testing.  This information is critical to decisions made
regarding the design and implementation of the current study.  In Chapter 4, the methods and
results for the phase I research – development of the WcS-DAT – are presented.  Chapter 5
reports the methodology and results for the reliability and validity testing of the WcS-DAT
(Phase II) and consists of the second manuscript.  Chapter 6 contains extensive reporting of the
methodology and results from the Phase III testing – the single subject design phase of this
research study.  The final chapter – Chapter 7 is a summary of the results and overall conclusions
from this research and some suggestions for future research in this area.  There are also several
appendices that include all of the data collection instruments used in the multiple research
phases.
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2.0 REVIEW OF RELEVANT LITERATURE
2.1 BACKGROUND AND SIGNIFICANCE OF THE PROBLEM
Individuals with multiple sclerosis (MS), amyotrophic lateral sclerosis (ALS), muscular
dystrophy (MD), and post polio syndrome (PPS) comprise the largest population of wheelchair
users with severe motor impairment and suitably intact sensation.  This is an important
population due to its relative size – a combined 150,000 wheelchair users in this country.  In
spite of the magnitude of this group, the majority of wheelchair seating research is focused on
the population of wheelchair users with spinal cord injuries resulting in quadriplegia and
paraplegia – a population of approximately 90,000 wheelchair users (Kaye, Kang, & LaPlante,
2000).
Research is just beginning regarding the problems associated with long duration
wheelchair use among individuals with the above-mentioned disabilities.  One of the major
problematic outcomes – wheelchair seating discomfort – is explored by this dissertation research.
There are two general research topics related to wheelchair seating discomfort.  The first
involves defining the constructs and problems of “discomfort” and “comfort” – their meaning,
previous research, and implications for the wheelchair using population.  The second pertains to
the effectiveness of a newly developed, user adjustable seating intervention – a relatively new
field of intervention and research when applied to individuals who use wheelchairs.  The
17
interplay of these areas is critical to the future development of wheelchair seating technology and
outcomes research.
It has been documented that prolonged sitting, particularly in a restricted environment,
leads to increased levels of discomfort or pain.  Several researchers have investigated this
phenomenon, including Helander & Zhang, (1997); Hertzberg, (1972);  Lee & Ferraiuolo,
(1993); Shackel, Chidsey, & Shipley, (1969); Shen & Vertiz, (1997) and Zhang et al., (1996).
Prolonged sitting occurs in office environments where individuals must sit for prolonged periods
of time as they work; in the automotive environment where individuals drive long distances
without stopping; in the aviation environment where pilots fly for extended hours; and in
wheelchair seating environments where individuals who have severe mobility impairments must
sit all day.  One problem common to all of these populations is discomfort and pain related to
restricted mobility over time.
2.2 COMFORT AND DISCOMFORT
One of the primary challenges in researching wheelchair seating discomfort is defining
discomfort and determining how it relates to its opposite, and more commonly used term,
comfort.  In his original studies, Shackel (1969) used comfort and discomfort as opposite ends of
a continuous spectrum of sensation.  Several other researchers (Branton, 1969; Lee, Schneider,
Reed, Saito, & Kakishima, 1991; Zhang et al., 1996) separated the concepts of comfort and
discomfort and focused their attention on the evaluation of discomfort.  Branton (1969) went as
far as redefining the discomfort continuum as a continuum from a point of indifference at one
end to a point of severe discomfort at the other and eliminated the concept of comfort altogether.
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Although this debate remains unresolved, most researchers have continued to use assessments
based on a continuum from comfort to discomfort as a component of their studies (Chesney,
Hsu, Wright, & Axelson, 1995; Christiansen, 1997; DiGiovine et al., 2000).  For this research, a
comfort-discomfort continuum is used in addition to a factor-related approach described by
Zhang (1996).
In one large study of office workers (Zhang et al., 1996), comfort and discomfort were
determined to be multifactorial in nature and each was related to multiple elements of the seat
and the environment. Discomfort was the factor more easily described.  Zhang (1996) also found
that discomfort was related to joint angles, muscle fatigue, and pressure distribution problems
that caused pain, numbness, stiffness, or other negative sensations.  Feelings of discomfort were
found to increase with time spent in a seat or when limited to movement in one task in an office
environment (Zhang et al., 1996).  Comfort was more difficult to define and has not been
extensively investigated in the literature (Christiansen, 1997; Fubini, 1997; Shackel et al., 1969).
In a follow up study these factors were delineated more clearly (Helander & Zhang, 1997).
Helander and Zhang (1997) found that comfort was based on feelings of relaxation, general well-
being and the aesthetic impression of the chair itself.  In a similar study involving persons who
use wheelchairs, the feelings of stability and satisfaction were added to this list (Monette et al.,
1999).  Because of the difficulty in defining and describing comfort, its antonym, discomfort is
the component most often evaluated in research studies.
A common theme of research into discomfort is that discomfort is related to the duration
of time in a confined or restricted position, such as sitting in a chair in an office, sitting in a car
while driving, or sitting in the cockpit of a jet.  Typical solutions have included: proper
contouring of a seat for maximal pressure distribution (Hertzberg, 1972), optimizing upholstery
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characteristics and providing thermal comfort (Fubini, 1997), and the introduction of a dynamic
element to allow seated individuals to move and adjust their positions (Elton & Hubbard, 1993;
van Dien, de Looze, & Hermans, 2001).  Dynamic seating for individuals who use wheelchairs
has been studied in the context of pressure relief (Burns & Betz, 1990; Koo, Mak, & Lee, 1995)
and the management of extensor spasticity (Ault, Girardi, & Henry, 1997), but few have
researched the impact of dynamic seating elements on comfort (Parent, Dansereau, Lacoste, &
Aissaoui, 2000).  This dissertation research expanded on the knowledge gained in previous
research on comfort and discomfort management for individuals who are seated by exploring its
applicability to individuals who are seated in wheelchairs.
2.3 RELATED RESEARCH
A large body of research on seating comfort is related to the field of office seating design.
Likewise, research in automotive and aeronautic cockpit seating design has provided a general
understanding of the concepts of seating comfort and discomfort.  These bodies of literature will
be reviewed because of their potential to guide research on seating discomfort among sensate
wheelchair users.
2.3.1 Office seat design research
Comfort and discomfort research in the field of office seat design has illuminated several
problems and potential solutions in seating.  These problems consist of discomfort and pain in
several regions of the body associated with prolonged sitting (Corlett & Bishop, 1976, Shackel,
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et al., 1969) and a limited ability to tolerate the seated position (Zhang et al., 1996).  Many
solutions have been evaluated, but the most successful focus on dynamic systems incorporating
spring loaded components used to allow office workers to move while they sit (Fenety, Putnam,
& Walker, 2000).  Individuals who work in office settings engage in prolonged sitting (Vergara
& Page, 2002) comparable to individuals who rely on wheelchairs for all of their mobility.
Although office workers studied were unimpaired, they share problems related to seating
discomfort and pain (Corlett & Bishop, 1976; Drury & Coury, 1982; Helander & Zhang, 1997;
Shackel et al., 1969; Zhang et al., 1996).  Researchers in this field have developed tools, such as
the General Comfort Rating Scale (Shackel et al., 1969), the Body Area Discomfort Map (Corlett
& Bishop, 1976) and the Chair Evaluation Checklist (Helander & Zhang, 1997), to assess or rate
levels of seating comfort and discomfort in this unimpaired population.  Other researchers have
used these tools in the assessment of office and home furniture to guide development of new
products (Fenety, Putnam, & Walker, 2000; Le Carpentier, 1969; Sweeney & Clarke, 1991).
While this research has enhanced the understanding of comfort in the unimpaired population,
only Monette (1999) has investigated the applicability of this information to the population of
wheelchair users.  Monette (1999) applied the work of Helander and Zhang (1997) to develop a
chair feature evaluation for individuals who use wheelchairs.  The outcome of her study became
one component of a discomfort assessment tool specific to individuals who use wheelchairs.
However, no further research has been conducted on the psychometric properties of this tool and
the tool itself was never validated for research purposes.
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2.3.2 Automotive/aeronautics industry research
Research in the automotive seat design and aeronautic industries has also enhanced our
understanding of seat comfort and comfortable seat design (Kolich, 2003).  This body of research
is focused around the study of three main variables – time spent in a seated position, the shape of
the seat itself, and the pressure distribution of a person’s body weight in the seat.  The primary
contribution of these studies is focused on the temporal aspect of comfort, namely, (a) comfort
tends to decrease as time spent in the seat increases, and (b) short duration trials may not
adequately determine what elements of a seat will be comfortable over time (Lee et al., 1991;
Pywell, 1993; Shen & Vertiz, 1997).  Automotive and aeronautic researchers also focused on
interventions that would improve comfort and investigated the relationship between certain
objective measures, such as pressure distribution or EMG activity, with subjective assessments
of comfort (Lee et al., 1991; Pywell, 1993; Shen & Vertiz, 1997).  For example, Hertzeberg
(1972) and Cohen (1998) found a positive relationship between comfort and increased pressure
distribution across a maximal surface area.  Moreover, both concluded that contoured seat
surfaces were more comfortable than flat surfaces in airplane cockpit seat studies.  Similarly,
Elton and Hubbard (1993) found that a contoured surface with multiple adjustable features was
more comfortable in automobile seating than a non-contoured surface with minimal adjustment.
A great deal of the focus in this research has been on the properties of seat cushions related to
pressure (Ebe & Griffin, 2000, 2001) because of the convincing evidence that the correct amount
of pressure exerted in proper locations will lead to increased seating comfort overall.
Other factors related to seating comfort have also been investigated in the automotive
seating arena.  Included among these is the effect of thermal comfort on overall seating comfort
(Brooks & Parsons, 1999), and the effects of vibration on comfort (which has also been
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investigated in the field of wheelchair seating discomfort) (Matsumoto & Griffin, 2002).
Thermal and vibration factors have been considered in this wheelchair seating discomfort
research as their effects on the discomfort of wheelchair users is largely unknown at this time.
The research in the automotive industry may once again, guide the wheelchair seating research in
these areas.
2.4 RESEARCH INVOLVING WHEELCHAIR USE AND PAIN
There has been a significant amount of research devoted to the prevalence and causes of pain and
wheelchair users with various disabilities.  This research includes topics such as low back pain in
persons with spinal cord injuries (Chantraine, Bosson, Malaise, Onkelinx, & de Leval, 2001), hip
pain experienced by wheelchair users with cerebral palsy (Hodgkinson et al., 2001), neck and
upper back pain among individuals who use wheelchairs for all of their mobility (Boninger et al.,
2003), upper limb and shoulder pain among individuals with late effects related to poliomyelitis
(Koh, Williams, & Povlsen, 2002; Werner, Waring, & Maynard, 1992), and the largest topic area
by far – shoulder pain related to wheelchair use, particularly among those with spinal cord
injuries (Burnham, May, Nelson, Steadward, & Reid, 1993; Curtis, Drysdale et al., 1999;
Sinnott, Milburn, & McNaughton, 2000).
Much of this research is quite focused in nature – on one particular pain syndrome (e.g.
shoulder pain) or on one particular population (e.g. individuals with polio).  In spite of this high
degree of focus, some general conclusions are found across areas including: pain has a negative
affect on an individual’s activity level (Boninger et al., 2003), causes increased medical visits
(Boninger et al., 2003; Chantraine et al., 2001), and may impair an individuals functional
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capabilities (Boninger et al., 2003; Chantraine et al., 2001; Willen & Grimby, 1998).  The
prevalence and implications of shoulder pain have even led to the development of a specialized
evaluation tool for quantification of shoulder pain in wheelchair users (Curtis et al., 1995a,
1995b) and the development of a related intervention program (Curtis, Tyner et al., 1999).
While some of these researchers acknowledged the impact of wheelchair seating and
postural support on these pain syndromes (Chantraine et al., 2001; Hodgkinson et al., 2001;
Sinnott et al., 2000), most focused on the internal body structures or root causes rather than on
the influence of the wheelchair seating environment (Curtis, Drysdale et al., 1999; Werner et al.,
1992).  None of these researchers explored the topic of postural discomfort as it related to
wheelchair seating or even as it related to the specific pain syndrome of interest.  Although this
research has made a significant contribution in the field of pain research and management, it has
little to say that directly relates to postural support and positioning that may impact the important
area of wheelchair seating discomfort.
2.5 WHEELCHAIR SEATING COMFORT AND DISCOMFORT RESEARCH
Research related to the comfort-discomfort continuum in wheelchair seating is limited.  Several
studies (Batavia & Hammer, 1990; Troy, Cooper, Robertson, & Grey, 1997; Weiss-Lambrou et
al., 1999; Zacharkow, 1988) evaluated consumer satisfaction and identified discomfort as a
problem in wheelchair seating.  In addition to this, researchers (Boothby, 1984; Chesney et al.,
1995; Monette et al., 1999; Nelham, 1984) have also examined the concepts of comfort and
discomfort as they relate to individuals who use wheelchairs, finding that the way individuals
who use wheelchairs describe comfort and discomfort differs from the way unimpaired
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populations describe comfort and discomfort.  In a Canadian study unlike any others, Gibson,
Albisser, and Koreska (1975) developed a seating system designed to decrease discomfort in a
population of wheelchair users with muscular dystrophy. They found that the seating system was
effective at providing comfort through enhanced postural support not found in previously used
wheelchairs. In a comfort-related study, DiGiovine et al. (2000) investigated the ride comfort of
various manual wheelchairs.  Similarly, VanSickle, Cooper, Boninger, and DiGivioine (2001)
analyzed vibration occurrence in manual wheelchair propulsion and found that they exceeded the
ISO standard “fatigue-decreased performance boundary” which could increase fatigue levels and
result in discomfort for manual wheelchair users.  While these studies have begun to examine the
comfort-discomfort continuum with wheelchair-seated individuals, they have neither
successfully identified a comprehensive methodology for assessing comfort and discomfort, nor
developed definitive seating devices that minimize discomfort and promote comfort.
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2.6 SIGNIFICANCE OF THE PROBLEM
In spite of the prevalence and importance of discomfort, most research in the field of wheelchair
seating has been focused on problems associated with pressure and pressure-related skin
breakdown (Koo et al., 1995) or postural management of individuals with spasticity-related
problems, such as those with cerebral palsy.  Because of the costs and health problems associated
with pressure ulcers, this has remained the focus of much seating research.  Another area of
research with individuals who use wheelchairs focused on the performance characteristics of the
wheelchairs themselves (Cooper et al., 1997).  While these areas are highly critical to meeting
the health and functioning needs of individuals who use wheelchairs, the issue of discomfort has
been largely overlooked and is just now coming to the attention of the research community.
2.7 SIZE OF THE TARGET POPULATION
Because there is no direct measure of the prevalence of discomfort among wheelchair users, an
indirect measure will be used based on the size of the target population and the prevalence
information that is known from the literature.  The target population of wheelchair users for this
study is made up of individuals who have problems with discomfort due to their severe motor
paralysis and are unable to shift their weight or re-position themselves in their seats.
Additionally, they have relatively intact sensation and are able to feel discomfort and pain at the
seat-buttock interface or other areas of their body.  Such characteristics are common to
individuals with diagnoses including: multiple sclerosis (MS), muscular dystrophy (MD),
amyotrophic lateral sclerosis (ALS), post-polio syndrome (PPS), Guillian Barre syndrome, and
severe debilitation found in frail elders, often due to arthritis or other musculoskeletal conditions.
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While it is difficult to determine the size of the sub-population of sensate wheelchair
users, there are some helpful statistics related to wheelchair use and the prevalence of diagnostic
groups associated with severe motor impairment and intact sensation.  Jones and Sanford (1996)
quantified nearly 1.4 million manual wheelchair users and 96,467 powered wheelchair users
among non-institutionalized individuals in the United States.  Another source, the NIDDR
Disability Statistics, similarly identified 1.5 million manual wheelchair, 155,000 power
wheelchair, and 142,000 scooter users (Kaye et al., 2000).  These figures, from 1990 National
Health Information Survey data, indicated a doubling of the wheelchair using population from
1980 to 1990.
Multiple Sclerosis is the third leading cause of wheelchair use among all age groups with
82,000 individuals reporting MS as the primary reason they use a wheelchair (Kaye et al., 2000).
When looking at ages 18 – 64 (a group likely to be living in the community) MS is actually the
number one cause for wheelchair use with 58,000 individuals or approximately 10% of all
individuals in this age group who use wheelchairs.  The prevalence of wheelchair use for those
with ALS is also quite high – 32,000 wheelchair users of all ages and 14,000 wheelchair users
age 18-64 (Kaye et al., 2000).  The primary cause of wheelchair use in all age groups is
cerebrovascular accident and the second is osteoarthritis.  These populations are also known to
have difficulties with discomfort and pain.  Muscular dystrophy is categorized with “other CNS
disorders” and this category accounts for an additional 37,000 wheelchair users (Kaye et al.,
2000).  If combined, these figures add up to 150,000, or 10%, of all non-institutionalized
wheelchair users in this country.
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3.0 PRELIMINARY RESEARCH
Two pilot studies were conducted to determine the prevalence of discomfort and the potential
effectiveness of a dynamic seating intervention at improving comfort.  The first study involved
the use of a questionnaire-based interview to determine the importance of comfort in a small
sample of the target population.  The second study introduced a dynamic seating device to a
small sample of participants to obtain their feedback based on a limited duration trial of this
equipment.  Nine participants completed the first study and six participants completed the second
study.  The results of these pilot studies are summarized below.
3.1 PILOT STUDY I
3.1.1 Participants
For this pilot study, a convenience sample of nine participants was recruited from the target
population in the greater Pittsburgh area.  The inclusion criteria were: (a) having a diagnosis of
MS, MD, ALS, or post polio syndrome, (b) being 18 years old or older, (c) having used a
wheelchair or scooter for at least three months, (d) using a wheelchair or scooter as the means of
primary locomotion (all day), and (e) having some problems related to discomfort.  Individuals
were excluded if they had experienced a pressure ulcer within the last year.
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3.1.2 Method
Pilot study I was a descriptive study using a structured interview.  All experimental procedures
were approved by the University of Pittsburgh’s Institutional Review Board prior to recruitment
of any participants.  The participants were visited in their homes or other locations of their
choosing in order that they might feel most comfortable.  After a detailed explanation of the
study and signing of an informed consent form, a structured questionnaire format was used to
interview the participants.  Both closed-ended and open-ended questions were included.  The
questionnaire contained demographic information questions, a description of the participant’s
current wheelchair, and individual suggestions for designing an “ideal” wheelchair seating
system.  A sample of these questions appears in Table 3-1.  (The complete questionnaire is
enclosed in Appendix A). Descriptive statistics and weighted rank order calculations were used
to analyze the responses.
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Table 3-1:  Pilot study one sample questions
Question
number
Question text Format of answer
Part two,
number 1
On an average day, how long do you spend in your
seating system?
Closed-ended – number
of hours
Part two,
number 2
What is a typical reason for getting out of your seating
system?
Closed- or open-ended
– given 5 choices or
able to list their own
reason
Part three,
number 4
Do you ignore your discomfort to function at your
current level?
Closed-ended – yes or
no
Part three,
number 8
How do you currently manage discomfort in your
seating system?
Closed- or open-ended
– given 5 choices or
able to list their own
method
Part four,
number 4
How important are these features of a seating system to
you?  Rated on a scale of 1 – 10, seven items:  comfort,
safety, mobility, ability to perform self care tasks,
independent use of all features, ability to adjust
multiple features, ability of caregiver to adjust features
Rated on a scale from 1
to 10: 1 – least
important, 10 – most
important
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3.1.3 Results
Nine participants completed the questionnaire-based interview for this phase.  All nine had intact
sensation determined through testing of light touch and proprioceptive sensory awareness on
their lower extremities.  Six of these were interviewed in their home and 3 were interviewed in a
laboratory setting.  The age of participants ranged from 18 to 66 years old with a mean age of 41
years old.  Seven of the participants were male and 2 were female.  Primary diagnoses included:
ALS – 2 participants, MS – 2 participants, MD – 5 participants.  Additional descriptive data are
summarized in Table 3-2.  Five participants interviewed used tilt in space seating systems (4
powered and one manual); 3 participants used reclining seating systems (2 powered and one
manual).  Seven participants used powered mobility systems and 2 participants used manual
systems.
Table 3-2: Pilot study one sample characteristics
Parameter Mean (n=9) Range
Age (in years) 41 18 to 66
Time in chair (in hours)
Height (in inches)
Weight (in pounds)
15
67
159
8 to 24
50 to 74
94 to 220
The range of hours the participants spent in their chairs on an average day was 8 to 24
with an average of 15 hours per day.  Participants reported three main reasons for getting out of
their wheelchairs – (1) fatigue (3 participants), (2) functional need (5 participants) and (3)
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discomfort (1 participant).  When asked if they experienced discomfort in their wheelchairs, all 9
reported that they did experience some level of discomfort.  Five reported experiencing this
discomfort on a daily basis, 3 reported experiencing discomfort at least once per week and one
reported experiencing discomfort after only a few hours in the chair.  All 9 reported that they
routinely ignored discomfort to participate in functional activities.  The most common site of
discomfort was the low back (7 participants reporting this as an area of discomfort) and the
second most common site was the buttocks (6 participants).  Most participants reported limited
options for relief of discomfort.  Three reported getting out of their chairs to relieve discomfort, 4
reported use of pain medications, 6 reported asking someone to reposition them in their chair, 4
reported repositioning themselves in their chair to the best of their abilities and one reported
using the power tilt option to relieve discomfort. When asked about a history of skin breakdown
problems, 5 participants reported that they had experienced at least one episode of skin
breakdown since they began using wheelchairs full time.  Pertinent results are summarized in
Table 3-3.
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Table 3-3: Summary of Interview Results
Question posed: Response n Response n Response n
What is the reason for
getting out of the
chair?
Functional
need
5 Fatigue 3 Discomfort 1
How often do you
experience discomfort?
Every day 5 At least once
per week
3 After a few
hours
1
What methods do you
use to relieve
discomfort?
Get help to
reposition
6 Pain
medications or
reposition self
4 Get out of
the chair
3
Most common sites of
discomfort
Low back 7 Buttocks 6 Legs 5
Do you experience
discomfort?
Yes 9 No 0
Do you ignore
discomfort to function?
Yes 9 No 0
Do you have a history
of skin breakdown
Yes 5 No 4
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Weighted rank order (WRO) was computed for two parameters.  The WRO for each
parameter was calculated by multiplying the number of responses by the value of the response
(from 1 –10) and then adding all resultant values and finally assigning a rank.  The weighted
rank order of various wheelchair attributes is as follows:  comfort and mobility were tied as the
most important attribute of a wheelchair, the ability to adjust multiple features was second,
independent use of all features of the chair was third, the ability to perform self care tasks in the
chair was fourth, and safety was fifth.  For details on these ranks, see Table 3-4.  The next
ranking was performed on the necessity or importance of adjustability of various features of the
chair.  An adjustable control mechanism was ranked most important, adjustable leg rests was
ranked second, adjustable seat temperature (if possible) was ranked third, adjustable arm rests
was ranked fourth, adjustable head support was ranked fifth, adjustable lateral supports was
ranked sixth, and an adjustable seat belt was ranked seventh and last of the features listed.
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Table 3-4:  Weighted rank order of seating system attributes
Parameter being ranked: Weighted rank score Rank order location
Seating system attributes:
Comfort 83 Tied - 1
Mobility 83 Tied - 1
Ability to adjust multiple features 81 3
Independent use of all features 71 4
Ability to performs self care in chair 67 5
Safety 66 6
Ability for care-giver to adjust
multiple features
60 7
Importance of adjustability:
Control mechanism location* 66 1
Leg rests 62 2
Seat temperature 52 3
Arm rests 50 4
Head support* 43 5
Lateral supports* 17 6
Seat belt* 16 7
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3.1.4 Discussion
The findings of this pilot study were in agreement with past research in this area and supported
the need for the research put forth the remainder of this dissertation.  All of the participants in
this study indicated comfort was very important to them.  The participants also agreed
unanimously that discomfort is a significant problem for them, even if they felt that they were
able to ignore discomfort to function (which most stated). The analysis of the functional impact
of discomfort is more difficult.  When asked directly if discomfort limited their time in their
chairs or limited function, all replied in the negative.  However, when asked what they did to
relieve discomfort, 3 reported that they got out of the chairs they described “necessary for
function” to manage discomfort.  These findings reiterated the importance of research on a
dynamic seating intervention proposed as a potential method of mitigating discomfort.
3.2 PILOT STUDY 2
The second pilot study focused on the development and initial testing of a dynamic seating
system.  The goal of this study was to obtain some specific feedback from individuals in the
target population to guide further development of the dynamic seating system for use in future
research.
3.2.1 Participants
For this pilot study, a subgroup of 6 participants from Pilot Study I were enrolled.  The inclusion
criteria were: (a) having a diagnosis of MS, MD, ALS, or post polio syndrome, (b) being 18
years old or older, (c) having used a wheelchair or scooter for at least three months, (d) using a
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wheelchair or scooter as the means of primary locomotion (all day), (e) having some problems
related to discomfort and (f) having intact sensation on their buttocks and lower extremities.
Individuals were excluded if they had experienced a pressure ulcer within the last year. This
group included 4 participants with Muscular Dystrophy, one with ALS, and one with MS.  One
female and 5 male subjects participated.  One of these participants used a manual wheelchair, the
remainder used power wheelchairs as their primary means of mobility.
3.2.2 Equipment
The pilot test seat (PTS1) used for this pilot study consists of an Amobi truck seat mounted on a
Permobil Chairman power wheelchair base (see Figure 3-1).  The PTS1 had six inflatable air
bladders – four in the seat area and two in the back – that were controlled through a custom, push
button interface (see Figure 3-2).  This interface was constructed to allow access of the controls
to a variety of motor-impaired individuals.  This interface also contained the controls for the tilt
and recline systems of the chair.  The power leg motion and power seat lift were not controlled
by the individual in the chair, but the researcher was able to adjust them upon request.  The
pneumatic controls were operated by a series of solenoids and a pneumatic system designed and
custom built for use with this seat.  This was necessary to allow the PTS1 to integrate with a
wheelchair base.
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Figure 3-1:  PTS1 - test seat
The control interface provided the user direct control over all of the pneumatic bladders
in the seat and the back (with the exception of the lateral supports) and also the position of the
system in space through the use of power tilt and power recline.  This allowed participants to
compare these dynamic features and provide feedback on their relative effectiveness during this
short-duration sitting test.
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Figure 3-2:  Control interface for PTS1
3.2.3 Method
For Pilot Study II, a descriptive study was implemented using a participant-observer design,
followed by an interview.  All of the participants came to the School of Health and
Rehabilitation Sciences at the University of Pittsburgh to test the PTS1 dynamic seating system.
The participants signed videotape recording releases and were instructed in proper operation of
all features of the chair.  Participants were transferred into the PTS1 and the control interface
operation was demonstrated to them. All participants sat in the PTS1 for a minimum of 1 hour
and a maximum of 1 hour 15 minutes.  During this time, they were free to make the desired
adjustments to the position in space or the inflation levels of all components at any time.  They
all watched a generic videotape that was interrupted approximately every 15 minutes to allow
them to respond to a series of questions related to the PTS1 and their comfort levels.
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There were 11 structured questions used for this interview process, some only asked at
the beginning of the interview, and some asked repeatedly throughout the interview.  The entire
session was videotaped to record verbal responses as well as any associated body language or
facial expressions.
The questions asked at the beginning of the interview process were:
1) Please describe your current level of comfort in this seat:
2) Please describe the sensations you are feeling sitting in this seat:
3) Would you like to make any adjustments to the seat surface or the position
of the seat tilt or recline?
4) Would you like your legs re-positioned?
5) Please describe any adjustments you would like to make that are not
available on this seat:
6) Please describe the features of this seat that allow you to be most
comfortable:
7) Please describe any features that are not on this seat that you feel would
allow you to sit more comfortably:
8) Do you have any other comments you would like to share regarding this
seat or a future seat to be designed?
The questions asked repeatedly throughout the interview process were:
1) How important would it be to have lateral supports that could inflate to give more upper body
support?
2) If these lateral supports are important, should they inflate both sides at the same time or
separately?
3) When the back of the chair reclined there is some friction happening between you and the
chair back; is this uncomfortable to you?
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The questions above were posed to the individual after transfer into the PTS1 chair and at
approximately 15-minute intervals throughout the evaluation process.  In addition to the
questions above, follow up probing questions based on initial responses were asked that differed
from individual to individual.  Participants were also free to comment on issues not addressed by
these particular questions and to make suggestions or comments at any time during the
evaluation process. Most participants were questioned 4 – 5 times during the session.
3.2.4 Data analysis
After completion of the session, the verbal responses to the questions and all other dialogue were
transcribed into a written account and all transcriptions were then combined into a summary
document.  A cross-interview analysis of each question was performed to determine the presence
of consistent themes among the subjects’ responses and comments.
3.2.5 Results
Five of the participants were physically able to operate the interface independently, one
individual was not because of his impairments and the position of the control interface on the
wheelchair.  This individual directed the researcher in all adjustments to the seating system
desired.  Several response themes developed from this brief in-chair testing. These responses will
be used to guide development of the next test seat (PTS2).
The overall response to the PTS1 was quite positive.  In terms of overall comfort, the
majority of the participants felt that the PTS1 seating was very comfortable and 4 of the 6 felt it
was more comfortable than any wheelchair seat they had ever used.  Two participants found it
was as comfortable as their own wheelchair seat currently in use.  The initial comfort response
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and follow up comfort responses remained similar for all subjects.  Several subjects actually
reported improving levels of comfort after being in the PTS1 for a longer duration because of
their ability to “fine-tune” the adjustments and make the seat more comfortable as time
progressed.  Related to comfort, all 6 of the participants reported a sensation of increased back
support, which made the PTS1 more comfortable than their own chairs.  Several subjects
described the importance of adjustability.  All of the participants preferred having the ability to
adjust the amount of lumbar support and 2 participants found the ability to periodically change
this and other areas of support allowed them postural shifts that they would be otherwise unable
to perform.
Another important feature was independent ability to adjust the seat features.  The 5
participants who were able to independently alter the support characteristics found this to be
essential and all 6 reported that the chair user should be able to adjust all features of the chair
without assistance.  Results related to the importance of various features were mixed.  Two
participants reported the tilt and recline features were the most comfortable features of the chair
(neither of these participants had this feature on their current chair), the other 4 reported the
pneumatic seat and back components were more comfortable (all 4 of these participants had
some type of tilt or recline system on their current chair).  In terms of the dynamic nature of the
PTS1 seating, three of the participants reported their feelings that the dynamic elements of the
seat would be critical at attaining and maintaining a comfortable level of seating over a long
duration.  One of these participants indicated that having these dynamic features would allow
him to perform postural shifts that would prevent him from getting stiff and sore over time.
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The participants who tested the PTS1 found all of the dynamic elements helpful in
attaining optimal comfort, but reported several features they considered important for additional
comfort.  These features included:  adjustable head and neck supports, adjustable arm and trunk
lateral supports, and adjustable lower extremity supports.  These additional features are included
in the PTS2 to the extent possible based on this input.  Overall, participant response was very
positive and supported the assumptions concerning essential design criteria for optimizing
comfort in the wheelchair.
3.2.6 Discussion
The results of this pilot study indicated that the introduction of dynamic seating, at least in a
short duration test, enhanced the comfort of the participants sitting in the chair.  This information
was used to guide development of the PTS2 seating system, which included all user-controlled
adjustments suggested to the extent feasible with available technology.
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The results from these pilot studies confirmed that discomfort is a problem in this target
population of sensate wheelchair users.  Similar to populations of office workers, automobile
drivers, and aircraft pilots, this population has discomfort related to the duration of time spent
sitting in one position.  However, the study population is less able to relieve discomfort through
voluntary body movement.  As described in the Chapter 2 of this dissertation, several solutions
have been tried including the provision of seats shaped to provide maximal pressure distribution,
seats and backs at various angles and with various configurations, and seats that have movement
or dynamic capabilities.  The process of describing and quantifying discomfort has been the
subject of research in these related fields.  The success of quantifying comfort and discomfort in
the office and automotive seating industries lead to a firm belief that this should be possible
among wheelchair users as well.  The use of dynamic interventions – or seats that can be
adjusted under user control has also been documented and provides hope that dynamic seating
will also be effective in mitigating discomfort among wheelchair users.
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4.0 DEVELOPMENT OF THE WHEELCHAIR SEATING DISCOMFORT ASSESSMENT
TOOL (WCS-DAT)
4.1 BACKGROUND
Several researchers have identified the problem of wheelchair seating discomfort (Chesney et al.,
1995; Harms, 1990; Herzberg, 1993; Monette et al., 1999; Scherer, 1996b; Shaw, 1992; Weiss-
Lambrou, Tremblay, Lacoste, LeBlanc, & Dansereau, 1998).  In spite of this, the challenges
associated with researching discomfort in a population of wheelchair users have been addressed
by relatively few (Chesney et al., 1995; Harms, 1990; Herzberg, 1993; Monette et al., 1999;
Scherer, 1996b; Shaw, 1992; Weiss-Lambrou et al., 1998).  Even among these researchers, their
primary focus was not discomfort, but rather consumer satisfaction (Scherer, 1996b; Weiss-
Lambrou et al., 1998) or issues related to function or pressure relief (Chesney et al., 1995).
Wheelchair seating discomfort research is complicated by many difficulties, not the least
of which is the subjective nature of discomfort (Christiansen, 1997).  Another difficulty is
determining what to measure – discomfort or comfort (Shackel et al., 1969). Moreover,
researchers often disagree on the meaning and nature of comfort (Christiansen, 1997; Shen &
Vertiz, 1997).
Among the significant challenges in studying discomfort is the lack of validated tools
quantifying discomfort in the research literature.  The tools that have been published have been
largely developed based on input from unimpaired individuals (Christiansen, 1997; Corlett &
Bishop, 1976; Helander & Zhang, 1997; Shackel et al., 1969; Zhang et al., 1996).  Two of the
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more widely-used tools are the General Comfort Rating Scale (Shackel et al., 1969) and the
Chair Evaluation Checklist (Helander & Zhang, 1997).  Others include Barkla's chair assessment
tool for rating chairs for a specific purpose (1964), Corlett and Bishop's Body Part Discomfort
Scale (1976), and the Chair Feature Checklist used by Drury and Coury (1982) and Fenety et al
(2000).  All of the aforementioned tools relate to the evaluation of office chairs or other seats
used by unimpaired populations.  In the wheelchair seating research area there was one attempt
to create a comprehensive assessment of wheelchair seat comfort and discomfort (Monette et al.,
1999), but to date, there has been no psychometric testing performed on this assessment tool.
The lack of a published valid tool specifically designed to quantify wheelchair-seating
discomfort prompted this research effort.
4.1.1 Research Question
For this qualitative research task, the primary question was "can individuals with sensation, who
use wheelchairs full time (more than 8 hours per day), describe concepts of discomfort and
comfort in such a way that a comprehensive tool to quantify discomfort can be developed?”
4.2 METHODS
4.2.1 Participants
After approval by the University of Pittsburgh Institutional Review Board, 10 participants were
recruited.  Based on experience with qualitative research and the specificity of the topic involved
in this research, the investigators estimated it would take approximately 10 interviews to reach a
point of data saturation, a requirement for this type of research.  Advertisements were placed in
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newsletters for the local multiple sclerosis, muscular dystrophy, and amyotrophic lateral sclerosis
associations.  Participants 1-4 volunteered based on seeing these advertisements.  Therapists
knowledgeable regarding the project nominated the remaining six participants.  Participant
characteristics are described in Table 4-1.
Table 4-1:  Participant characteristics
Participant Age Gender *Diagnosis Vocation or avocation
1 22 male MD junior in college
2 45 male ALS retired firefighter (disability retirement)
3 66 male MS retired engineer
4 57 male MD volunteer community based activities
5 33 female MS
active in her home only – former university
student
6 20 male MD
full time student in vocational training
program
7 55 male MS retired university professor
8 60 female MS retired - disability
9 53 female polio therapy technician in rehab hospital
10 90 female polio retired – active in her community
* MD = muscular dystrophy, ALS = amyotrophic lateral sclerosis, MS = multiple sclerosis,
polio = poliomyelitis or post polio syndrome
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Participants were all full-time wheelchair users who had limited ability to shift their
weight or change their seated posture -- but had intact sensation.  With the exception of
Participant 5, all participants used electric-powered wheelchairs for their mobility.  See Table 4-
2 for additional information regarding the wheelchair use characteristics of the participants.
Table 4-2: Wheelchair use characteristics of Phase I participants
Participant Length of
wheelchair
use
Special wheelchair
features
Sitting
time
(hours/day)
Areas of
discomfort
1 10 years power standing 12 back, legs
2 7 years
power tilt, recline and
elevating legrests
8
buttocks, neck
back
3 >30 years
power recline and power
seat tilt
12 – 15
buttocks, back,
neck, legs
4 >10 years
specialty seat cushion,
no powered seating
12
buttocks, lower
body
5 5 – 10 years contoured seat cushion 8 – 14 back, arms
6 >10 years special seat cushion 15 buttocks, legs
7 15 years power tilt system 14 neck, buttocks
8 >5 years
power tilt and recline,
power elevating legrests
12
back, buttocks,
feet, legs
9 30 years special seat cushion >15
back, buttocks,
legs
10 >50 years
manual elevating
legrests
12 multiple areas
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4.2.2 Data Collection
Prior to undertaking any participant interviews the investigator practiced probing interviewing
techniques with an experienced qualitative researcher until consistency was achieved.  Upon
initial contact, the participants were asked to select the interview site where they would feel most
at ease during the interview process.  Seven participants were interviewed in their homes, two
were interviewed at a vocational training center and one (participant 10) was interviewed in the
hospital, prior to discharge.  After obtaining informed consent a study investigator proceeded
with each participant using a semi-structured ethnographic process.  Each interview consisted of
10 grand tour questions (listed below), followed by multiple probes emanating from each
participant's responses to each of the grand tour questions.  Interview questions were open-ended
to allow participants to develop and express fully their thoughts and ideas.  Grand tour questions
were printed in large print on brightly colored cards and as the interviewer moved from one
grand tour question to the next, a printed card was placed in front of participants to help them
maintain focus on the particular topic of interest.  The interviews ranged in length from 20 to 60
minutes with an average of 30 minutes per interview.  The grand tour questions used are as
follows:
1. When you are sitting in your wheelchair, what does the word discomfort mean to you?
2. When you are sitting in your wheelchair, what does the word comfort mean to you?
3. How are comfort and discomfort alike?
4. How are comfort and discomfort different?
5. What kinds of things cause you to be uncomfortable?
6. What kinds of things allow you to be more comfortable?
49
7. How are discomfort and pain alike or different?
8. How does using your wheelchair affect your levels of discomfort?
9. How does using your wheelchair affect your levels of comfort?
10. Is there any thing else you can tell me about your experiences with comfort and
discomfort that we have not covered?
4.2.3 Data Analysis
The interview tapes were transcribed into text files and prepared for importation into Nu-Dist
version 4 (N4) qualitative analysis software (Qualitative Solutions & Research, Pty. Ltd. 1991-
1997).  The questions and responses were divided into short text units, with each text unit
containing no more than one thought or idea.  These transcripts were then imported into N4 for
the purpose of analysis.  See Figure 4-1 for graphical representation of analysis procedures used.
Coding of the transcript materials was done immediately following each interview to reduce the
potential for data loss and to determine when data saturation was being reached.  Coding
consisted of analyzing each text unit and assigning it to appropriate general topic area(s) or
classification(s) based on its content (Bailey, 1991; Patton, 1990).  In this way, all text units are
categorized and linked with other text units that have similar meanings or topics.  Data saturation
was predetermined to be the point when new interview transcripts were fully coded with existing
codes and new codes no longer needed to be created.  As anticipated, this point was reached at
interviews 9 and 10, which were coded simultaneously due to the timing of the interviews.
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Figure 4-1:  Phase I data analysis procedures
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A preliminary coding structure was built into the N4 project database that included 11
basic categories.  One category contained basic demographic information and the other 10
categories each contained one of the topics covered in the grand tour questions.  This gave the
coding a preliminary structure and is considered a form of "top-down" coding.  The remainder of
the coding structure was built using a "bottom-up" coding methodology (Bailey, 1991; Patton,
1990), meaning codes were developed from the actual text of the interview data.  After all
documents were coded the coding tree was built within the N4 software.  Cross-classifying
matrices were constructed around each major topic area to assess commonalities across
participants.  Ideas or descriptors used by greater numbers of participants were considered more
essential to the discomfort assessment process.  In addition to the cross-classifying matrices, data
were triangulated with two different research sources.  One data source was a study that
examined discomfort among office workers (Zhang et al., 1996) and the other was a similar
study done with a population of wheelchair users (Monette et al., 1999).  Data from this study
matched closely with results from both of these previous studies.
From these data and methods, the content of the Wheelchair Seating Discomfort
Assessment Tool (WcS-DAT) was determined and the tool was constructed.  The tool was
distributed to all research participants for a member-checking process.  The investigator
conducted a follow-up interview with each participant to confirm the accurate interpretation of
their input and the relevance of the tool that was created.
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4.3 RESULTS
Overall, 103 unique codes were established to represent the information provided by the
participants.  These were divided into 12 major categories or themes.  Ten of these categories
were directly related to the 10 grand tour questions.  One was a compilation of themes or ideas
that spanned more than one grand tour question.  The final category was an expansion of the
grand tour question related to wheelchair use.  Major categories that emerged from the nodes
included: (1) the meaning of comfort, (2) the meaning of discomfort, (3) body areas most
affected by discomfort, (4) the impact of using a wheelchair on comfort and discomfort, (5) the
similarities or differences of comfort and discomfort, (6) the similarities of discomfort and pain
experiences, and (7) the causes or contributors of comfort and discomfort.
The three categories considered to be most essential in quantifying discomfort included:
(1) the meaning of comfort, (2) the meaning of discomfort, and (3) the body areas most affected
by discomfort.  Therefore, information and descriptors in these three categories were primarily
used in construction of the WcS-DAT.  The participants used 16 unique descriptors of
discomfort (see Table 4-3 for examples) and 13 unique descriptors of comfort (see Table 4-4 for
examples).  Ten body areas were described as being particularly problematic when discomfort
occurred.
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Table 4-3:  Examples of discomfort descriptors used by participants
Discomfort descriptor used: Number of participants
Number of
text units
having aches and pains 10 32
feeling like I need to move 8 30
having pressure points 4 9
feeling poorly positioned 3 19
feeling like I am unable to concentrate 3 7
embarrassment 2 18
discomfort is frustration induced 2 13
discomfort is induced by physical stress 2 4
feeling stiffness 1 11
feeling like I am unstable 1 10
irritability 1 6
just feeling not comfortable 1 6
psychological discomfort 1 1
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Table 4-4: Examples of comfort descriptors used by participants
Comfort descriptor used Number of participants
Number of
text units
comfort means the absence of discomfort 5 28
feeling like I am in a good position 4 20
comfort is made up of multiple factors 4 10
comfort means having no pain 4 8
feeling like I am able to concentrate 3 13
feeling good 2 2
not thinking about discomfort 1 6
I can stay in the chair longer 1 4
I feel like I am able to relax 1 3
feeling of relief 1 3
having a good or supportive social
environment
1 3
feeling like I can enjoy sitting in chair 1 2
feeling a positive attitude 1 2
The comfort and discomfort descriptors were analyzed to identify commonalities.  In this
analysis, 8 of the discomfort descriptors and 6 of the comfort descriptors were discussed by at
least two of the participants.  In the analysis of the body areas involved in discomfort, back and
lower-body discomfort were noted by several of the participants, with buttocks being the most
frequently identified region for discomfort.
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When similar concepts were combined into more global categories, the two strongest
themes that emerged were the importance of being able to shift or repositioning one's body to
reduce levels of discomfort and the physical symptoms of discomfort.  In addition, the critical
role of support and positioning provided by a wheelchair was discussed by 9 of the 10
participants.  During the follow up interviews with participants (the member-checking process)
some of the statements used in the tool required minor wording changes for clarification.  After
clarification, all participants felt the WcS-DAT content to be appropriate and relevant.  No major
content changes were recommended by the participants.
The WcS-DAT was developed directly from the information generated in the participant
interviews, which was then compared with related research tools and research findings.  The
result is a three-part tool.  Part I of the tool is used to collect information about factors that
directly affect discomfort such as the amount of time spent in one position in the wheelchair and
whether the individual in the chair was transferred and positioned properly initially.  Part II
contains 8 statements related to discomfort and 5 statements related to comfort that are rated on a
7-point Likert scale.  These statements are all prefaced with “While seated in my wheelchair …”
and are as follows:
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Discomfort statements used:
1. I feel poorly positioned
2. I feel like I have been in one position for too long
3. I feel like I need to move or shift my position
4. I feel aches, stiffness, or soreness
5. I feel pressure in some part or parts of my body
6. I feel too hot or cold or damp
7. I seek distraction to relieve discomfort
8. I feel uncomfortable
Comfort statements used:
1. I feel no pain
2. I feel stable (not sliding or falling)
3. I feel comfortable
4. I feel good
5. I feel able to concentrate on my work or activities
Part III includes 7 body areas (back, neck, buttocks, legs, arms, feet, and hands) that are
rated for the degree of discomfort intensity on a 0 to 10 scale.  Space is also provided for the
addition of body areas that are not listed.  The WCS-DAT concludes with a general discomfort
intensity rating on the same 0 to 10 scale.
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4.4 DISCUSSION
The prevalence of wheelchair related discomfort has been well established in several studies
(Bardsley, 1984; Crane & Hobson, 2002; DiGiovine et al., 2000; Harms, 1990; Monette et al.,
1999; Redford, 1993; Shaw, 1992; Shaw & Taylor, 1991; Weiss-Lambrou et al., 1999).
Discomfort negatively impacts consumer satisfaction for wheelchair users (Weiss-Lambrou et
al., 1999) and overall usability of wheelchairs and seating systems.
The newly developed WcS-DAT is a valid tool for quantifying wheelchair seat
discomfort in sensate long-term wheelchair users.  The three parts of this tool combine critical
aspects of the experience of discomfort as expressed by sensate wheelchair users who sit for 8
hours or more per day.  Although several formats for such a tool were suggested in the literature
– particularly in the field of ergonomics, this type of tool has not been described in the
wheelchair-seating research literature.  Quantifying discomfort is essential to the measurement of
wheelchair seating outcomes (Weiss-Lambrou et al., 1999).
It is anticipated that the WcS-DAT will have multiple applications.  This tool may be
useful in clinical settings to evaluate the discomfort-related outcomes of seating interventions.  In
addition, the WcS-DAT is useful in quantifying discomfort in wheelchair seating research.  Data
from the WcS-DAT may also be used to guide the design and development of new products to
mitigate seat discomfort related to long-duration sitting in a wheelchair.
The validity of the WcS-DAT has been established in this preliminary study, but the
sensitivity of this tool to change over time or in detecting discomfort differences among various
seating interventions remains unknown.  Also, this tool has been developed with a specific
population of wheelchair users – namely those with intact sensation and severe difficulty
moving.  The applicability of this tool to other wheelchair users is unknown at this time.
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Future research is needed to determine the sensitivity of this tool in measuring changes in
discomfort levels – either due to time factors or due to seating changes.  Research is also needed
to determine the applicability of this tool to wheelchair users with diagnoses not included in this
study or who have different motor and sensory abilities than those described in this study.
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5.0 RELIABILITY AND CONCURRENT VALIDITY OF THE WCS-DAT
5.1 BACKGROUND
People who use wheelchairs, particularly those who sit for more than 8 hours per day, often
experience discomfort (Scherer, 1996b; Shaw & Taylor, 1991; Weiss-Lambrou et al., 1999).
Discomfort leads to negative consumer satisfaction (Weiss-Lambrou et al., 1999), decreased
quality of life (Herzberg, 1993), problems related to propulsion ergonomics (DiGiovine et al.,
2000), adoption of poor postures to relieve discomfort (Engstrom, 2002) and may impair
everyday function and the ability to remain in the wheelchair (Kotajarvi, Basford, & An, 2002).
Yet, few researchers have investigated the nature and causes of wheelchair seat discomfort, or
possible solutions to this problem (Monette et al., 1999; Shaw, 1992).  One of the basic problems
with investigating discomfort is that there is no proven way to reliably quantify wheelchair
seating discomfort.  While there are many validated assessment tools in existence to measure the
similar construct of pain (Keele, 1983; Melzack, 1975; Rudy, Turk, & Brody, 1992; Rybstein-
Blinchik, 1983; Sworkin & Whitney, 1992; Turk & Melzack, 1992, Jensen, 1992), the
development of a tool to quantify discomfort has not had the same attention.
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Discomfort in office chairs and vehicle seats has been studied extensively.  Several tools
have been developed in these fields related to seat discomfort (Corlett & Bishop, 1976; Helander
& Zhang, 1997; Pywell, 1993; Shackel et al., 1969; Zhang et al., 1996).  These tools have been
used extensively to investigate the discomfort associated with long duration sitting by
unimpaired office workers (Fenety et al., 2000; Helander & Zhang, 1997) or for assessing
specific ergonomic seat designs and comparing products (Barkla, 1964; Le Carpentier, 1969).
Few investigators have attempted to measure seating discomfort among wheelchair users
(Monette et al., 1999; Shaw, 1992; Weiss-Lambrou et al., 1999).  These researchers have either
used an assessment tool developed for a different population, usually an unimpaired population,
or have developed their own tools but not conducted extensive psychometric testing of these
tools relating to reliability or validity (DiGiovine et al., 2000; Monette et al., 1999; Shaw, 1993;
Shaw, 1992).
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The Wheelchair Seating Discomfort Assessment Tool (WcS-DAT) was developed using
long-term wheelchair users feedback about seating related discomfort (Crane,  Holm, & Hobson,
2003).  The WcS-DAT consists of three sections or parts.  Part I collects general information
about factors that directly affect discomfort in one's wheelchair such as the amount of time spent
in one position in the chair and whether the individual in the chair was transferred and positioned
properly initially.  Part II contains eight statements related to discomfort and five statements
related to comfort that are rated on a 7-point Likert scale.  Part III includes seven body areas
(back, neck, buttocks, legs, arms, feet, and hands) that are rated for a degree of discomfort
intensity on a 0 to 10 scale.  Space is also included for the user to list additional body areas, and
for a general discomfort intensity rating on the same 0 to 10 scale.  These three parts produce
two measures of discomfort – the 13 items in part II make up the General Discomfort
Assessment score (GDA) and the items in part III make up the Discomfort Intensity Score (DIS).
5.1.1 Hypotheses
The purpose of this study was to determine the test-retest reliability, internal consistency, and
concurrent validity of the WcS-DAT (Crane et al., 2003).  Our hypothesis was that the WcS-
DAT will allow persons who use wheelchairs and have intact sensation in their buttocks and
lower extremities to quantify reliably their levels of discomfort after a minimum of 2-hours
sitting in and using their wheelchairs.
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5.2 METHODS
5.2.1 Participants
Thirty full time wheelchair users were recruited from the greater Pittsburgh and Johnstown,
Pennsylvania regions for participation in the study.  All participants used their wheelchairs for a
minimum of 8 hours per day, had difficulty shifting their own posture due to motor weakness,
and had intact sensation in their buttocks and lower extremities.  Sensation was verified by
testing with Semmes Weinstein monofilament #6.65 (279.4 grams of force).  Diagnostic groups
included in this study were multiple sclerosis (n=12), amyotrophic lateral sclerosis (n=4), post-
polio syndrome (n=4), and muscular dystrophy (n=10).  Although exact distribution of each
diagnosis in the population of wheelchair users is unknown, an attempt was made to recruit
individuals in each group according to their relative proportions in the population as a whole
(e.g. multiple sclerosis has the highest prevalence in the population and it was the largest group
recruited for this study).
5.2.2 Method
The research protocol was approved by the University of Pittsburgh Institutional Review Board
prior to any research being conducted.  Each participant was visited in his or her home for the
purposes of obtaining informed consent, completing a screening sensory test procedure, and
explaining the research procedures.  At the time of the visit, each participant was given a packet
of information including written directions, four questionnaire sets, four inner envelopes, and
one larger return mailing envelope.  Each participant completed one questionnaire set with the
researcher on site (if they met the requirement of a minimum of 2 hours sitting in their
wheelchair at the time of the visit) or at a later time as needed.  Each participant then completed
63
the three remaining duplicate questionnaire sets over a period of one week. The questionnaire
sets were completed in pairs – each pair was completed approximately one hour apart on the
same day and the two pairs were completed one week apart.  The one hour interval was felt to be
short enough that participants' discomfort levels would not have changed substantially, but long
enough to minimize any carryover effect from one set to the next.  This type of interval has been
used in reliability validation of pain measurement scales (Ferraz et al., 1990).  Participants were
followed up with reminder calls the day prior to scheduled completion of the second pair of
questionnaires and were given the option of having a researcher assist them with completion of
these questionnaires via telephone.
5.2.3 Questionnaire Content
Each questionnaire set contained the following:  the three page WcS-DAT; a one page "average
day" rating form; the two page Chair Evaluation Checklist (CEC) (Helander & Zhang, 1997);
and the one page Short Form of the McGill Pain Questionnaire (SF-MPQ) (Melzack, 1987).
Within each questionnaire set, there were 89 individual items to be completed and the average
time to complete all items was 20 minutes.  All questionnaires were presented in the same order
for each assessment.
5.2.4 Analysis
The data were coded and entered into a data file for SPSS version 11 (SPSS for Windows,
release 11.0.1, © SPSS Inc., 1989-2001).  Test-retest reliability was performed using the ICC
(2,k) form.  The Intra Class Correlation Coefficient was selected to assess the consistency and
average agreement between the two data sets (tests and retests).  This scale reflects both the
degree of correspondence and the agreement among the ratings and is therefore preferable to
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using two separate measures of correlation, such as a Pearson Product correlation and a t-test.
(Portney & Watkins, 2000).  ICC values range from 0.00 to 1.00 and values over 0.75 indicate
good reliability.  Values above 0.90 are often preferred (Portney & Watkins, 2000), but due to
the variable nature of the construct being measured in this case (discomfort), an ICC of 0.80 or
higher was selected a priori to be evidence of good reliability for the WcS-DAT (Dworkin &
Whitney, 1992; Portney & Watkins, 2000).
Cronbach's Alpha (a) was used to measure the internal consistency of the items within
each of these scales.  Internal consistency reflects the correlation among all items in a particular
measurement instrument.  Although the possible range of values is 0.00 to 1.00, the preferred
range is 0.70 to 0.90 which suggests internal consistency without redundancy (Dworkin &
Whitney, 1992; Portney & Watkins, 2000).
Correlations between the two parts of the WcS-DAT, the WcS-DAT and Chair
Evaluation Checklist (CEC), and the WcS-DAT and the Short Form McGill Pain Questionnaire
(SF-MPQ) were also analyzed using the Pearson product-moment correlation.  By correlating the
results of the WcS-DAT to the established CEC and SF-MPQ ratings it is possible to establish
concurrent validity of the WcS-DAT, even though the latter is designed for a slightly different
intent.  The WcS-DAT is a measure of wheelchair seating discomfort that should correlate with
both the SF-MPQ and the discomfort assessment portion of the CEC – also a measure of seat
discomfort, but used in unimpaired populations.
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5.3 RESULTS
One of the participants (diagnosis of ALS) recruited for this research became unavailable, due to
an illness, prior to beginning data collection.  In total, 29 participants entered this research study
and 28 completed all four questionnaire sets, one individual was lost to follow up (diagnosis of
MD) after completing only the first of the four questionnaire sets.
Each of the discomfort scales of the WcS-DAT were analyzed during this process.  The
General Discomfort Score (GDS) is based on 13 items all related to feelings of comfort or
discomfort while sitting in a wheelchair.  Each item is scored on a 7-point Likert scale and then
all 13 scores are summed to obtain the GDS.  The Discomfort Intensity Score (DIS) is the sum of
9 scores – eight individual body areas and one overall or general discomfort intensity score.
Reliability of the chair evaluation checklist (CEC) and the Short Form of the McGill Pain
Questionnaire (SF-MPQ) were also calculated.
ICC (2,k) scores were calculated to determine the reliability of the instruments in multiple
combinations of test pairs.  These included the one-hour intervals (tests 1+2 and tests 3+4) as
well as the one-week intervals (tests 1+3 and tests 2+4).  In addition, for the GDS and DIS
scores, tests one and three were combined into a large group of "pre-tests" and tests two and four
were combined into "post-tests" and the pretest-posttest ICC was calculated.  ICC scores ranged
from a low of 0.83 to a high of 0.97.  All scores for the DIS and GDS met the established criteria
of greater than 0.80, indicating acceptable levels of reliability.  See Table 5-1 for specific ICC
scores from these analyses.
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Table 5-1:  Test-retest reliability scores from WcS-DAT, CEC, and SF-MPQ
Test name aTest # bRetest # n ICC(2,k) score
GDS scale of WcS-DAT 1 2 17 0.92c
GDS scale of WcS-DAT 3 4 24 0.83c
GDS scale of WcS-DAT 1 and 3
(all tests)
2 and 4
(all re-tests)
41 0.86c
GDS scale of WcS-DAT 1 3 20 0.89d
GDS scale of WcS-DAT 2 4 20 0.87d
DIS scale of WcS-DAT 1 2 23 0.97c
DIS scale of WcS-DAT 3 4 25 0.95c
DIS scale of WcS-DAT 1 3 24 0.97d
DIS scale of WcS-DAT 2 4 22 0.95d
CEC, Part 1 (items 1 - 7) 1 2 26 0.90c
CEC, Part 1 (items 1 - 7) 3 4 26 0.93c
CEC, Part 2 (items 8 – 14) 1 2 27 0.91c
CEC, Part 2 (items 8 – 14) 3 4 27 0.88c
SF-MPQ, Items 1-15 1 2 26 0.95c
SF-MPG, Items 1-15 3 4 22 0.95c
a #1 = first administration, week 1; #2 = second administration, week 1
b #3 = first administration, week 2; #4 = second administration, week 2
c One-hour  intervals
d One-week intervals
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Internal consistency was assessed using Cronbach's alpha.  These analyses were only
used for the two parts of the WcS-DAT to determine if there were redundant items that needed to
be removed from the tool.  Cronbach's alpha (a) scores for the GDS portion of the WcS-DAT
ranged from 0.89 to 0.92.  DIS alpha scores ranged from 0.82 to 0.91.  These scores show good
internal consistency of the items involved without indicating redundancy within the measures.
See Table 5-2 for specific results of the internal consistency testing.
Table 5-2:  Internal consistency of items in the WcS-DAT
Scale aTest # n Standardized Item Alpha (a)
GDS scale of WcS-DAT 1 21 0.91
GDS scale of WcS-DAT 2 23 0.92
GDS scale of WcS-DAT 3 27 0.89
GDS scale of WcS-DAT 4 24 0.89
DIS scale of WcS-DAT 1 25 0.82
DIS scale of WcS-DAT 2 24 0.86
DIS scale of WcS-DAT 3 27 0.91
DIS scale of WcS-DAT 4 25 0.91
a #1 = first administration, week 1; #2 = second administration, week 1
   #3 = first administration, week 2; #4 = second administration, week 2
Pearson product-moment correlations were used to evaluate the relationships between the
new measures of seating discomfort (the GDS and the DIS) and existing similar measures –
including the Chair Evaluation Checklist (CEC) and the Short Form of the McGill Pain
Questionnaire (SF-MPQ).  The CEC is divided into two parts – the first 7 items measure
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discomfort and the last 7 items measure comfort.  The SF-MPQ is divided into three scores – the
sum of the 15 pain-related questions, the pain visual analog scale (VAS) and the present pain
intensity score (PPI).  The final three of the 15 questions on the SF-MPQ relate specifically to
the affective component of pain, therefore items 1 – 15 and 1 – 12 were analyzed separately
Each of these scores was analyzed for correlation with each of the two parts of the WcS-
DAT.  The two parts of the WcS-DAT (GDS and DIS) were also evaluated for their correlation
with each other, as they measure two aspects of seat discomfort.  These analyses were completed
for each of the four administrations of the questionnaire sets.  Correlation coefficients ranged
from a low of -0.024 correlation between the comfort score of the CEC and the GDS score of the
WcS-DAT, to a high of 0.932 correlation between the visual analogue portion of the SF-MPQ
and the DIS scale of the WcS-DAT.  Out of 52 separate correlations assessed, 45 of them were
significant at the 0.001 level, six were significant at the 0.01 level and one was significant at the
0.05 level.  These measures indicate good concurrent validity of the new measure with these
already established measures.  Details of the correlations are presented in Table 5-3.
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Table 5-3:  Correlations between discomfort measurement tools
Discomfort measurement
tool/scale
Test # n Correlation with
GDS scale
Correlation with
DIS scale
DIS 1 19 0.719 a --
DIS 2 20 0.593 b --
DIS 3 26 0.794 a --
DIS 4 22 0.817 a --
CEC, Items 1 – 7 (discomfort) 1 21 0.716 a 0.795 a
CEC, Items 1 – 7 (discomfort) 2 22 0.783 a 0.818 a
CEC, Items 1 – 7 (discomfort) 3 27 0.820 a 0.907 a
CEC, Items 1 – 7 (discomfort) 4 23 0.794 a 0.917 a
CEC, Items 8 – 14 (comfort) 1 21 -0.531 b -0.551 b
CEC, Items 8 – 14 (comfort) 2 23 -0.024 c -0.529 b
CEC, Items 8 – 14 (comfort) 3 27 -0.680 a -0.709 a
CEC, Items 8 – 14 (comfort) 4 24 -0.582 b -0.593 b
SF-MPQ (Q1-15) 1 21 0.742 a 0.849 a
SF-MPQ (Q1-15) 2 23 0.770 a 0.867 a
SF-MPQ (Q1-15) 3 24 0.826 a 0.853 a
SF-MPQ (Q1-15) 4 22 0.714 a 0.763 a
SF-MPQ (Q1-12) 1 21 0.770 a 0.856 a
SF-MPQ (Q1-12) 2 23 0.797 a 0.865 a
SF-MPQ (Q1-12) 3 25 0.846 a 0.863 a
SF-MPQ (Q1-12) 4 22 0.718 a 0.774 a
SF-MPQ VAS 1 20 0.720 a 0.897 a
SF-MPQ VAS 2 18 0.852 a 0.845 a
SF-MPQ VAS 3 23 0.849 a 0.914 a
SF-MPQ VAS 4 18 0.832 a 0.932 a
SF-MPQ PPI 1 20 0.705 a 0.752 a
SF-MPQ PPI 2 22 0.767 a 0.703 a
SF-MPQ PPI 3 24 0.786 a 0.847 a
SF-MPQ PPI 4 21 0.710 a 0.800 a
ap < .001
bp < .01
cp < .05
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5.4 DISCUSSION
Measurement of a construct such as discomfort, which can change rapidly, is challenging.  Yet,
the data show that the WcS-DAT is a highly stable and reliable measure of seating discomfort for
individuals who have sensation and are long-duration wheelchair users (i.e. those who sit for
more than 8 hours per day).  Both the reliability of the WcS-DAT as a whole and the internal
consistency of the individual items contained within it met or exceeded the predetermined targets
for indicating reliable and consistent performance.  Due to these positive results, no changes in
the content of the WcS-DAT were necessary.  The WcS-DAT was shown to allow sensate long
duration wheelchair users to reliably quantify their levels of sitting discomfort.
Our data also established the concurrent validity of the WcS-DAT without duplicating the
criterion tools.  The high correlations found with previously established measures, such as the
Chair Evaluation Checklist (CEC) and the Short Form of the McGill Pain Questionnaire (SF-
MPQ) indicated good concurrent validity of the WcS-DAT.  These relationships confirm that the
WcS-DAT measures what it was designed to measure – wheelchair seat discomfort.  Moreover,
the correlations were not so high as to indicate that the WcS-DAT duplicated the CEC or SF-
MPQ, or so low that as to suggest that the CEC or SF-MPQ may have more adequately
quantified wheelchair seat discomfort.  Similarly, the correlations between the two major parts of
the WcS-DAT, the GDS and the DIS, confirmed measurement of associated constructs without
redundancy.
The goal of keeping the WcS-DAT short enough to make it realistic for use in research
and in clinical practice, while still developing a stable and reliable tool, was also met.  The WcS-
DAT is a three-part tool with approximately 31 total items, most of which require a yes/no
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response or a numeric response.  Participants reported completing the WcS-DAT in 5 minutes
once they became familiar with the format.  This tool was self-administered with the exception
of the first administration and participants reported little difficulty understanding or responding
to any of the items.  Some formatting modifications were suggested to prevent some of the more
common errors in recording results.  Even participants without the ability to manually record the
responses themselves had little difficulty communicating the results to an assistant.  This was
true even when an alternative communication device was used.  Ease of administration is
requisite for a tool to be useful in a clinical setting in which many different levels of
communication are common.
Our findings must also be considered with the limitations of the study in mind.  First, the
participants were not randomly selected.  Participants volunteered for the study after seeing
advertisements or hearing of the study from a third party.  However, there is no evidence that this
sample is not representative of sensate, long-duration wheelchair users.  Second, when
completing duplicate assessments within a one-hour interval, the potential for carry over effects
exists. This could not be avoided, as the interval between assessments needed to be short enough
so that a significant change in discomfort itself would not have occurred.  This risk of carryover
was minimized by the complexity of the entire questionnaire packet (i.e. the presence of multiple
tools) and the intervening activities of the participants.  Also, judging from the similarity of the
one-hour interval result and the one-week interval results, there is no indication that carryover
effects were a detriment to the reliability of the study.  Thirdly, the inclusion of only sensate
wheelchair users with severe motor impairment limits the generalizability of these results to
other groups of wheelchair users.  Reliability testing with wheelchair users with different
characteristics may yield different results than those presented in this study.
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Future research with the WcS-DAT will include an examination of the sensitivity of the
tool and an analysis of its reliability and validity among wheelchair users with different
impairments or levels of sensory and motor abilities than those in the current study.  The WcS-
DAT should also be examined for measuring discomfort in situations where change in
discomfort levels is expected – either due to the passage of time, or to the introduction of
different seating surfaces or components.
In summary, the evidence supports the use of the WcS-DAT as a robust measurement
tool for assessing seating discomfort in future research.  This tool may also be valuable as a
clinical outcome measures for assessing discomfort following provision of seating interventions
with the goal of reducing or eliminating discomfort.
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6.0 EFFICACY OF THE WCS-DAT IN SINGLE SUBJECT RESEARCH OF WHEELCHAIR
SEAT DISCOMFORT
6.1 INTRODUCTION
The purpose of this study was to examine the effectiveness of the Wheelchair Seating
Discomfort Assessment Tool (WcS-DAT) for quantifying discomfort over time by eliciting the
comfort-discomfort continuum using alternative seating equipment.  In addition, a test
wheelchair introducing new user-adjustable seating was tested for its effectiveness at relieving
discomfort for the participants.  New techniques for studying wheelchair-seating discomfort were
examined to guide future research in this important aspect of wheelchair seating outcomes.
People who use wheelchairs, particularly those who sit for more than 8 hours per day,
often experience discomfort (Scherer, 1996b; Shaw & Taylor, 1991; Weiss-Lambrou et al.,
1999).  Discomfort leads to negative consumer satisfaction (Weiss-Lambrou et al., 1999),
decreased quality of life (Herzberg, 1993), problems related to wheelchair propulsion
ergonomics (DiGiovine et al., 2000), and adoption of poor sitting postures to relieve discomfort
(Engstrom, 2002) -- all of which may impair everyday function and the ability to remain seated
in a wheelchair (Crane & Hobson, 2002).  Yet few researchers have investigated the nature and
causes of wheelchair seat discomfort, or possible solutions to this problem (Monette et al., 1999;
Shaw, 1992).
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The Wheelchair Seating Discomfort Assessment Tool (WcS-DAT) was developed using
long-term wheelchair users’ feedback about wheelchair-seating-related discomfort (Brosh &
Arcan, 2000).  There are two discomfort-related scores associated with the WcS-DAT. The
General Discomfort Assessment (GDA) – contains eight statements related to discomfort and
five statements related to comfort that are rated on a 7-point Likert scale.  The responses are
coded on a scale of 1 – 7, with 1 indicating maximum comfort and 7 indicating maximum
discomfort, and then all individual item scores are summed to form the GDA score.  The
Discomfort Intensity Score (DIS) - combines seven specified body areas (back, neck, buttocks,
legs, arms, feet, and hands), which are rated for degree of discomfort intensity on a 0 to 10 scale
(0 = no discomfort, 10 = maximum discomfort), with one optional body area that the rater may
identify, as well as a general discomfort intensity rated on the same 0 to 10 scale.  During the
coding process, each score is increased by one, to eliminate zero scores for data analysis,
resulting in a final score range of 1 to 11.  As with the GDA score, these 9 item scores are
summed to arrive at a DIS score.
The reliability and validity of the WcS-DAT have been established (Crane,  Holm, &
Hobson, 2003), but its effectiveness in showing changes in levels of discomfort over time or with
the introduction of novel wheelchair seating has not been established.  To be an effective
outcome measure of wheelchair seating discomfort, this tool must be capable of reflecting
changes in actual discomfort levels of wheelchair users, as would be expected with increased
sitting duration and with changes in wheelchair seating equipment.   Moreover, consistent
methodology for examining discomfort among long duration wheelchair users has not been
established and this study examined the effectiveness of a single subject research design as a
methodology to evaluate this serious and prevalent problem.
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6.2 METHODS
6.2.1 Participants
A convenience sample of six wheelchair users was initially recruited from the greater Pittsburgh
area.  The participants all reported using powered wheelchairs for a minimum duration of 8 hours
per day.  All had severe motor impairment and intact sensation on their buttocks and lower
extremities and experienced discomfort associated with sitting in their wheelchairs.  None of the
participants had experienced skin breakdown on their seating surfaces (buttocks or posterior
thighs) within the year prior to enrollment.  Of the original six recruited participants, only four
completed the full trial.  One individual withdrew following 2-weeks of testing and another
withdrew prior to commencing testing.  One of these six participants completed two trials – one
with each test wheelchair design; he will be designated as participants “1” and “1a.” to reflect the
results of both of these separate trials.  Due to the loss of two participants, one additional
participant was recruited for the study for a total of seven participants recruited and six complete
trials.  See Table 6-1 for participant descriptions and study design used.
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Table 6-1:  Participant diagnosis and study design assignment
Participant Diagnosis Gender Study Design Result
1 MD Male A1 C1 A2 Partial TestChair1 trial
1a MD Male A1 C2 B2 A2 Complete TestChair2 trial
2 MS Male A1 B1 B2 C2 A2
Partial TestChair1 trial and
complete TestChair2 trial
3 MS Male A1 C2 B2 A2 Complete TestChair2 trial
4 MS Male A1 B2 C2 A2 Complete TestChair2 trial
5 ALS Female A1 C2 B2 A2 Complete TestChair2 trial
6 MS Male A1 B2 C2 A2 Withdrew following 2 weeks
7 MD Male A1 C2 B2 A2 Withdrew prior to testing
MD = Muscular dystrophy
MS = Multiple sclerosis
ALS = Amyotrophic lateral sclerosis
6.2.2 Design
A single subject, multiple baseline, alternating treatment design was used to conduct the testing
of the WcS-DAT and the user adjustable test wheelchair.  The study was conducted to assess
changes in sitting discomfort levels across several alternating phases consisting of different
baseline or intervention conditions (see Table 6-2 for summary):
1. Phase A1: (Baseline, Condition 1) Participant seated in his or her own wheelchair
using his or her seating system.
2. Phase B1: (Intervention, Condition 2) Participant seated in the first design of the
test wheelchair (TestChair1) with features consisting of powered seat tilt,
powered back recline, and powered elevating leg rests (FeatureSet1).
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3. Phase C1: (Intervention, Condition 3) Participant seated TestChair1 with features
consisting of powered seat tilt, powered back recline, powered elevating leg rests
and powered pneumatic air bladders embedded in contoured foam seat (4
bladders) and back (3 bladders) supports (FeatureSet2).
4. Phase B2: (Intervention, Condition 4) Participant seated in the second design of
the test wheelchair (TestChair2) with FeatureSet1.  TestChair2 differed from
TestChair1 in that the seat cushion was no longer made primarily of foam, but
was replaced with a 4 inch thick, air filled cushion.
5. Phase C2: (Intervention, Condition 5) Participant seated in the TestChair2 with
FeatureSet2 – 3 pneumatic bladders embedded in the foam back cushion and the
ability to control the inflation levels of each of the four quadrants of the air filled
seat cushion.
6. Phase A2 (Return to baseline, Condition 6) Participant seated in his or her own
wheelchair using his or her seating system.
Participants were randomly assigned to one of two alternating designs – ABCA or ACBA
to control for possible order effects of the intervention conditions (phases B1, B2, C1, and C2)
involving the different test chair features.
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Table 6-2:  Conditions involved in this research
Condition Condition
number
Wheelchair Feature set Phase
Designation
Baseline 1 Participant’s
own
NA A1
Intervention 2 TestChair1 FeatureSet1 B1
Intervention 3 TestChair1 FeatureSet2 C1
Intervention 4 TestChair2 FeatureSet1 B2
Intervention 5 TestChair2 FeatureSet2 C2
Return to
baseline
6 Participant’s
own
NA A2
6.2.3 Baseline Measures
Three baseline measures were used to assess wheelchair-seating discomfort.  These were: (1)
time in chair (TIC) or total sitting time per day; (2) the GDA score of the WcS-DAT for each 4-
hour sitting period; and (3) the DIS score of the WcS-DAT for each 4-hour sitting period.  For
each condition, seven days of data collection with the three baseline measures yielded a
maximum of 28 days of testing per trial (with the exception of participant 2, who completed
more than 28 total days).
6.2.3.1 Time in Chair (TIC)
The first baseline measure used to assess wheelchair-seating discomfort in sensate wheelchair
users was total sitting time per day (TIC).  This measure consisted of the total amount of time
spent seated in either the participant’s own wheelchair (phases A1 and A2) or a combined total
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of time spent sitting in the relevant test wheelchair and the participant’s own wheelchair (phases
B1, B2, C1, C2).  This combined sitting time was necessary as participants 1 and 2 were unable
to exclusively use either test chair during conditions 2 – 5 due to problems unrelated to sitting
discomfort. As this measure was a once per day measure, there was a maximum of seven data
points per condition for each participant.
6.2.3.2 GDA score
The second baseline measure, the GDA score, is the first discomfort score obtained from the
WcS-DAT.  The GDA score has a possible range of 13 – 91, with higher scores representing
increased levels of discomfort.  This measure is recorded for each 4-hour period of time spent
sitting.  Based on an 8 – 12 hour sitting day, the typical number of data points for this measure
was 14 (2 times per day) to 21 (3 times per day) points per condition.
6.2.3.3 DIS score
Baseline measure three, the DIS score, is the second discomfort score obtained from the WcS-
DAT.  This score has a possible range of 8 – 99.  A score of 8 indicates no discomfort in any part
of the body and a score of 99 indicates a maximum amount of discomfort in 8 body areas and in
the body as a whole.  This measure is recorded with the same frequency as the GDA scores.
6.2.4 Data collection
Prior to participation in this study, all participants signed informed consent documents as per the
study protocol approved by the University of Pittsburgh’s institutional review board.  For the
baseline measures discussed previously, participants completed daily logs and WcS-DAT
questionnaires.  The logs enabled participants to easily record their daily sitting schedule,
allowing tabulation of the number of total hours spent sitting each day.  Each participant was
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provided with a notebook for each week of participation in the study.  The notebook contained
data collection forms for 7 days, including for each day: a daily log sheet, 5 copies of the WcS-
DAT – each in a different color (enough for up to 20 hours of sitting per day), a page on which to
record comments or questions, a form prompting the participant to compare the current day with
an average day experienced over the past three months, and a checklist to determine if all
necessary paperwork had been completed for that day.  The researcher contacted each participant
several times per week to answer any questions and clarify procedures as needed.  Participants
were also encouraged to call or page the researcher if there were any problems or question
regarding either the documentation or the test wheelchair.  The researcher visited with each
participant weekly to transition the participant from one condition to the next and to collect data
and provide the following week’s notebook.
6.2.5 Analysis
Both traditional graphic visual analyses (Ottenbacher, 1986) and specialized semi-statistical and
statistical procedures designed for use in single subject design (Franklin, Allison, & Gorman,
1996; Ottenbacher, 1986), were used to analyze the effectiveness of the TIC data and the GDA
and DIS scores for measuring change in sitting discomfort.  All discomfort-related data were
manually entered into an SPSS data file and then summary data were transferred into a Microsoft
Excel spread sheet, and graphs were developed for performing visual analysis.  Semi-statistical
and statistical procedures used included: tests for serial dependency using Bartlett’s test of the
lag-1 autocorrelation coefficients (Ottenbacher, 1986), celeration line analyses, two-standard
deviation band analyses (Ottenbacher, 1986), and Tryon’s C-Statistic (Tryon, 1982).
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Prior to any visual or statistical analysis, Bartlett’s test of the lag-1 autocorrelation
coefficients was performed on each phase of data collected for each participant.  This is a
conservative approach for determining the degree of serial dependency of the data, with a
significant result for any individual phase causing all data for that participant to be treated as
serially dependent (Ottenbacher, 1986).  When serial dependency of the data was found, the C
Statistic alone was relied on for indications of a significant intervention effect, as the C Statistic
may be applied to data that are serially dependent (Tryon, 1982).
Following the autocorrelation testing, a hierarchical approach to data analysis was
undertaken.  The data were assessed for significant inter-phase differences using four approaches
with increasing levels of statistical rigor.  Analysis began with a basic visual inspection of the
data, which is the hallmark of single subject research analysis (Kazdin, 1982).  Following this
basic visual inspection, semi statistical and statistical methods developed specifically for
enhanced single subject data analysis were employed.  The celeration line analysis is the most
basic of these semi statistical approaches, followed by a two standard deviation band analysis
and finally a C-Statistic analysis – the highest level of statistical rigor used in this single subject
data analysis and a method that is acceptable for use with serially dependent data (Tryon, 1982).
For visual analysis, data were plotted and phase transitions were marked with a vertical
line dividing each phase.  Mean lines were then added as horizontal lines passing through the
mean for each phase data set.  In addition, trend lines for each data set were added to the graphed
data for comparison purposes.  Finally, these data were inspected and a judgment was made as to
whether the mean or trend of the data differed across phases.
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The celeration line, or split middle, procedure was used as a semi-statistical enhancement
of the data to determine the presence of a significant difference in a dependent variable across
phases.  For the celeration line analysis, graphed data were enhanced by the addition of a
baseline trend line.  This trend line was then extended into the subsequent conditions as a
celeration line (graphed as a dashed line to represent the expected trend if no intervention were
initiated) and the ratio of points above or below the celeration line was used in conjunction with
Bloom’s probability table (Ottenbacher, 1986) to determine the presence of a significant
difference in the dependent variable across phases at the p < 0.05 level (one tailed).
Following the celeration line analysis, another semi statistical procedure with an even
higher degree of scientific rigor was used.  This was the two standard deviation band method.
For the two standard deviation band procedure, the mean of the data points for a selected
baseline or intervention phase (depending on the particular phase to phase comparison required)
was plotted as a horizontal line and extended across subsequent phases.  Two dashed horizontal
lines were then added, one each at two standard deviations above the mean and two standard
deviations below the mean.  In order for one condition to be deemed significantly different from
another at the p < 0.05 level (one tailed), there must be two consecutive data points outside the
relevant two standard deviation band (Ottenbacher, 1986).
The final statistical analysis method used, and the one with the highest degree of
scientific and statistical rigor, was the C Statistic method described by (Tryon, 1982).  The C
Statistic is a modified time series analysis methodology designed to evaluate treatment
interventions with small data sets derived from single subject research designs (Tryon, 1982).
As described by Tryon, the C Statistic was first calculated for the data within one phase.
Following this, data were combined from phases as needed for comparison between phases.  If
83
the data within any phase resulted in a non-significant Z score (Z < 1.64), then the combined data
of the two phases requiring comparison were assessed for level of significance.  If, however, the
Z score for the data within any phase was found to be significant (Z ≥ 1.64), this was an
indication of a significant trend in the baseline data.  If this occurred, the analysis of the baseline
and intervention phase data was accomplished using a comparison series – a less powerful
approach, but necessary in the presence of a significant baseline trend (Tryon, 1982).  This
comparison series was generated by subtracting the baseline values from the treatment values
until all values were used.  This comparison series was then tested for significance using the
same C Statistic analysis.
6.3 RESULTS
Results from subject testing under each of the stated conditions have been included to
demonstrate the effectiveness of the WcS-DAT, the methodology used in testing, and the user
adjustable seating introduced.  Results have been organized according to the associated baseline
measure to demonstrate the effectiveness of the measure and the adjustable seating across
subjects.  Means and standard deviations for all baseline measures, all participants, and all
conditions are presented in Table 6-3.
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Table 6-3:  Means and standard deviations of discomfort measures of each participant
TIME IN WHEELCHAIR
Condition (Phase)
Participant 1 (A1) 2 (B1) 3 (C1) 4 (B2) 5 (C2) 6 (A2)
1 10.4 (2.7) NA 10.2 (2.6) NA NA 9.9 (2.5)
1a 8.9 (1.7) NA NA 9.5 (0.6) 8.4 (2.5) 8.1 (1.1)
2 11.7 (0.6) 11.8 (2.8) NA 11.6 (1.2) 11.8 (1.2) 12.4 (0.6)
3 11.9 (1.3) NA NA 12.0 (2.3) 12.6 (1.2) 12.5 (3.2)
4 8.7 (0.8) NA NA 7.9 (1.2) 7.4 (1.2) 7.9 (0.9)
5 7.9 (1.4) NA NA 8.1 (0.9) 7.9 (1.0) 7.9 (0.2)
GDA SCORE
Condition (Phase)
Participant 1 (A1) 2 (B1) 3 (C1) 4 (B2) 5 (C2) 6 (A2)
1 57.1   (6.4) NA 52.7 (4.2) NA NA 49.6   (4.8)
1a 50.2   (3.0) NA NA 49.5   (2.2) 50.0   (3.2) 51.7   (1.9)
2 39.6   (9.3) 54.4 (3.9) NA 36.0   (8.8) 43.6 (10.2) 40.1 (10.4)
3 58.3   (9.8) NA NA 28.8   (1.2) 28.9   (4.1) 62.3 (13.1)
4 52.8 (10.5) NA NA 56.0 (10.2) 59.6   (9.0) 49.5   (2.9)
5 60.9   (4.1) NA NA 57.7   (2.7) 50.1   (8.5) 60.5   (3.5)
DIS SCORE
Condition (Phase)
Participant 1 (A1) 2 (B1) 3 (C1) 4 (B2) 5 (C2) 6 (A2)
1 33.8 (5.1) NA 27.4 (2.8) NA NA 24.9 (1.9)
1a 21.4 (1.6) NA NA 19.5 (1.0) 21.3 (2.1) 20.6 (1.2)
2 12.7 (1.0) 14.8 (1.3) NA 12.5 (1.4) 12.9 (0.2) 12.9 (0.9)
3 36.7 (8.8) NA NA 9.8  (2.2) 15.5 (5.5) 21.5 (8.0)
4 16.8 (4.8) NA NA 20.3 (3.9) 21.9 (4.8) 15.5 (1.3)
5 45.3 (2.1) NA NA 47.1 (3.8) 33.4 (6.5) 51.2 (6.7)
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6.3.1 Time in chair baseline
Results of the Bartlett test indicated no significant degree of autocorrelation for any of the
subjects across any of the conditions.  A summary of all autocorrelation testing may be found in
Table 6-4.  A summary of all of the TIC analysis results is presented at the conclusion of all of
the time in chair results in Table 6-5.
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Table 6-4:  Autocorrelation test results for the time in chair (TIC) measure
Participant/ test phase Autocorrelation Coefficient (r) Bartlett’s Test Autocorrelated?
Participant 1:
A1 0.2463 0.7559 No
C1 0.2524 0.8944 No
A2 0.1566 0.7559 No
Participant 1a:
A1 0.3571 0.7559 No
B2 0.3750 0.7559 No
C2 0.3700 0.7559 No
A2 0.4263 0.7559 No
Participant. 2
A1 0.1870 0.7559 No
B1 0.0018 1.1547 No
B2 0.3054 0.8165 No
C2 0.3902 0.8165 No
A2 0.4935 0.7559 No
Participant 3:
A1 0.6943 0.7559 No
B2 0.3710 0.7559 No
C2 0.1595 0.7559 No
A2 0.1320 0.7559 No
Participant 4:
A1 0.5863 0.7559 No
B2 0.1702 0.7559 No
C2 0.1118 0.7559 No
A2 0.2476 0.7559 No
Participant 5
A1 0.4721 0.7559 No
B2 0.0693 0.7559 No
C2 0.1794 0.7559 No
A2 0.0238 0.7559 No
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6.3.1.1 Participant 1
Phase A1: Baseline, Condition 1
For this baseline condition, Participant 1 used a Permobil Chairman powered wheelchair with a
powered standing feature.  His seating consisted of a Roho Quattro seat cushion and the standard
Permobil contoured foam back cushion.  He spent an average of 10.4 hours per day sitting in his
wheelchair (standard deviation of 2.7 hours).  There was a high degree of variability in these data
and the trend line for this phase had a prominent negative slope (see Figure 6-1 for mean levels
and trends).  Participant 1 was randomized to an ACBA research design.
Figure 6-1:  TIC means and trends for Participant 1
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Phase C1: Intervention, Condition 3 (TestChair1, FeatureSet2)
During this intervention phase (C1), Participant 1 sat in TestChair1 an average of 10.2 hours per
day with a standard deviation of 2.6 hours.  Visual analysis of these data indicated no differences
between phases A1 and C1 (see Figure 6-1) in either mean sitting duration or trend.  For the
Phase A1 (baseline) to Phase C1 (intervention) comparison, none of the results of the celeration
line, two standard deviation band, or C Statistic (Z = 0.69) analyses were significant (see Figure
6-2), indicating no difference in sitting duration when using his own wheelchair or TestChair1.
TestChair1 use was halted after 5 days due to development of redness under this participant’s
ischial tuberosity.  This had been an established stopping point due to safety considerations.  For
this reason, this participant did not continue with Phase B1, but moved directly to the return to
baseline phase (A2).
Phase A2: Return to baseline, Condition 6
 Upon return to baseline, mean time sitting in his own wheelchair for Participant 1 was 9.9 hours
per day (SD = 2.5 hours).  Visual analysis indicated the persistence of great variability in this
measure, but no difference in mean sitting duration from when he was sitting in TestChair1 and
very little difference in the slope of the trend line (see Figure 6-1).  As illustrated in Figure 6-2,
celeration line testing of Phase A2 data using the Phase A1 trend line indicated a significantly
greater sitting duration during Phase A2.  Celeration line comparison of Phase C1 and Phase A2
also indicated a greater sitting duration when Participant 1 returned to using his own wheelchair
than when he was using TestChair1.  There were no significant findings from any of the two
standard deviation band analyses, or for the C-Statistic analysis (Z = 0.43).
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Figure 6-2:  TIC celeration lines and two standard deviation bands for
Participant 1
6.3.1.2 Participant 1a
Phase A1: Baseline, Condition 1
This participant used a different baseline wheelchair for this trial than that used during his first
trial.  His baseline wheelchair for this trial was a Permobil powered wheelchair with powered
seat tilt and powered back recline systems.  The seat cushion was a Roho Quattro air filled
cushion and the back support cushion was a standard Permobil contoured foam back cushion.
Mean sitting duration for this baseline phase was 8.9 hours per day with a standard deviation of
1.7 hours.  These data were somewhat less variable than this participant’s first trial, but still
exhibited a downward sloping trend (see Figure 6-3).  For this trial, Participant 1a was
randomized to an ACBA design.
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Phase C2: Intervention, Condition 5 (TestChair2, FeatureSet2)
Mean sitting duration in TestChair2 with FeatureSet2 was 8.4 hours with a standard deviation of
2.5 hours.  Visual analysis of these data revealed no differences in mean sitting duration in
TestChair2 compared to his own wheelchair.  The trend lines do show a change in trend to an
upward sloping trend line when using TestChair2.  See Figure 6-3 for graphical illustration of
means and trends for Participant 1a.  Celeration line, two standard deviation band (see Figure 6-
4), and C Statistic (Z = 0.07) analyses all indicated no significant difference in sitting duration
between Phase A1 and Phase C2.
Figure 6-3:  TIC means and trends for Participant 1a
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Phase B2: Intervention, Condition 4 (TestChair2, FeatureSet1)
The mean time spent sitting in TestChair2 with FeatureSet1 (Phase B2) was 9.5 hours per day
(SD = 0.6 hours).  Visual analysis continued to reveal no mean sitting duration difference from
the baseline (Phase A1) condition for this measure (see Figure 6-3), however the trend slope
became slightly downward during this intervention phase, showing a change from the earlier
intervention (Phase C2).  Celeration line analysis of Phase B2 compared with Phase A1 indicated
that Participant 1a tolerated a significantly greater sitting duration in TestChair2 than in his own
wheelchair (see Figure 6-4), however the two standard deviation band test did not show a
significant effect.  The C-statistic test of Phase A1 and Phase B2 data confirmed the significant
result found with the celeration line (Z = 1.73).
Visual comparison of mean durations between phases C2 and B2 (the two intervention
phases) indicated only a slight change in average sitting duration, however inspection of the
trends lines revealed a difference in slope from an upward slope for TestChair2 with FeatureSet2
to a slightly downward slope for TestChair2 with FeatureSet1 – indicating a decline in sitting
duration when the traditional user adjustable feature set was in use.  Celeration line comparison
of sitting duration for Phase C2 and Phase B2 indicated a significantly lower sitting duration
during Phase B2 (TestChair2 with FeatureSet1), but there was no significant difference detected
by the two standard deviation band analysis (see Figure 6-4).  The Z score from the C statistic
test of the Phase B2 and Phase C2 data was also not significant (Z = 0.15).
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Figure 6-4:  TIC celeration lines and two standard deviation bandsfor Participant
1a
(darker bands in lower frame are for B2 to A2 comparison)
Phase A2: Return to baseline, Condition 6
Upon returning to use of his own wheelchair, Participant 1a spent an average of 8.1 hours sitting
per day (SD = 1.1 hours).  Visual analysis did not indicate a difference in mean sitting duration
between Phase A2 and the interventions, phases B2 and C2 (see Figure 6-3) or the original
baseline phase (A1).  The trend line for Phase A1 returned to a slightly positive slope, a change
from the Phase B1 downward sloping trend.  Celeration line and two standard deviation band
analyses both indicated a significantly lower sitting duration when he returned to sitting in his
own wheelchair compared with his sitting duration in TestChair2 with FeatureSet1 (Phase B2).
In contrast, the C-statistic comparison of Phase B2 and Phase A2 data was not significant (Z =
1.39).
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6.3.1.3 TestChair1 and TestChair2 comparison
For the first participant, additional analyses were performed based on his testing of both
experimental wheelchairs.  For these analyses, results from conditions 3 (Phase C1 from the first
trial), 4 (Phase B2 from the second trial) and 5 (Phase C2 from the second trial) testing were
analyzed to determine the presence of significant differences between TestChair1 and
TestChair2.  Visual comparison of Phase C1 (Participant 1, Condition 3) with Phase C2
(Participant 1a, Condition 5) revealed small differences in sitting duration means, but a reversal
of trend slopes from a downward slope during Phase C1 to an upward slope during Phase C2
(see Figure 6-5).
Figure 6-5:  TIC means and trends - TestChair1 and TestChair2
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The celeration line analyses indicated a significant increase in sitting duration from
TestChair1 (Phase C1) to TestChair2 with either FeatureSet1 (Phase B2) or FeatureSet2 (Phase
C2).  The two standard deviation band results were not significant for either phase C1 to C2 or
phase C1 to B2 comparisons (see Figure 6-6), nor were C statistic analyses (Z = 0.45 for C1 to
C2; Z = 0.15 for C1 to B2).
Figure 6-6:  TIC celeration line and two standard deviation bands - TestChair1 and
TestChair2
95
6.3.1.4 Participant 2
Phase A1: Baseline, Condition 1
Participant 2 spent an average of 11.7 hours (SD = 0.6 hours) per day seated in his own Permobil
powered wheelchair with powered seat tilt, back recline, and powered elevating leg rests during
this baseline phase (A1).  His seating consisted of the standard Permobil contoured foam seat and
back cushions on solid seat and back pans.  His sitting schedule was quite consistent from day to
day, leading to minimal variability.  The trend line for these data had a slight positive slope (see
Figure 6-7 for means and trends).  This participant was randomized to an ABCA design.  His
TestChair1 trial was interrupted during Phase B1 and he moved to TestChair2 testing in Phase
B2 upon his return.
Figure 6-7:  TIC means and trends for Participant 2.
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Phase B1: Intervention, Condition 2 (TestChair1, FeatureSet1)
During Phase B1, Participant 2 sat in TestChair1 an average of 11.8 hours per day (SD = 2.8).
Due to problems with discomfort and with functional use of TestChair1 in his environment, this
phase was interrupted after 3 days to alter the test wheelchair.  For this reason, there were only 3
TIC data points collected during this phase.  Visual analysis of these data (presented in Figure 6-
7) revealed no change in mean level from baseline (Phase A1), but a significant change in trend
with an upward sloping trend during Phase B1 – caution must be applied with this inspection due
to the small number of observations.  There were not enough observations in Phase B1 for
celeration line analysis and neither the two standard deviation band analysis nor the C Statistic
(Z = 0.17) indicated any significant difference in sitting duration between Phase A1 and Phase
B1.
Phase B2: Intervention, Condition 4 (TestChair2, FeatureSet1)
After construction of TestChair2, this trial was resumed with Participant 2.  Mean sitting time in
TestChair2 with FeatureSet1 was 11.6 hours (SD = 1.2).  Visual analysis of graphed data
revealed no change in mean duration from Phase A1, baseline, but the trend for Phase B2 had a
slightly more negative slope.  Celeration line comparison of Phase A1 and Phase B2 indicated a
significantly lower sitting duration when Participant 2 was using TestChair2 compared with that
in his own wheelchair.  Neither the two standard deviation band nor the C Statistic (Z = 0.98)
analysis indicated a significant difference in sitting duration between TestChair2 with
FeatureSet1 and his own wheelchair.
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Visual comparison of the sitting duration data from use of TestChair1 (Phase B1) and
TestChair1 (Phase B2) indicated no difference in mean sitting duration, but the slopes of the two
trend lines are quite different from each other.  Celeration line analysis of Phase B2 data
compared with that of Phase B1 indicated a significantly lower sitting duration when use of
TestChair2 was initiated (Phase B2).  Neither the two standard deviation band nor the C Statistic
(Z = 0.58) analysis was significant.
Phase C2: Intervention, Condition 5 (TestChair2, FeatureSet2)
Mean sitting time in TestChair2 using FeatureSet2 (C2) was 11.8 hours (SD= 1.2 hours).  Visual
analysis of this data indicated no substantial difference in average sitting duration during this
phase compared with previous phases (see Figure 6-7). The trend in the Phase C2 data was very
similar to that found in the first baseline phase (A1).  The celeration line analysis of Phase C2
data compared with Phase A1 data indicated a significantly lower sitting duration in TestChair2
compared with his baseline wheelchair.  As with Phase B2, neither the two standard deviation
band, nor the C Statistic (Z = 0.67) indicated any significant difference in sitting duration
between TestChair2 and his own wheelchair.
To determine any sitting duration differences between use of FeatureSet1 and use of
FeatureSet2, analysis of Phase B2 and Phase C2 data was undertaken.  The mean sitting duration
across these two phases did not differ.  The trend of the Phase C2 data did change from a slightly
negative slope found in Phase B2 to a slightly positive slope in Phase C2 (see Figure 6-7).
Celeration line analysis of this data indicated a greater sitting tolerance in TestChair2 when using
FeatureSet2 as opposed to that when using FeatureSet1 (see Figure 6-8).  Neither the two
standard deviation band nor the C Statistic (Z = 0.99) analysis confirmed this difference.
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Figure 6-8:  TIC celeration lines and two standard deviation bands for Participant
2.
Phase A2: Return to baseline, Condition 6
Mean sitting duration upon return to baseline was 12.4 hours (SD = 0.6 hours).  Visual analysis
revealed no differences in average sitting duration between Phase A2 and either of the
intervention phases B2 and C2 (see Figure 6-7) or the first baseline phase (A1).  Variability and
trend of the sitting duration data during this phase (A2) closely resembled those found during the
first baseline phase (A1).  Celeration line comparison of the return to baseline data (Phase A2)
and the original baseline data (Phase A1) indicated a significantly lower sitting duration upon
return to baseline.  Neither the two standard deviation band nor the C Statistic (Z = 0.96) analysis
indicated this significant difference between sitting durations of the two baseline phases.
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Comparison of the return to baseline phase (A2) to the final intervention phase (C2) was
also carried out.  Visual analysis of the data from these two phases indicated no differences in
mean sitting duration or in trends for these data.  Neither the celeration line nor the two standard
deviation band analysis of phase C2 and A2 data was significant.  Additionally, the C Statistic
indicated no significant differences in sitting duration between these two phases (Z = 1.54).
6.3.1.5 Participant 3
Phase A1: Baseline, Condition 1
Participant 3 used a Pride Jazzy powered wheelchair with a van style seat system during his
baseline phase (A1).  The seating consisted of a solid seat pan with a contoured foam seat
cushion (Invacare Infinity Seat with a visco-foam ischial insert), and a manually reclining
contoured foam back support.  Average sitting duration in this wheelchair was 11.9 hours (SD =
1.3 hours).  The trend of these data had a steep positive slope (see Figure 6-9 for mean level and
trend graphs).  Participant 3 was randomized to an ACBA design.
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Figure 6-9:  TIC means and trends for Participant 3.
Phase C2: Intervention, Condition 5 (TestChair2, FeatureSet2)
Mean sitting duration in TestChair2 using FeatureSet2 was 12.6 hours per day (SD = 1.2 hours).
Visual analysis did not indicate any differences in mean sitting duration from Phase A1 to Phase
C2 (see Figure 6-9), however there was a reversal in the direction of the trends for these two data
sets.  Celeration line analysis indicated a significantly lower sitting duration in TestChair2
compared with his own wheelchair (see Figure 6-10).  The two standard deviation band analysis
was not significant, but the C Statistic (Z = 1.66) indicated significantly less sitting time in
TestChair2.
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Figure 6-10:  TIC celeration lines and two standard deviation bands for Participant 3.
Phase B2: Intervention, Condition 4 (TestChair2, FeatureSet1)
For Participant 3, the mean sitting duration in TestChair2 using FeatureSet1 was 12.0 hours per
day (SD = 2.3 hours).  Visual analysis of this data was complicated by increased data variability
during this phase (Phase B2), but indicated no differences in mean sitting duration among any of
the phases (A1, C2 or B2).  The trend for the Phase B2 data had a prominent negative slope,
more negative than that found during Phase C2 and a reversal of direction from Phase A1.  The
celeration line analysis of Phase B2 compared with Phase A1 indicated a significantly lower
amount of sitting time using TestChair2 with FeatureSet1 than when using his own wheelchair.
The two standard deviation band analysis of Phase A1 compared with Phase B2 indicated no
significant differences in sitting duration, however, the C Statistic (Z = 4.92) indicated a
significantly lower sitting duration in TestChair2 with FeatureSet1.
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Visual comparison of the two intervention phases B2 and C2 revealed no mean sitting
duration difference and little variation in trend with a slightly steeper slope exhibited by the
Phase B2 data (see Figure 6-9).  The celeration line analysis comparing these phases indicated a
significantly higher sitting duration in TestChair2 when using FeatureSet1 compared that when
using FeatureSet2 (see Figure 6-10), however the two standard deviation band analysis of these
data was not significant.  The C statistic (Z = 1.39) was also not significant, indicating no
significant difference in sitting duration across intervention phases.
Phase A2: Return to baseline, Condition 6
Upon return to baseline, Participant 3 sat in his own wheelchair an average of 12.5 hours per day
(SD = 3.2 hours).  Visual analysis of these data compared with those of his final intervention
phase (B2) indicated no difference in mean sitting duration, but the trend of the data contained a
dramatic reversal in slope with a steep negative slope during Phase B2 and a steep positive slope
during Phase A2.  Celeration line analysis indicated a significantly higher sitting duration during
in his own wheelchair compared with that in TestChair1 with FeatureSet1, however the more
rigorous two standard deviation band analysis was not significant.  The C Statistic (Z = 3.67)
reconfirmed the celeration line result, indicating a significantly greater sitting duration in his own
wheelchair.
Finally, comparison of the two baseline phases was performed.  Visual inspection of the
Phase A1 and Phase A2 data indicated a higher mean sitting duration during the second baseline
phase, but the trends in the two data sets were quite similar.  Celeration line comparison of these
two phases indicated a significantly lower sitting duration during the second baseline phase
(most likely attributable to the steep positive slope of the Phase A1 trend line).  Neither the two
standard deviation band, nor the C Statistic (Z = 0.80) indicated this difference.
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6.3.1.6 Participant 4
Phase A1: Baseline, Condition 1
Participant 4 used a powered wheelchair base with a powered tilt seating system during his
baseline phase.  His seat and back cushions were made of contoured foam mounted on solid
support structures.  He also had a detachable, adjustable posterior head support.  Mean sitting
duration during this phase was 8.7 hours per day (SD = 0.8 hours).  Participant 4 was
randomized to an ABCA design.
Phase B2: Intervention, Condition 4 (TestChair2, FeatureSet1)
Mean sitting duration in TestChair2 with FeatureSet1 was 7.9 hours per day (SD = 1.2 hours).
Visual analysis revealed no difference between Phase A1 and Phase B2 in mean sitting duration
(see Figure 6-11), although there was a difference in the slope of the trend lines for these two
phases, with a much steeper positive slope occurring when he was seated in TestChair2 (Phase
B2).  Celeration line analysis indicated a significantly lower sitting duration when using
TestChair2 compared with that when he was using his own wheelchair (see Figure 6-12),
however neither the two standard deviation band nor the C Statistic (Z = 0.02) analysis
confirmed this difference in sitting duration between the two wheelchairs.
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Figure 6-11:  TIC means and trends for Participant 4.
Phase C2: Intervention, Condition 5 (TestChair2, FeatureSet2)
For Participant 4, daily sitting duration in TestChair2 with FeatureSet2 was 7.4 hours (SD = 1.2
hours).  Visual analysis revealed increased variability of the data during this phase, but little
difference in mean sitting duration from either of the earlier phases (A1 or B2).  The trend of this
data reversed back to a slightly negative slope – more similar to that found during the baseline
phase (A1) than that for the Phase B2 data (see Figure 6-11).
Both the celeration line and two standard deviation band analyses comparing phases A1
and C2 data indicated a significantly lower sitting duration when this participant was using
TestChair2 than when he used his own wheelchair (see Figure 6-12).  However, the C Statistic (Z
= 0.21) result indicated no significant difference in sitting duration between the two wheelchairs.
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Celeration line comparison (see Figure 6-12) of the two interventions - phases B2 and C2
- indicated a significantly lower sitting duration when Participant 4 used TestChair2 with
FeatureSet2 (Phase C2) than when he used TestChair2 with FeatureSet1 (Phase B2), however
neither the two standard deviation band nor the C Statistic (Z = 0.21) analysis confirmed this
difference in sitting duration across interventions.
Figure 6-12:  TIC celeration lines and two standard deviation bands for Participant 4.
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Phase A2: Return to baseline, Condition 6
Mean sitting duration upon return to baseline was 7.9 (SD = 0.9).  Visual analysis indicated little
change in mean sitting duration or trend from the previous intervention phase (C2) to this return
to baseline phase (see Figure 6-11).  Analysis of this return to baseline data compared with that
in the previous phase (C2) using the celeration line, two standard deviation band, and C Statistic
(Z = 0.51) indicated no significant differences in sitting duration between TestChair2 with
FeatureSet2 and this participant’s own wheelchair.
Celeration line, two standard deviation band and C statistic analysis of data from the two
baseline phases (A1 and A2) were also not significant (Z = 0.31) indicating no significant
difference in sitting duration when using across the two baselines.
6.3.1.7 Participant 5
Phase A1: Baseline, Condition 1
During her baseline phase, Participant 5 used either a folding frame powered wheelchair with an
alternating pressure air and foam seat cushion and sling upholstery for back support or a power
seat lift chair (not a wheelchair) for all of her sitting.  Her baseline sitting duration was 7.9 hours
per day (SD = 1.4 hours).  The trend of this data had a steep negative slope.  Figure 6-13 presents
the means and trends for all phases of TIC data for Participant 5.  Participant 5 was randomized
to an ACBA design.
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Figure 6-13:  TIC means and trends for Participant 5
Phase C2: Intervention, Condition 5 (TestChair2, FeatureSet2)
Mean sitting duration in TestChair2 using FeatureSet2 was 7.9 hours per day (SD = 1.0 hours).
Visual analysis revealed no difference in mean sitting duration between that in her chair and that
in TestChair2 with FeatureSet2 (see Figure 6-13), however the trend of the data changed from a
steep negative slope during Phase A1 to a slight positive slope during Phase C2, indicating
increasing sitting durations when this participant was using TestChair2.  Celeration line analysis
indicated a significantly increased sitting duration when this participant was using TestChair2
with FeatureSet2 (see Figure 6-14) than when she was using her own wheelchair, however the
two standard deviation band analysis failed to confirm this difference.  The C statistic (Z = 2.15)
analysis did confirm the significantly higher sitting duration when this participant was using
TestChair2.
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Figure 6-14:  TIC celeration lines and two standard deviation bands for Participant 5
Phase B2: Intervention, Condition 4 (TestChair2, FeatureSet1)
Mean sitting duration in TestChair2 using FeatureSet1 was 8.1 hours per day (SD = 0.9 hours).
Visual analysis revealed little difference in sitting duration mean levels from Phase A1 to Phase
B2, however the trends for these two conditions were opposite from each other – with the trend
for Phase A1 having a strong negative slope and the trend for Phase B2 having a slight positive
slope (see Figure 6-13).  Celeration line analysis of the Phase B2 data compared with the Phase
A1 data indicated increased sitting duration in TestChair2 than that in her own wheelchair (see
Figure 6-14).  Neither the two standard deviation band nor the C Statistic (Z = 1.60) test
indicated any significant difference in sitting duration from Phase A1 to Phase B2.
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Analysis of Phase C2 and Phase B2 data, indicated no significant differences in sitting
duration when using the two interventions (FeatureSet1 and FeatureSet2).  Visual analysis
indicated little difference between the mean sitting durations or trends of the data for these two
interventions.  The celeration line, two standard deviation band and C Statistic (Z = 0.46)
analyses all indicated no significant difference in sitting duration when she used TestChair2 with
FeatureSet1 or TestChair2 with FeatureSet2.
Phase A2: Return to baseline, Condition 6
Due to the delivery of this participant’s new wheelchair, she used a different wheelchair for
Phase A2 than she had used during Phase A1.  Her new wheelchair was a powered wheelchair
with powered seat tilt, powered back recline, and powered elevating legrests.  The seat and back
cushions were made of contoured foam on solid seat and back pans.  Her mean sitting duration in
this wheelchair was 7.9 hours per day (SD = 0.2 hours).  Visual analysis of these data indicated a
substantial decrease in the variability of her sitting duration, but very little difference in mean
sitting duration between this phase and each of the other phases and a leveling out of the trend,
while still maintaining a slight positive slope during this final phase (see Figure 6-13).
Celeration line analysis of Phase B2 and Phase A2 data indicated a significantly lower
sitting duration when she returned to sitting in her own wheelchair, however neither the two
standard deviation band analysis nor the C Statistic (Z = 0.10) indicated any significant
difference in sitting duration between Phase B2 and Phase A2.
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Comparison of the data from the two baseline phases was also performed.  It is important
to remember that the two wheelchairs used during these phases actually differed because of the
delivery of a new wheelchair to this participant.  Visual analysis of phase A1 and A2 data
revealed no difference in mean sitting durations, but a large difference in trend of the data with a
large negative slope for Phase A1 and very little positive slope for the Phase A2 data.  Celeration
line testing of the Phase A2 data using the trend from Phase A1 indicated significantly higher
sitting duration when she was sitting in her new wheelchair (Phase A2).  The two standard
deviation band analysis of these two phases indicated no significant difference in sitting duration,
but the C Statistic (Z = 2.12) result indicated significantly higher sitting duration for her new
wheelchair used in the return to baseline phase (A2).
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Table 6-5:  TIC summary of results
Participant and type of comparison Comparison Celeration line Two standard
deviation band
C-Statistic
Sig.** Sig.** Z Score p Sig.**
Participant 1: (ACBA design)
Baseline Æ Intervention A1 Æ C1 NS NS 0.69 0.2451 NS
Baseline 1 Æ Baseline 2 A1 Æ A2 SIG higher NS 0.43 0.3336 NS
Participant 1a: (ACBA design)
Baseline Æ Intervention A1 Æ C2 NS NS 0.07 0.4721 NS
Baseline Æ Intervention A1 Æ B2 SIG higher NS 1.73 0.0418 SIG
Intervention Æ Intervention C2 Æ B2 SIG lower NS 0.15 0.4404 NS
Intervention Æ Baseline B2 Æ A2 SIG lower SIG lower 1.39 0.0823 NS
Baseline 1 Æ Baseline 2 A1 Æ A2 NS NS 0.41 0.3409 NS
TestChair1 and TestChair2:
Intervention 1 Æ Intervention 2 C1 Æ C2 SIG higher NS 0.45 0.3264 NS
Intervention 1 Æ Intervention 2 C1 Æ B2 SIG higher NS 0.15 0.4404 NS
Participant 2: (ABCA design)
Baseline Æ Intervention A1 Æ B1 Not enough
data points
NS 0.17 0.4325 NS
Baseline Æ Intervention A1 Æ B2 SIG lower NS 0.98 0.1635 NS
Intervention Æ Intervention B1 Æ B2 SIG lower NS 0.58 0.2810 NS
Baseline Æ Intervention A1 Æ C2 SIG lower NS 0.67 0.2514 NS
Intervention Æ Intervention B1 Æ C2 SIG lower NS 0.17 0.4325 NS
Intervention Æ Intervention B2 Æ C2 SIG higher NS 0.99 0.1611 NS
Intervention Æ Baseline C2 Æ A2 NS NS 1.54 0.0618 NS
Baseline 1 Æ Baseline 2 A1 Æ A2 SIG lower NS 0.96 0.1685 NS
Participant 3: (ACBA design)
Baseline Æ Intervention A1 Æ C2 SIG lower NS 1.66* 0.0485 SIG
Baseline Æ Intervention A1 Æ B2 SIG lower NS 4.92* < .001 SIG
Intervention Æ Intervention C2 Æ B2 SIG higher NS 1.39 0.0823 NS
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Participant and type of comparison Comparison Celeration line Two standard
deviation band
C-Statistic
Sig.** Sig.** Z Score p Sig.**
Intervention Æ Baseline B2 Æ A2 SIG higher NS 3.67* 0.0001 SIG
Baseline 1 Æ Baseline 2 A1 Æ A2 SIG lower NS 0.80 0.2119 NS
Participant 4: (ABCA design)
Baseline Æ Intervention A1 Æ B2 SIG lower NS 0.02* 0.4920 NS
Baseline Æ Intervention A1 Æ C2 SIG lower SIG lower 0.21* 0.4168 NS
Intervention Æ Intervention B2 Æ C2 SIG lower NS 0.37 0.3557 NS
Intervention Æ Baseline C2 Æ A2 NS NS 0.51 0.3050 NS
Baseline 1 Æ Baseline 2 A1 Æ A2 NS NS 0.31 0.3783 NS
Participant 5: (ACBA design)
Baseline Æ Intervention A1 Æ C2 SIG higher NS 2.15* 0.0158 SIG
Baseline Æ Intervention A1 Æ B2 SIG higher NS 1.60* 0.0548 NS
Intervention Æ Intervention C2 Æ B2 NS NS 0.46 0.3228 NS
Intervention Æ Baseline B2 Æ A2 SIG lower NS 0.10 0.4602 NS
Baseline 1 Æ Baseline 2 A1 Æ A2 SIG higher NS 2.12* 0.0170 SIG
* Comparison series used for analysis
** Significance at the p < 0.05 level
Table 6-5 (continued)
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6.3.2 GDA score baseline
The Bartlett test indicated serially dependent data for Participant 1a, Phase A2 (return to
baseline) and for Participant 5, Phase A2.  This serial dependency may interfere with accurate
visual analysis (Bengali & Ottenbacher, 1998) and with the semi statistical procedures used for
data analysis (Ottenbacher, 1986), therefore, the C-Statistic is relied on for indications of
significant results for the GDA discomfort measure in these two participants. Table 6-6 indicates
the results of the autocorrelation tests for the GDA scores.  A summary of all of the GDA score
results for all participants and across all analysis methods is presented at the conclusion of all of
the GDA score results in Table 6-7.
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Table 6-6:  Autocorrelation test results for the GDA score discomfort measure
Participant/ test phase Autocorrelation Coefficient (r) Bartlett’s Test Autocorrelated?
Participant 1:
A1 0.2752 0.4714 No
C1 0.0751 0.7559 No
A2 0.1015 0.5345 No
Participant 1a:
A1 0.3829 0.4714 No
B2 0.1379 0.4851 No
C2 0.4100 0.6030 No
A2 0.6311 0.5164 Yes
Participant. 2
A1 0.4181 0.4364 No
B1 0.2821 0.7559 No
B2 0.4466 0.6030 No
C2 0.0945 0.6030 No
A2 0.2612 0.4264 No
Participant 3:
A1 0.2832 0.4364 No
B2 0.0574 0.4714 No
C2 0.1095 0.4472 No
A2 0.4080 0.4588 No
Participant 4:
A1 0.1456 0.5774 No
B2 0.3383 0.5774 No
C2 0.1209 0.6030 No
A2 0.3372 0.5547 No
Participant 5
A1 0.0646 0.4364 No
B2 0.1336 0.5345 No
C2 0.0141 0.4714 No
A2 0.7763 0.5345 Yes
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6.3.2.1 Participant 1
Phase A1: Baseline, Condition 1
The mean GDA discomfort score for Participant 1 when using his own wheelchair was 57.1 (SD
= 6.4).  Visual analysis of these data showed a high degree of variability and a downward sloping
trend line (see Figure 6-15).  Participant 1 was randomized to an ACBA design.
Figure 6-15:  GDA score means and trends for Participant 1
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Phase C1: Intervention, Condition 3 (TestChair1, FeatureSet2)
During Phase C1 testing, the mean GDA score for this participant was 52.7 (SD = 4.2).  Visual
analysis of these data compared with those in Phase A1 indicated decreased variability, a lower
mean level, and a decrease in the slope of the trend line, but still maintaining a slightly negative
slope (see Figure 6-15 for GDA means and phase trends).  There were no significant differences
in GDA score between Phase A1 and Phase C1 indicated by celeration line, two standard
deviation band (see Figure 6-16), or C Statistic (Z = 1.62) analyses.  This indicates no significant
differences in discomfort levels between this participant’s own wheelchair and TestChair1 with
FeatureSet2.
Figure 6-16:  GDA celeration line and two standard deviation bands for Participant 1
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Phase A2: Return to baseline, Condition 6
For the return to baseline phase, the mean GDA score was 49.6 (SD = 4.8).  Visual analysis
revealed a lower degree of variability of these data as compared with the original baseline (A1)
data, particularly through the first several days of testing.  The GDA mean was lower during this
phase than during the original baseline (A1) and Phase C1, indicating a decline in discomfort as
he progressed from phase to phase.  The trend of this data did however have a reversed slope –
with a moderate positive slope indicating increasing levels of discomfort during this final
baseline phase.  Celeration line and two standard deviation band analyses of the Phase C1 and
Phase A2 data indicated no significant differences in discomfort level when he returned to using
his own wheelchair.  Analysis of the two baseline phases using the celeration line and two
standard deviation band methods indicated no significant differences in discomfort from Phase
A1 to Phase A2, but the C Statistic (Z = 2.59) comparison of phases A1 and A2 did indicate a
significant difference in GDA score, which may have been due to the change in mean or the
change in trend or a combination of the two (Tryon, 1982).
6.3.2.2 Participant 1a
Phase A1: Baseline, Condition 1
Due to the presence of serially dependent data for this participant (Phase A2, return to baseline),
the C Statistic is relied on for determination of significant intervention effects.  The GDA mean
for this participant when using his own wheelchair was 50.2 (SD = 3.0).  This participant was
randomized to an ACBA design.
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Phase C2: Intervention, Condition 5 (TestChair2, FeatureSet2)
The GDA score mean while seated in TestChair2 with FeatureSet2 was 50 (SD = 3.2).  C
Statistic (Z = 1.43) analysis of Phase A1 and Phase C2 data indicated no difference in discomfort
level when this participant was seated in either his own wheelchair or TestChair2 with
FeatureSet2.
Phase B2: Intervention, Condition 4 (TestChair2, FeatureSet1)
The GDA score mean for Phase B2 was 49.5 (SD = 2.2).  The Z score from the C Statistic was
0.03, indicating no significant difference in discomfort between Phase A1 and Phase B2.  The C
Statistic (Z = 1.34) analysis of phases B2 and C2 data also indicated no significant difference in
discomfort between the two different intervention phases (FeatureSet1 and FeatureSet2).
Phase A2: Return to baseline, Condition 6
The GDA mean for the return to baseline phase was 51.7 (SD = 1.9).  When Phase B2 and Phase
A2 data were analyzed using the C Statistic, there was no significant difference (Z = 0.30).  Due
to the serially dependent data, celeration line and two standard deviation band analyses were not
performed for this participant, but these are presented in Figure 6-18 for illustration purposes.
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Figure 6-17:  GDA score means and trends for Participant 1a
Figure 6-18:  GDA score celeration line and two standard deviation bands for
Participant 1a
(analysis not used due to serial dependency of Phase A2 data)
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6.3.2.3 TestChair1 and TestChair2 comparison
For the first participant, additional analyses were performed based on his testing of both
TestChair1 and TestChair2.  For these analyses, results from Phase C1 (Participant 1, Condition
3) were compared with those from phases C2 and B2 (Participant 1a, conditions 4 and 5) to
determine the presence of significant differences in discomfort level experienced between
TestChair1 and TestChair2.
Visual analysis of these data graphed together indicated a slight difference in mean level
from Phase C1 to phases C2 and B2 and differences in the slopes of the trend lines, with a
slightly negative slope during Phase C1 and a slightly positive slope during phases C2 and B2
(see Figure 6-19).  Celeration line comparisons of Phase C2 and B2 with Phase C1 indicated no
significant change in discomfort level between TestChair1 with FeatureSet1 and TestChair2 with
either FeatureSet1 or FeatureSet2.  Two standard deviation band comparisons of Phase C1 with
C2 and Phase C1 with B2 were also not significant (see Figure 6-20).  The C Statistic (Z = 1.94)
for Phase C1 and Phase C2 comparison was significant – indicating a significant difference in
discomfort from TestChair 1 with FeatureSet2 to TestChair2 with FeatureSet2, but the Z score
for the Phase C1 and Phase B2 comparison was not significant (Z = 1.54) indicating no
differences in discomfort once both the test chair and the feature set in use were altered
(TestChair1 with FeatureSet2 compared with TestChair2 with FeatureSet1).  The comparison of
Phase C2 and Phase B2 is discussed during the analysis of Participant 1a, as these phases were
both completed during this trial and are not repeated here.
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Figure 6-19:  GDA means and trends for TestChair1 and TestChair2
(used for chair to chair comparison for the first research participant)
Figure 6-20:  GDA score celeration line and two standard deviation bands for
TestChair1 and TestChair2
(used for chair to chair comparison for the first research participant)
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6.3.2.4 Participant 2
Phase A1: Baseline, Condition 1
For Participant 2, the baseline mean of the GDA discomfort score was 39.6 (SD = 9.3).  Visual
analysis of these data showed a high degree of variability and a repeating pattern – with two
lower scores and one high score per day (at the end of the day).  The trend of these data had
neither a positive nor a negative slope (see Figure 6-21).  This participant was randomized to an
ABCA design.  Due to problems discussed previously, his testing of TestChair1 was interrupted
during Phase B1.  He resumed his trial using TestChair2 with FeatureSet1 (Phase B2).
Figure 6-21:  GDA score means and trends for Participant 2
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Phase B1: Intervention, Condition 2 (TestChair1, FeatureSet1)
The Phase B1 GDA score mean was 54.4 (SD = 3.9).  These data appeared to have less
variability and a higher mean level upon visual inspection (see Figure 6-21).  The trend of the
GDA data with use of TestChair1 also became slightly positive – indicating an increasing
discomfort level while using this wheelchair.  The celeration line analysis of the Phase B1 and
Phase A1 GDA scores indicated significantly higher discomfort when Participant 2 was using
TestChair1 (see Figure 6-22), however the more rigorous two standard deviation band and C
Statistic (Z = 1.52) analyses did not show a significant difference in this discomfort measure
between this participant’s own wheelchair and TestChair1 with FeatureSet1.
Phase B2: Intervention, Condition 4 (TestChair2, FeatureSet1)
When testing resumed following TestChair2 construction, this participant resumed his trial using
TestChair2 with FeatureSet1 (Phase B2).  The GDA mean score for this phase was 36.0 (SD =
8.8).  Visual inspection of these data in comparison with the baseline data (Phase A1) indicated a
slight change in GDA mean and a change in trend to a negative slope (from a neutral slope
during Phase A1).  Neither the celeration line nor the two standard deviation band analyses (see
Figure 6-22) demonstrated any difference on this discomfort measure between the participant’s
own wheelchair (Phase A1) and TestChair2 with FeatureSet1 (Phase B2). The C Statistic test of
Phase A1 and B2 data was also not significant (Z = 0.49).
Visual inspection of the data from phases B1 and B2 revealed differences in GDA
discomfort score means and trends between these two phases.  The GDA mean for Phase B1 was
substantially higher than that for Phase B2 – indicating higher discomfort levels with TestChair1
use.  The two trends also differ in slope – the Phase B1 trend had a positive slope and the Phase
B2 trend a negative slope.  This indicated increasing discomfort levels when this participant used
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TestChair1 with FeatureSet1 and decreasing levels when he used TestChair2 with FeatureSet1.
Celeration line analysis was problematic for this phase comparison.  Even though all Phase B2
points fell below the celeration line generated from the Phase B1 trend line, the high proportion
of points below the Phase B1 trend line necessitated a high number of observations below the
celeration line to attain significance.  Therefore, the results of celeration line analysis of Phase
B1 to Phase B2 were not significant as this number was not attained during Phase B2 (11 points
were collected and were all below the celeration line (see Figure 6-22), but 12 were necessary for
a significant result).  The two standard deviation band analysis did indicate a significantly lower
discomfort level during Phase B2 when compared with Phase B1.  Also, the C-Statistic (Z =
2.93) analysis confirmed this significant result.
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Figure 6-22:  GDA celeration lines and two standard deviation bands for Participant 2
(Upper panel includes celeration lines for Phase A1 trend, Phase B1 trend and Phase B2 trend for
comparisons of the intervention phases (B1, B2 and C2).  Middle panel shows mean and two
standard deviation bands for Phase A1, lower panel has mean and two standard deviation bands
for Phase B1 (bold) and Phase B2)
Phase C2: Intervention, Condition 5 (TestChair2, FeatureSet2)
While seated in TestChair2 with FeatureSet2, Participant 2 had a GDA mean score of 43.6 (SD =
10.2).  Visual inspection confirmed the increased variability of these data and indicated a
difference in both mean and trend between the Phase C2 and Phase A1 data (see Figure 6-21).
This participant had a higher mean for the GDA score data during Phase C2 – indicating
increased levels of discomfort compared with those he experienced when using his own
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wheelchair.  The slope of the trend line during Phase C2 was also slightly positive and steeper
than the slope of the trend line for the Phase A1 data, indicating an increasing level of discomfort
based on the GDA measure.  Celeration line analysis of data from phases A1 and C2 indicated no
significant difference in discomfort between these two phases, however, the two standard
deviation band did indicate a significantly higher discomfort score when this participant used
TestChair2 with FeatureSet2 (Phase C2) than when he used his own wheelchair (see Figure 22).
The C Statistic test of phase A1 and C2 data was in agreement with the celeration line result,
indicating no difference in discomfort between GDA scores for these two phases (Z = 0.72).
Visual comparison of Phase B1 data and Phase C2 data indicated a lower mean GDA
when this participant was using TestChair2 with FeatureSet2 (Phase C2) than when he was using
TestChair1 with FeatureSet1 (Phase B1).  The trends of these two data sets were quite similar,
with the phase B1 trend having only a slightly steeper positive slope.  Celeration line testing of
Phase B1 and Phase C2 was not significant, due to the same problem with the number of data
points collected (as described under phase B1 to B2 comparison results reported above). For the
two standard deviation band analysis using Phase B1 as a baseline, Phase C2 GDA scores were
significantly lower, indicating decreased levels of discomfort when using TestChair2 with
FeatureSet2 (C2). C Statistic comparison of phases B1 and C2 was not significant (Z = 1.24), in
agreement with the celeration line testing.
The final intervention-to-intervention analysis performed for the GDA measure of
Participant 2 was the Phase B2 to Phase C2 comparison.  Visual analysis again indicated a
difference in both means and trends between these two intervention phases.  The Phase C2 mean
GDA was higher than that of Phase B2 and the trend indicated an increasing discomfort level,
rather than a decreasing level associated with Phase B2.  Both the celeration line and two
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standard deviation band analyses indicated significantly higher discomfort levels during Phase
C2 – use of TestChair2 with FeatureSet2, but the more rigorous C Statistic comparison of these
phases was not significant (Z = 0.57) indicating no significant difference in discomfort levels
across these two phases.
Phase A2: Return to baseline, Condition 6
The return to baseline phase resulted in a GDA mean score of 40.1 (SD = 10.4).  Again, a high
degree of data variability in this measure was noted on visual analysis, but little difference in
GDA mean from compared with Phase C2 and a slight decrease in the slope of the trend line as
compared with that in Phase C2.  None of the analysis methods used (celeration line, two
standard deviation band, or C Statistic) indicated any significant differences in GDA scores
between the Phase C2 intervention phase and the return to baseline (A2) phase (Z = 0.54 for the
C Statistic).
Visual comparison of the baseline (Phase A1) and return to baseline (Phase A2) indicated
no differences in either means or trends for the data in these two phases.  Celeration line, two
standard deviation band and C Statistic (Z = 0.54) analyses all resulted in non significant results,
indicating similarity of discomfort levels between the two baseline phases, as would be expected
in the absence of carry over effects from the intervention phases.
6.3.2.5 Participant 3
Phase A1: Baseline, Condition 1
The GDA mean score for Participant 3 using his own wheelchair was 58.3 (SD = 9.8).  Visual
analysis revealed a high degree of variability and a positive sloping trend in these data (see
Figure 6-23).  This participant was randomized to an ACBA design.
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Phase C2: Intervention, Condition 5 (TestChair2, FeatureSet2)
When using TestChair2 with FeatureSet2 (Phase C2), the GDA score mean for Participant 3 was
28.9 (SD = 4.1).  Visual analysis of these data compared with those in Phase A1 indicated a large
difference in GDA means between the two phases, indicating lower discomfort levels when this
participant used TestChair2 (see Figure 6-23). Both the celeration line and the two standard
deviation band analyses were significant (see Figure 6-24), as was the result of the C Statistic (Z
= 5.50) comparison of Phase C2 and Phase A1.
Figure 6-23:  GDA score means and trends for Participant 3
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Phase B2: Intervention, Condition 4 (TestChair2, FeatureSet1)
In TestChair1 with FeatureSet1 the GDA mean score for this participant was 28.8 (SD = 1.2).
As with Phase C2, visual analysis of these data revealed a dramatic difference in GDA score
means and trends from the baseline phase (A1).  These mean and trend differences indicated
lower discomfort levels when this participant was using TestChair2 than when he used his own
wheelchair.  As with the Phase C2 data, celeration line, two standard deviation band and C
Statistic (Z = 5.02) analyses all indicated a significantly lower discomfort level when this
participant used TestChair2 with FeatureSet1 (see Figure 6-24).
A comparison of Phase C2 and Phase B2 data was also performed to determine if there
was a difference between discomfort levels associated with two feature sets.  Visual inspection
of this data (See Figure 6-23) indicated very similar means and trends for phases B2 and C2.
Celeration line analysis of these two phases was significant, showing a higher GDA score or
increased discomfort when using FeatureSet1 (Phase B2), however the two standard deviation
band analysis of the these two phases did not indicate a significant difference in discomfort level.
The C statistic analysis of Phase C2 and Phase B2 data was significant, in agreement with the
celeration line result (Z = 2.69) and indicating a significant difference in discomfort levels with a
higher discomfort when using FeatureSet1 compared with FeatureSet2.
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Figure 6-24:  GDA celeration lines and two standard deviation bands for Participant 3
(lower panel shows mean and two standard deviation bands for Phase A1 data and
Phase B2 data in bold)
Phase A2: Return to baseline, Condition 6
The GDA mean score for the return to baseline condition was 62.3 (SD = 13.1).  Visual analysis
of these data indicated a difference in GDA mean from Phase B2 to Phase A2 and a return to a
mean similar to that of the original baseline – Phase A1.  These data were much more variable
than those of the intervention phases (B2 and C2) and the trend of the data had a steep positive
slope – also different from the intervention phases and similar to the first baseline phase.  Both
celeration line and two standard deviation band analyses of Phase B2 and Phase A2 revealed
significantly higher GDA scores upon return to baseline (A2).  The C statistic also indicated a
significant difference between the phase B2 and A2 data (Z = 5.67).
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Visual inspection of the data from the two baselines indicated very similar means and
trends, with a slight increase in the slope of the positive trend found in Phase A2.  Celeration
line, two standard deviation band and C Statistic (Z = 2.22) analyses all indicated a significantly
lower discomfort level for the return to baseline phase than for the original baseline phase.  This
may have been due to a carry over effect from the transition between the final intervention phase
(B2) back to a baseline phase.  This participant’s discomfort levels remained low for part of the
Phase A2 data collection period because they had been so low during the intervention phases.
The steepness of the trend line for the Phase A1 data also played a role in the celeration line
significance for this final phase (see Figure 6-24).
6.3.2.6 Participant 4
Phase A1: Baseline, Condition 1
The baseline GDA score mean for this participant was 52.8 (SD = 10.5).  Visual analysis of these
scores indicated a high degree of variability and a trend with a positive slope – indicating an
increasing level of discomfort through the baseline phase.  Particularly high variability was noted
during the first few days of testing, possibly due to this participant’s unfamiliarity with the
assessment tool itself.  This participant was randomized to an ABCA design.
Phase B2: Intervention, Condition 4 (TestChair2, FeatureSet1)
Use of TestChair2 with FeatureSet1 (Phase B2) resulted in a mean GDA score of 56.0 (SD =
10.2).  Variability of these data continued at approximately the same level as that found in the
baseline phase (A1).  Visual analysis revealed very little difference from the baseline phase in
GDA mean and a slight decrease in the slope of the trend (see Figure 6-25).  The celeration line
analysis of the Phase B2 and Phase A1 data indicated a significantly lower GDA score, or lower
level of seating discomfort, when he was seated in TestChair2 with FeatureSet1 than when he
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was seated in his own wheelchair, however neither the two standard deviation band nor the C
Statistic (Z = 0.87) analysis resulted in a finding of a significant difference in sitting discomfort
between these two phases.
Figure 6-25:  GDA score means and trends for Participant 4
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Phase C2: Intervention, Condition 5 (TestChair2, FeatureSet2)
The GDA mean discomfort level for Participant 4 when using TestChair2 with FeatureSet2 was
59.6 (SD = 9.0).  Visual analysis of these data indicated a slight increase in mean GDA scores
during Phase C2 as compared with the baseline phase (A1).  The slope of the trend line was not
different from that of the Phase A1 data (see Figure 6-25).  The celeration line comparison of
Phase C2 and A1 data indicated a significantly lower discomfort level during this intervention.
The two standard deviation band analysis was not significant for this phase (see Figure 6-26), nor
was the result of the C-Statistic (Z = 0.91), indicating no significant difference in seating
discomfort between TestChair1 with FeatureSet2 and his own wheelchair for these more rigorous
analyses.
Visual comparison of the Phase C2 and Phase B2 data also indicated a slight increase in
mean GDA scores.  In addition, the trend lines for these two phases were also different – with the
trend of the Phase C2 data having a steeper positive slope, indicating a more rapidly increasing
level of seating discomfort when using TestChair2 with FeatureSet2 (see Figure 6-25).
Celeration line, two standard deviation band (see Figure 6-26) and C Statistic (Z = 0.04) analyses
of Phase B2 data compared with Phase C2 data all resulted in no significant differences in mean
GDA scores between these two intervention phases, indicating no significant difference in
discomfort levels between the two different feature sets (FeatureSet1 and FeatureSet2).
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Figure 6-26:  GDA score celeration lines and two standard deviation bands for
Participant 4
Phase A2: Return to baseline, Condition 6
Upon return to baseline, the GDA mean was 49.5 (SD = 2.9).  Visually, these data appeared
much more stable in nature.  The mean level of these data appeared lower than those of all
previous phases and the trend in these data was much more level (see Figure 6-25).  Celeration
line analysis of data from phases A2 and C2 indicated a significantly lower discomfort level
upon return to baseline.  Two standard deviation band analysis of this same data did not result in
a significant finding.  However, the C Statistic analyses of Phase A2 and Phase C2 data was
significant (Z = 1.94), confirming the significantly lower discomfort level found with the
celeration line analysis and the change in trend of the Phase A2 data compared with that of the
Phase C2 data.
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Comparison of the data from both baselines (A1 and A2) indicated a lower mean level
upon return to baseline, but not substantially.  The trend from the Phase A2 data was much more
level than that in Phase A1 which had a positive sloping trend.  Celeration line comparison of
Phase A1 and Phase A2 data was significant indicating a lower level of discomfort during the
return to baseline phase than that of the first baseline (Phase A1).  Neither the two standard
deviation band nor the C Statistic (Z = 0.02) analysis resulted in a significant finding.
6.3.2.7 Participant 5
Phase A1: Baseline, Condition 1
For Participant 5, the baseline GDA mean score was 60.9 (SD = 4.1).  Participant 5 was
randomized to an ACBA design. Graphic representation of these data is presented in Figure 6-27,
but was not used during analysis, due to the serial dependency of the Phase A2 data, discovered
using Bartlett’s test.  Due to this serial dependency, the C Statistic was relied on for all phase
comparisons for this participant.
Phase C2: Intervention, Condition 5 (TestChair2, FeatureSet2)
The mean GDA score when this participant sat in TestChair2 with FeatureSet2 was 50.1 (SD =
8.5).  The C Statistic result was significant (Z = 1.92) indicating a significantly lower discomfort
level between her own wheelchair and TestChair2 with FeatureSet2.
Phase B2: Intervention, Condition 4 (TestChair2, FeatureSet1)
When Participant 5 was seated in TestChair2 with FeatureSet1, his GDA discomfort score mean
was 57.7 (SD = 2.7).  The C-Statistic test of the Phase B2 and A1 data was not significant (Z =
0.59), indicating no difference in discomfort level between her own wheelchair and TestChair2
with FeatureSet1.  When an analysis of the difference between GDA scores for phases B2 and
C2, the result was significant (Z = 2.05) at the 0.05 level, indicating a significant difference
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between FeatureSet1 and FeatureSet2 on TestChair2.  This test indicated a higher mean level for
FeatureSet1 and a change in trend for this data when compared with the GDA data when she was
using TestChair2 with FeatureSet2.
Phase A2: Return to baseline, Condition 6
The GDA mean for the return to baseline phase was 60.5 (SD = 3.5).  These data were found to
be serially dependent using Bartlett’s test.  The C Statistic analysis of Phase A2 and Phase B2
data was not significant (Z = 0.94), indicating no significant difference in discomfort between
TestChair2 with FeatureSet1 and her own wheelchair (used during the return to baseline phase).
The C Statistic (Z = 1.05) analysis of data from phases A1 and A2 was also not significant,
indicating no difference in discomfort between the two chairs she used for her baseline phases
(A1 and A2).
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Figure 6-27:  Graphed GDA score data for Participant 5
(mean levels and trends (top half of figure) and celeration lines and two standard deviation bands
(lower half of figure).  These were not used during analysis due to serial dependency of Phase
A2 data)
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Table 6-7:  GDA score summary of results
Participant and type of comparison Comparison Celeration line Two standard
deviation band
C-Statistic
SIG** SIG** Z Score p SIG**
Participant 1: (ACBA design)
Baseline Æ Intervention A1 Æ C1 NS NS 1.62 0.0526 NS
Baseline 1 Æ Baseline 2 A1 Æ A2 NS NS 2.59 0.0048 SIG
Participant 1a: (ACBA design)
Baseline Æ Intervention A1 Æ C2 † † 1.43* 0.0764 NS
Baseline Æ Intervention A1 Æ B2 † † 0.03* 0.4880 NS
Intervention Æ Intervention C2 Æ B2 † † 1.34* 0.0901 NS
Intervention Æ Baseline B2 Æ A2 † † 0.30 0.3821 NS
Baseline 1 Æ Baseline 2 A1 Æ A2 † † 1.80 0.0359 SIG
TestChair1 and TestChair2:
Intervention 1 Æ Intervention 2 C1 Æ C2 NS NS 1.94 0.0262 SIG
Intervention 1 Æ Intervention 2 C1 Æ B2 NS NS 1.54 0.0618 NS
Participant 2: (ABCA design)
Baseline Æ Intervention A1 Æ B1 SIG higher NS 1.52* 0.0643 NS
Baseline Æ Intervention A1 Æ B2 NS NS 0.49* 0.3121 NS
Intervention Æ Intervention B1 Æ B2 Not enough
data points
SIG lower 2.93 0.0017 SIG
Baseline Æ Intervention A1 Æ C2 NS SIG higher 0.72* 0.2358 NS
Intervention Æ Intervention B1 Æ C2 Not enough
data points
SIG lower 1.24 0.1075 NS
Intervention Æ Intervention B2 Æ C2 SIG higher SIG higher 0.57* 0.2843 NS
Intervention Æ Baseline C2 Æ A2 NS NS 0.54 0.2946 NS
Baseline 1 Æ Baseline 2 A1 Æ A2 NS NS 1.29* 0.0985 NS
Participant 3:
Baseline Æ Intervention A1 Æ C2 SIG lower SIG lower 5.50 < .001 SIG
Baseline Æ Intervention A1 Æ B2 SIG lower SIG lower 5.02 < .001 SIG
Intervention Æ Intervention C2 Æ B2 SIG higher NS 2.69* 0.0036 SIG
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Participant and type of comparison Comparison Celeration line Two standard
deviation band
C-Statistic
SIG** SIG** Z Score p SIG**
Intervention Æ Baseline B2 Æ A2 SIG higher SIG higher 5.67 < .001 SIG
Baseline 1 Æ Baseline 2 A1 Æ A2 SIG lower SIG lower 2.22 0.0132 SIG
Participant 4:
Baseline Æ Intervention A1 Æ B2 SIG lower NS 0.87 0.1921 NS
Baseline Æ Intervention A1 Æ C2 SIG lower NS 0.91 0.1814 NS
Intervention Æ Intervention B2 Æ C2 NS NS 0.04 0.4840 NS
Intervention Æ Baseline C2 Æ A2 SIG lower NS 1.94 0.0262 SIG
Baseline 1 Æ Baseline 2 A1 Æ A2 SIG lower NS 0.02 0.4920 NS
Participant 5:
Baseline Æ Intervention A1 Æ C2 † † 1.92 0.0274 SIG
Baseline Æ Intervention A1 Æ B2 † † 0.59 0.2776 NS
Intervention Æ Intervention C2 Æ B2 † † 2.05 0.0202 SIG
Intervention Æ Baseline B2 Æ A2 † † 0.94 0.1736 NS
Baseline 1 Æ Baseline 2 A1 Æ A2 † † 1.05 0.1469 NS
* Comparison series used for analysis
** Significance at the p < 0.05 level
† Excluded these analyses secondary to serially dependent data (relied solely on C Statistic for analysis of significance)
Table 6-7 (continued)
(continued)
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6.3.3 DIS score baseline
The Bartlett test indicated serially dependent data for Participant 1, Phase A1, and for Participant
5, Phase A2 (see Table 6-8).  As noted previously, this serial dependency may interfere with
accurate visual analysis (Bengali & Ottenbacher, 1998) and with the semi statistical procedures
used (Ottenbacher, 1986), so the C-statistic is relied on for judging significance of the results for
these two participants under all conditions.  A summary of all of the DIS results for all
participants and all analysis methods is presented in Table 6-9, found at the conclusion of this
section of results.
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Table 6-8:  Autocorrelation test results for the DIS score measure
Participant/ test phase Autocorrelation Coefficient (r) Bartlett’s Test Autocorrelated?
Participant 1:
A1 0.6662 0.4714 Yes
C1 0.3415 0.7559 No
A2 0.0924 0.5345 No
Participant 1a:
A1 0.0231 0.4714 No
B2 0.2798 0.4851 No
C2 0.3131 0.6030 No
A2 0.3259 0.5164 No
Participant. 2
A1 0.0775 0.4364 No
B1 0.1321 0.7559 No
B2 0.5105 0.6030 No
C2 0.1887 0.6030 No
A2 0.2296 0.4264 No
Participant 3:
A1 0.2037 0.4364 No
B2 0.4245 0.4714 No
C2 0.2860 0.4472 No
A2 0.1760 0.4472 No
Participant 4:
A1 0.1252 0.5345 No
B2 0.5407 0.5774 No
C2 0.2609 0.6030 No
A2 0.0298 0.5547 No
Participant 5
A1 0.2143 0.4364 No
B2 0.3161 0.5547 No
C2 0.0028 0.4714 No
A2 0.5815 0.5345 Yes
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6.3.3.1 Participant 1
Phase A1: Baseline, Condition 1
The DIS mean score for this baseline phase was 33.8 (SD = 5.1).  Due to the serial dependency
found in these data, the C-Statistic is relied on for a determination of significant treatment effects
under the intervention phase (Phase C1). This participant was randomized to an ACBA design.
Phase C1: Intervention, Condition 3 (TestChair1, FeatureSet2)
The mean DIS score for this phase was 27.4 (SD = 2.8).  The C-statistic comparison of Phase A1
and Phase C2 was not significant (Z = 0.54), indicating no difference in discomfort as measured
by the DIS scale between this participant’s own wheelchair and TestChair1 with FeatureSet2.
As noted, visual analysis, celeration line and two standard deviation band analyses were not
performed due to the serial dependency of these baseline data.  This trial was interrupted
following five days of testing due to the development of redness under this participant’s ischial
tuberosity – a pre-established stopping point due to safety considerations.  TestChair1 use was
discontinued and this participant moved directly into Phase A2 – return to baseline testing.
Phase A2: Return to baseline, Condition 6
For the return to baseline phase, the mean DIS score was 24.9 (SD = 1.92).  C-Statistic analysis
comparing phase A1 and A2 data was significant (Z = 2.06), indicating a significant difference in
discomfort level or in the trends of these data from the first baseline condition to the second.
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6.3.3.2 Participant 1a
Phase A1: Baseline, Condition 1
The mean DIS score for Participant 1a when he was using his own wheelchair during this phase
was 21.4 (SD = 1.6).  Visual analysis of these data indicated a nearly level trend with only a
slightly negative slope, indicating a declining discomfort level during this phase of testing.  This
participant was randomized to an ACBA design.
Phase C2: Intervention, Condition 5 (TestChair2, FeatureSet2)
The mean DIS score while using TestChair2 with FeatureSet2 was 21.3 (SD = 2.1).  Visually,
the DIS means remained unchanged between Phase A1 and C2, but the trends of the Phase C2
data had a much steeper negative slope – indicating declining discomfort levels through the
Phase C2 period (see Figure 6-28).  None of the semi-statistical (celeration line or two standard
deviation band – see Figure 6-29) or statistical (C Statistic, Z = 1.18) procedures used to compare
the A1 to C2 data indicated a significant difference in these data – indicating no difference in
discomfort levels between this participant’s own wheelchair and TestChair1 with FeatureSet2.
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Figure 6-28:  DIS score means and trends for Participant 1a
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Phase B2: Intervention, Condition 4 (TestChair2, FeatureSet1)
The DIS mean score for this participant while using TestChair2 with FeatureSet1 was 19.5 (SD =
1.0).  Visual analysis of these data indicated a lower DIS mean during the intervention phase
(B2) than that of the baseline phase (A1) and a trend line with a more negative slope than the
trend of the baseline data, indicating a decreasing amount of discomfort throughout the
intervention phase that was not present during the baseline.  The celeration line comparison of
the Phase A1 and Phase B2 data was significant – with significantly lower discomfort scores
found when this participant was using TestChair2 with FeatureSet1 than those when he was
using his own wheelchair (see Figure 6-29).  Moreover, the two standard deviation band
comparison and the C Statistic test were also significant (Z = 2.55) indicating a significantly
lower discomfort level during Phase B2 than during Phase A1 (baseline).
Visual analysis of the Phase B2 data compared with the Phase C2 data indicated a lower
DIS mean during the second intervention phase (B2) and a shallower sloping trend during Phase
B2 than during Phase C2 – still indicative of a declining discomfort level, but not as rapidly
declining as that when using TestChair2 with FeatureSet2.  Neither the celeration line nor the
two standard deviation band comparison of Phase B2 and C2 data indicated a significant
difference in discomfort level between these two interventions (FeataureSet1 and FeatureSet2),
but the C-Statistic comparison was significant (Z = 2.78) indicating not only the difference in
discomfort level, but also in the trends of the data in these two phases. This indicated that the
effects from the FeatureSet1 were different from those of FeatureSet2 for this participant.
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Figure 6-29:  DIS score celeration lines and two standard deviation bands for Participant 1a
(Upper panel shows celeration lines from phase A1, C2 and B2 trend lines, lower panel shows
mean and two standard deviation bands for Phase A1 data and Phase B2 data - in bold)
Phase A2: Return to baseline, Condition 6
For the return to baseline phase, the mean DIS score was 20.6 (SD = 1.2).  Visual analysis of
these data in comparison with those of the preceding intervention (Phase B2) indicated a return
to a higher mean discomfort score and a reversal of trend to one with a positive slope rather than
a negative slope – indicating an increasing discomfort level when this participant returned to
using his own wheelchair.  All of the semi statistical and statistical (C Statistic - Z = 2.37)
comparisons of the data from phases B2 and A2 were significant (See Figure 6-29 for celeration
line and two standard deviation band depictions), indicating higher levels of discomfort when
this individual returned to using his own wheelchair compared with those experienced during use
of TestChair2 with FeatureSet1.
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Visual comparison of the data from the two baseline phases – A1 and A2 indicated no
substantial difference in means, but a difference in trend from a fairly neutral slope during the
first baseline (A1) to a trend with a positive slope during the second baseline phase (A2).
Neither the celeration line nor the two standard deviation band analyses comparing the two
baseline phases was significant, indicating no significant differences in DIS levels between the
two baseline phases.  The C-Statistic comparing these data sets (phases A1 and A2) was also not
significant (Z = 1.47), indicating no significant difference in discomfort level or trends between
the two baseline phases.
6.3.3.3 TestChair1 and TestChair2 comparison
For this first participant, additional analyses were performed based on his testing of both test
wheelchairs.  These included comparisons of Phase C1 with Phase C2 and Phase C1 with Phase
B2 to determine the presence of significant differences between TestChair1 and TestChair2.
Visual comparison of Phase C1 (Participant 1, Condition 3) with Phase C2 (Participant
1a, Condition 5) revealed a difference in mean levels, with Phase C2 data exhibiting a lower
mean DIS level (see Figure 6-30) or lower participant discomfort.  The trends of these data also
differed with both phases exhibiting downward sloping trends, but that in Phase C2 had an
increased amount of slope – indicating a more rapidly declining discomfort level during testing
of TestChair2 with FeatureSet2.  Both the celeration line and the two standard deviation band
analyses indicated a significantly lower DIS score for TestChair2 over TestChair1 (see Figure 6-
31).  The C statistic (Z = 2.58) was also significant for the Phase C1 and Phase C2 comparison,
again indicating the lower discomfort level and the change in trend when using TestChair2.
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Comparison of Phase C1 and Phase B2 data also revealed a different mean level on visual
inspection, with a lower discomfort level when this participant was seated in TestChair2 with
FeatureSet1 than that he experienced when using TestChair1 with FeatureSet2.  The trends of the
data for these two phases were very similar – both containing a slight downward slope indicative
of a declining discomfort level within each phase.  All other analyses also indicated a lower
discomfort level when this participant used TestChair2 with FeatureSet1(C Statistic Z = 3.72)
than when he used TestChair1 with FeatureSet2.
Figure 6-30:  DIS score means and trends for TestChair1 and TestChair2
(first participant)
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Figure 6-31:  DIS score celeration lines and two standard deviation bands
(graphs for TestChair1 and TestChair2 comparison - first participant)
6.3.3.4 Participant 2
Phase A1: Baseline, Condition 1
The baseline mean DIS score for Participant 2 was 12.7 (SD = 1.0).  These baseline data
exhibited a trend with a positive slope, indicating increasing discomfort levels through his
baseline phase.  This participant was randomized to an ABCA design and, due to discomfort and
function related problems he experienced with TestChair1, completed an interrupted trial of
TestChair1 (FeatureSet1 only) and a full trial of TestChair2.
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Phase B1: Intervention, Condition 2 (TestChair1, FeatureSet1)
For Phase B1 testing (TestChair1 with FeatureSet1), the DIS mean score for this participant was
14.8 (SD = 1.3).  Visual analysis of these data indicated a slight increase in mean and a decline in
the amount of positive slope in the trend from Phase A1 to Phase B1 (see Figure 6-32).  The
other very noticeable trait is the small number of observations in Phase B1 compared with Phase
A1.  Both the celeration line and the two standard deviation band analyses indicated a
significantly higher discomfort level when this participant was using TestChair1 with
FeatureSet2 than he experienced when using his own wheelchair (see Figure 6-33).  The result of
the C Statistic comparison of these two phases confirmed this difference in discomfort level (Z =
2.53).  These results were also in agreement with his anecdotal reports of discomfort – which
were the main reason for removing and redesigning the test wheelchair.
Figure 6-32:  DIS score means and trends for Participant 2
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Phase B2: Intervention, Condition 4 (TestChair2, FeatureSet1)
The mean DIS score for Participant 2 using TestChair2 with FeatureSet1 was 12.5 (SD = 1.4).
Visual analysis of these data revealed very little difference in DIS means, but a reversal of trends
for these two phases of data.  The Phase A1 trend had a slight positive slope – indicating
increasing discomfort levels when he was using his own wheelchair, but the trend for the Phase
B2 data had a steep downward slope – indicating decreasing discomfort levels during the time he
used TestChair2 with FeatureSet1.  Both the celeration line and the two standard deviation band
comparisons of these phases indicated significantly lower discomfort levels (see Figure 6-33)
when he was using TestChair2 with FeatureSet1, however, the more rigorous C Statistic result
did not reach a level of significance (Z = 1.45), failing to confirm the results of the other analyses
and indicating no significant difference in discomfort between his own wheelchair and
TestChair2 with FeatureSet1.
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Figure 6-33:  DIS score celeration lines and two standard deviation bands for Participant 2
(Upper panel shows celeration lines from Phase A1, B1, B2, and C2 trend lines.  Middle panel
shows mean and two standard deviation band lines for Phase A1 and Phase B1 (bold) data.
Lower panel shows mean and two standard deviation band lines for Phase C2 data)
Visual comparison of the Phase B1 data with the Phase B2 data indicated differences in
both means and trends for these two phases (see Figure 6-32).  The mean DIS score was
substantially higher when this participant used TestChair1 with FeatureSet1 than when he used
TestChair2 with FeatureSet1.  The trend of the data was also reversed – the TestChair1 data had
a slight positive slope – indicative of an increasing discomfort level during this phase, and the
TestChair2 data had a much steeper negative slope – indicative of a declining discomfort level
when this participant used TestChair2 with FeatureSet1.  The celeration line comparison of
Phase B1 with B2 failed to reach a significant level because there were too few data points
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during phase B2, even though all of the data points collected fell below the celeration line.
However the two standard deviation band result indicated a significantly lower discomfort score
for Participant 2 when he used TestChair2 with FeatureSet1 than when he used TestChair1 with
FeatureSet1 (See Figure 6-33).  Additionally, the C Statistic comparison of these two phases was
significant (Z = 3.0) also indicating significantly lower discomfort when he was using
TestChair2.
Phase C2: Intervention, Condition 5 (TestChair2, FeatureSet2)
During Phase C2 testing, the mean DIS score was 12.9 (SD = 0.2).  Visual analysis of these data
revealed no difference in mean level between Phase A1 and Phase C2, but the trends for these
two data sets had reversed slopes.  The Phase A1 data had a slight positive slope and the Phase
C2 data had a slight negative slope – indicating a declining discomfort level during Phase C2
testing.  Celeration line comparison of the phase A1 and C2 data indicated a significantly lower
discomfort level in TestChair2 with FeatureSet2 than that experienced in this participants own
wheelchair.  The more rigorous two standard deviation band analysis, however, failed to indicate
any significant difference in discomfort between these two wheelchairs.  In agreement with the
two standard deviation band, the C Statistic also failed to indicate any significant difference in
discomfort level ( Z = 0.36).
In the comparison of phases B1 and C2 data, visual analysis indicated a difference in
means and a slight difference in trends between these two phases.  The mean of the Phase C2
data was lower – indicating a lower discomfort level, and the trend of the data had a slightly
negative rather than a slightly positive slope – indicating a decreasing discomfort level rather
than an increasing one.  As with the comparison of phase B1 and B2, the celeration line
comparison of phase B1 and C2 failed to reach significance because of the lack of an adequate
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number of observations during Phase C2, even though all observations present fell below the
celeration line.  The two standard deviation band analysis of phases B1 and C2 was also not
significant.  In spite of these results, the more rigorous C Statistic comparison of phase B1 and
C2 data was significant (Z = 2.69) indicating a significantly lower discomfort level when this
participant was using TestChair2 with FeatureSet2 than when he used TestChair1 with
FeatureSet1.
Visual comparison of the means and trends for phases B2 and C2 indicated very little
difference in phase means, but a substantial difference in trends for these data.  The Phase B2
data had a trend with a very steep negative slope and the phase C2 data trend had only a slight
negative slope.  This indicated a much less dramatic decline in discomfort level during the Phase
C2 testing as compared with the Phase B2 test phase.  Celeration line comparison of phase B2
and phase C2 data indicated significantly higher DIS scores during Phase C2, or significantly
higher discomfort when this participant used TestChair2 with FeatureSet2 than when he used
TestChair2 with FeatureSet1.  The two standard deviation band comparison of phases B2 and C2
was not significant, indicating no differences in discomfort level experienced when using these
two different feature sets, however the C statistic, which assesses both mean and trend
differences (Tryon, 1982), was significant (Z = 1.72), most likely indicating a significant
difference in the trend of the two data sets – with the phase B2 data revealing a rapidly declining
discomfort rate and the phase C2 data not sharing this same trend.
Phase A2: Return to baseline, Condition 6
The mean DIS score for the return to baseline phase was 12.9 (SD = 0.9).  Visual analysis
indicated no detectable differences in mean levels and only a slight shift in trend between the
Phase C2 and Phase A2 data.  The trend for the return to baseline phase  resumed a slight
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positive slope – indicating an increasing level of discomfort within this phase.  Both the
celeration line and two standard deviation band analyses indicated significantly higher DIS
scores on return to baseline (using his own wheelchair) than those recorded during the final
intervention phase using TestChair2 with FeatureSet2, however the C Statistic comparison of
phases C2 and A2 failed to reach a significant level (Z = 1.15), indicating no difference in
discomfort mean or trends between these two wheelchairs.
Visual comparison of the two baseline phase – A1 and A2 – indicated very little
difference in mean DIS and only a slight change in trend – from a steeper trend for the Phase A1
data to a shallower, but still positive sloping trend for the Phase A2 data.  Celeration line
comparison of these two phases indicated a significantly lower discomfort level during the return
to baseline phase than during the first baseline – even though his chair was unchanged, however,
neither the more rigorous two standard deviation band nor the C Statistic result (Z = 0.75)
indicated any significant difference between the two baseline phases.
6.3.3.5 Participant 3
Phase A1: Baseline, Condition 1
For this baseline phase, the mean DIS score was 36.7 (SD = 8.8).  These data appeared to be
quite variable with a repeated daily pattern of low DIS scores in the morning progressing to
higher scores at the end of each day.  The trend of these data had a downward slope, indicating a
decreasing discomfort level during this baseline phase. This participant was randomized to an
ACBA design.
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Phase C2: Intervention, Condition 5 (TestChair2, FeatureSet2)
The mean DIS score for Participant 3 when he was using TestChair2 with FeatureSet2 was 15.5
(SD = 5.5).  Visual analysis of these data revealed a large difference in DIS mean but very little
change in trend for these data compared with the baseline data (see Figure 6-34).  All semi-
statistical (see figure 6-35) and statistical analyses indicated a significantly lower level of
discomfort when this participant was using TestChair2 with FeatureSet2 than when he was using
his own wheelchair (C Statistic Z = 4.97).
Figure 6-34:  DIS score means and trends for Participant 3
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Phase B2: Intervention, Condition 4 (TestChair2, FeatureSet1)
The mean DIS score for this condition was 9.8 (SD = 2.2).  Visual analysis revealed a large
difference between the baseline data (Phase A1) and the Phase B2 data in mean level and in
trend.  The mean for this discomfort measure was substantially lower when this participant used
TestChair2 with FeatureSet1 than when he used his own wheelchair.  The trends changed from a
negative sloping trend during the baseline phase to a slight positive slope during Phase B2 –
indicating a slightly increasing discomfort level when he was using TestChair2 with FeatureSet1.
Both the celeration line and two standard deviation band analysis revealed significant differences
between the baseline (A1) data and the Phase B2 data (see Figure 6-35), indicating significantly
lower levels of discomfort when he was using TestChair2 with FeatureSet1 than when he used
his own wheelchair.  The C Statistic analysis confirmed this finding of a significant difference
between these two wheelchairs (Z = 5.20).
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Figure 6-35:  DIS score celeration lines and two standard deviation bands for
Participant 3
(Upper panel includes celeration lines from Phase A1, C2 and B2 trends, lower panel
includes mean and two standard deviation band lines for Phase A1 and Phase B2 (bold)
data)
Analysis of Phase B2 data compared to Phase C2 data was also performed to determine
the differential effects of FeatureSet1 and FeatureSet2.  Visual analysis revealed a lower mean
level under Phase B2 but a slight change in trend from a slight negative slope during Phase C2 to
a slight positive slope – indicating increasing discomfort levels - during Phase B2 (when he was
using FeatureSet1).  Neither the celeration line nor two standard deviation band comparisons of
phases B2 and C2 indicated a significant difference between his comfort level when using
FeatureSet1 versus FeatureSet2, however, the C statistic comparison result was significant (Z =
2.82), indicating a difference in mean, or more likely in trend for his discomfort level while
using these two feature sets.
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Phase A2: Return to baseline, Condition 6
The mean DIS score for the return to baseline phase for this participant was 21.5 (SD = 8.0).
Visual analysis of these data compared with the data from the preceding intervention phase (B2)
indicated a difference in mean – with a higher DIS mean during the second baseline phase, and a
change in trend.  The trend of the Phase B2 data had a slight positive slope – indicating a slowly
increasing discomfort level during this phase, however the trend of the return to baseline phase
had a steep positive slope – indicating a rapidly increasing level of discomfort during this phase.
Celeration line and two standard deviation band comparisons of Phase A2 and the preceding
intervention phase (Phase B2) data indicated a significant increase in DIS scores when he
returned to using his own wheelchair, indicating increased levels of discomfort.  In addition, a C
statistic analysis of the final intervention phase data and this baseline data (phase B2 and A2)
was significant (Z = 4.35), again indicating a significant increase in his discomfort level when he
returned to sitting in his own wheelchair.
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Visual analysis of the Phase A2 data compared with the data from the first baseline phase
(A1) indicated a difference in mean – with a lower DIS mean during the second baseline phase,
and a reversal in trend.  The trend of the Phase A1 data had a negative slope – indicating a
declining discomfort level during this phase, and the trend of the Phase A2 data had a steep
positive slope – indicating a rapidly increasing level of discomfort during this phase.  The
celeration line comparison of these two baseline phases indicated a significantly higher
discomfort level during the return to baseline phase (A2) than that experienced during the first
baseline (A1).  However, the two standard deviation band indicated a significantly lower
discomfort level during the second baseline phase (A2).  This conflicting result was most likely
due to the reversal in trends between these two phases.  The C Statistic comparison of these data
was also significant (Z = 3.48) reflecting both the change in mean level and in trend and
indicating a lower overall discomfort level during the return to baseline phase (A2).
6.3.3.6 Participant 4
Phase A1: Baseline, Condition 1
For Participant 4, the mean DIS score when seated in his own wheelchair was 16.8 (SD = 4.8).
There was a high degree of variability at the beginning of the baseline phase with a trend that had
a slightly negative slope, indicating a decline in discomfort level during this phase.  This
participant was randomized to an ABCA design.
Phase B2: Intervention, Condition 4 (TestChair2, FeatureSet1)
For Phase B2, the DIS mean was 20.3 (SD = 3.9).  Visual analysis of these data indicated a
higher mean level than that of the baseline data and an increasing rather than a decreasing trend
(see Figure 6-36).  The result of the celeration line analysis indicated a significantly higher
discomfort score when he was using TestChair2 with FeatureSet1 compared with his own
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wheelchair (see Figure 6-37), however neither the more rigorous two standard deviation band nor
the C Statistic results were significant (Z = 0.39), indicating no difference in discomfort level for
this participant seated in his own wheelchair compared with when he was seated in TestChair1
with FeatureSet1.
Figure 6-36:  DIS score means and trends for Participant 4
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Phase C2: Intervention, Condition 5 (TestChair2, FeatureSet2)
The mean DIS score for Phase C2 was 21.9 (SD = 4.8).  Visual analysis again revealed a high
degree of data variability and a higher mean level than that of the baseline data (Phase A1) with a
very similar trend slope (see Figure 6-36).  The celeration line analysis indicated a significantly
higher level of discomfort when he was using TestChair2 with FeatureSet2 than that when he
was using his own wheelchair (see Figure 6-37), however, as with the Phase B2 analysis, the
more rigorous tests – the two standard deviation band and C Statistic (Z = 0.68) failed to indicate
any difference in discomfort levels between this participant’s own wheelchair and TestChair2
with FeatureSet2.
Comparison of the two intervention phases – B2 and C2 revealed no substantial
difference in mean or in trend upon visual analysis (see Figure 6-36).  Neither the celeration line
nor the two standard deviation band analysis indicated any significant difference in discomfort
level between use of FeatureSet1 and FeatureSet2, however, the C Statistic comparison of these
two phases yielded a significant result (Z = 1.70), indicating a difference between the two
intervention conditions.
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Figure 6-37:  DIS score celeration lines and two standard deviation bands for
Participant 4
Phase A2: Return to baseline, Condition 6
When Participant 4 resumed sitting in his own wheelchair, his mean DIS score was 15.5 (SD =
1.3).  Visual comparison of the final intervention phase (C2) and this return to baseline phase
(A2) indicated a drop in mean DIS score when he resumed using his own wheelchair.  The trend
remained very similar, with only a slight increase in the slope noted during Phase A2.  Celeration
line analysis indicated a significantly lower discomfort level in his own wheelchair than in
TestChair2 with FeatureSet2, but this result was not found when employing the two standard
deviation band or C Statistic analysis methodology (Z = 1.40), failing to indicate any significant
difference in discomfort level when he returned to his own wheelchair.
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When an a visual comparison of the two baseline phases (A1 and A2) was performed, the
DIS means were very similar, with a slightly lower mean during the return to baseline phase, and
the trends were also quite similar in slope, but opposite in direction.  The Phase A1 trend had a
slight negative slope – indicating a declining discomfort level during this phase, but the Phase
A2 trend had a slight positive slope – indicating an increasing discomfort level during this phase.
The Phase A2 data were also far less variable than those in Phase A2 – perhaps due to increased
familiarity with the data collection instrument.  The celeration line comparison of phase A1 and
A2 data indicated a significantly higher discomfort level during the return to baseline phase than
what would have been predicted from the original baseline (Phase A1).  Neither the two standard
deviation band nor the C Statistic indicated any difference in discomfort levels between these
two baseline phases (Z = 0.86).
6.3.3.7 Participant 5
Phase A1: Baseline, Condition 1
The baseline mean DIS score for this final participant was 45.29 (SD = 2.1).  Due to the
significant result from the Bartlett test for autocorrelation for the Phase A2 data, all data from
this participant was considered serially dependent (Ottenbacher, 1986) and the C-Statistic was
relied on for testing of significance of these data across all phases.  This participant was assigned
to an ACBA test order.
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Phase C2: Intervention, Condition 5 (TestChair2, FeatureSet2)
The Phase C2 mean DIS score was 33.44 (SD = 6.45).  The C statistic comparison of Phase A1
and Phase C2 data was significant (Z = 3.59), indicating a change in discomfort between these
two phases – in this case due in part to a lower discomfort mean score and a change in the trend
of the data (both are detected by the C Statistic).  This result indicated a significantly lower
discomfort level when this participant used TestChair2 with FeatureSet2.
Phase B2: Intervention, Condition 4 (TestChair2, FeatureSet1)
The mean DIS score for Phase B2 was 47.1 (SD = 3.8).  The C Statistic comparison of Phase B2
with the baseline phase (A1) was not significant (Z = 0.29), indicating no difference in mean
discomfort level or trend between her own wheelchair and TestChair2 with FeatureSet1.  The C
Statistic comparison of discomfort level using TestChair2 with FeatureSet1 (Phase B2) with that
when using TestChair2 with FeatureSet2 (Phase C2) was significant (Z = 3.67), indicating a
significant difference in discomfort level experienced between use of FeatureSet1 and
FeatureSet2.  This result indicates that Participant 5 experienced significantly greater levels of
discomfort when using FeatureSet1 than when using FeatureSet2, both on TestChair2.
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Phase A2: Return to baseline, Condition 6
The Phase A2 DIS data for this participant were found to be serially dependent.  The mean score
for these data was 51.2 (SD = 6.73).  C Statistic comparison of Phase B2 and Phase A2 data was
not significant (Z = 1.57) indicating no differences between her discomfort levels when using
TestChair2 with FeatureSet2 and her return to baseline wheelchair.  C Statistic comparison of
Phase A1 and Phase A2 data was also not significant (Z = 0.01) indicating no difference in
discomfort levels between these two baseline conditions.  Graphed data for this participant are
presented in Figure 6-38 but were not used during these analyses due to the presence of serially
dependent data for Phase A2.
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Figure 6-38:  DIS score graphed data for Participant 5
(Top frame – mean levels and trends, bottom frame – celeration line and two standard
deviation bands)
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Table 6-9:  DIS score summary of results
Participant and type of comparison Comparison Celeration line Two standard
deviation band
C-Statistic
SIG** SIG** Z Score p SIG**
Participant 1: (ACBA design)
Baseline Æ Intervention A1 Æ C1 † † 0.54* 0.2946 NS
Baseline 1 Æ Baseline 2 A1 Æ A2 † † 2.06* 0.0197 SIG
Participant 1a: (ACBA design)
Baseline Æ Intervention A1 Æ C2 NS NS 1.18 0.1190 NS
Baseline Æ Intervention A1 Æ B2 SIG lower SIG lower 2.55 0.0054 SIG
Intervention Æ Intervention C2 Æ B2 NS NS 2.78 0.0027 SIG
Intervention Æ Baseline B2 Æ A2 SIG higher SIG higher 2.37 0.0089 SIG
Baseline 1 Æ Baseline 2 A1 Æ A2 NS NS 1.47 0.0708 NS
TestChair1 and TestChair2 (Participant 1):
Intervention Æ Intervention C1 Æ C2 SIG lower SIG lower 2.58 0.0049 SIG
Intervention Æ Intervention C1 Æ B2 SIG lower SIG lower 3.72 < 0.001 SIG
Participant 2: (ABCA design)
Baseline Æ Intervention A1 Æ B1 SIG higher SIG higher 2.53 0.0057 SIG
Baseline Æ Intervention A1 Æ B2 SIG lower SIG lower 1.45 0.0735 NS
Intervention Æ Intervention B1 Æ B2 Not enough data points SIG lower 3.00 0.0013 SIG
Baseline Æ Intervention A1 Æ C2 SIG lower NS 0.36 0.3594 NS
Intervention Æ Intervention B1 Æ C2 Not enough data points NS 2.69 0.0036 SIG
Intervention Æ Intervention B2 Æ C2 SIG higher NS 1.72* 0.0427 SIG
Intervention Æ Baseline C2 Æ A2 SIG higher SIG higher 1.15 0.1251 NS
Baseline 1 Æ Baseline 2 A1 Æ A2 SIG lower NS 0.75 0.2266 NS
Participant 3: (ACBA design)
Baseline Æ Intervention A1 Æ C2 SIG lower SIG lower 4.97 < 0.001 SIG
Baseline Æ Intervention A1 Æ B2 SIG lower SIG lower 5.20 < 0.001 SIG
Intervention Æ Intervention C2 Æ B2 NS NS 2.82 0.0024 SIG
Intervention Æ Baseline B2 Æ A2 SIG higher SIG higher 4.35 < 0.001 SIG
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Participant and type of comparison Comparison Celeration line Two standard
deviation band
C-Statistic
SIG** SIG** Z Score p SIG**
Baseline 1 Æ Baseline 2 A1 Æ A2 SIG higher SIG lower 3.48 0.0003 SIG
Participant 4: (ABCA design)
Baseline Æ Intervention A1 Æ B2 SIG higher NS 0.39 0.3483 NS
Baseline Æ Intervention A1 Æ C2 SIG higher NS 0.68 0.2483 NS
Intervention Æ Intervention B2 Æ C2 NS NS 1.70* 0.0446 SIG
Intervention Æ Baseline C2 Æ A2 SIG lower NS 1.40 0.0808 NS
Baseline 1 Æ Baseline 2 A1 Æ A2 SIG higher NS 0.86 0.1949 NS
Participant 5: (ACBA design)
Baseline Æ Intervention A1 Æ C2 † † 3.59 0.0002 SIG
Baseline Æ Intervention A1 Æ B2 † † 0.29 0.3859 NS
Intervention Æ Intervention C2 Æ B2 † † 3.67 0.0001 SIG
Intervention Æ Baseline B2 Æ A2 † † 1.57 0.0582 NS
Baseline 1 Æ Baseline 2 A1 Æ A2 † † 0.01 0.4960 NS
* Comparison series used for analysis
** Significance at the p < 0.05 level
† Analyses not used for this participant due to the presence of serially dependent data
Table 6-9 (continued)
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6.4 DISCUSSION
As the results presented in the preceding sections and summarized in tables 6-5, 6-7 and 6-9
indicate, the three measures considered to be related to discomfort – time spent sitting in one’s
wheelchair (TIC), and the WcS-DAT GDA and DIS discomfort scores performed very
differently from each other and across participants in this study.  A hierarchical approach to
analysis of these data was used – starting with the most basic single subject design method of
visual analysis.  Following autocorrelation testing, three semi statistical and statistical
approaches were then used in increasing level of rigor.  The first of these was the celeration line
method, the next was the two standard deviation band and the final and most rigorous test was
the C Statistic.  Performance of each of the outcome measures (TIC, GDA, and DIS), of the
methodology applied, and of the user adjustable seating was evaluated based on the outcomes
and level of agreement of all of these analysis methods.  Consideration was also given to the
agreement of data analysis with anecdotal reports from the participants themselves.
The time in wheelchair, or TIC, data were the most inconsistent across the conditions,
with only 7 phase-to-phase analyses having full agreement on all methods, and TIC also showed
the fewest total phase comparison significant results (32 of 99 total).  One advantage of these
data was that they were least likely to be autocorrelated – with none of the participants’ phases
testing positive for serial dependency.  There were too few points for celeration line analysis for
Participant 2, Phase B1 due to the interruption of testing.  Both participants 1 and 2 reported
significantly increased discomfort using TestChair1 (phases B1 and C1), but the time they spent
sitting was not significantly different from that when using their own wheelchairs.  Participant 3,
who demonstrated significantly decreased discomfort levels using TestChair2 on both the GDA
and DIS measures, also had mixed results on all tests of his TIC data – two of which indicated
171
significantly less sitting time and one significantly more.  Because of the low frequency of data
points, typically 6 –7 per phase, the baseline trend lines may not have been very accurate
representations of true sitting time behavior (Ottenbacher, 1986).
Another problem with the measure of sitting time is that participants tested in this study
had little ability to control how long they sat each day.  Only two of the participants (participants
3 and 5) could transfer independently, all the others relied on other family members or personal
care attendants to assist them with transfers.  Their sitting schedules were largely determined by
the schedules of those around them and their own activities for the day (e.g. for Participant 1, a
college student, his class schedule).  They were not typically able to alter these sitting schedules
when they became uncomfortable.  For this reason, total sitting time did not perform well as an
indication of wheelchair seating discomfort among these participants.  For populations with
higher levels of discomfort – high enough to demand action – this may not hold true and
discomfort may indeed limit sitting time, but this was not the case with the participants tested in
this study.
The GDA scores performed more consistently, particularly in the cases of clearly
increased or decreased discomfort levels.  There were 40 significant results, 9 of which were
excluded due to the serially dependent data, leaving 31 significant out of 77 total analyses.
Additionally, 10 of the phase to phase comparison combinations had full agreement across all
analysis methods.  Two of the participants had serially dependent data on this measure, therefore
the C Statistic was relied on for these analyses.  Participant 3 reported dramatically lower levels
of discomfort while using TestChair2 and his GDA scores showed significantly lower discomfort
levels on all analyses.  Conversely, Participant 2 indicated increased discomfort when using
TestChair2, and although his increased discomfort levels were not as pronounced, his GDA data
172
demonstrated significantly higher levels of discomfort on 2 out of the 4 analyses.  Overall, the
four analysis methods had better agreement as to significance or non-significance for the GDA
data than for the TIC data.
The final measure used – the DIS scores – was the best of the three in terms of overall
significance (55 total significant results, 7 of which were excluded due to serially dependent data
– leaving 48 significant results out of 85 total analyses) and level of consistency across analysis
methods (11 full phase to phase comparison agreements).  As with the GDA scores, this measure
resulted in serially dependent data for two of the participants.  Due to the previously noted
dramatic change in discomfort level, DIS data from Participant 3 indicated significant results
across all treatment phases and across all analysis methods.  Data from Participant 1a were also
significant for all analysis methods for comparison of Phase A1 and Phase B2 and not significant
across all methods comparing Phase A1 and Phase C2.  Visual analysis was simpler for these
data as well due to the decreased variability of the data.
Both the DIS scores and the GDA scores related closely to the participants’ anecdotal
reports of increased or decreased discomfort levels.  Comparisons of the test wheelchair with the
baseline wheelchair and TestChair1 to TestChair2 were facilitated by both the GDA and DIS
measures.  For all participants, the DIS and GDA measures were sensitive to differences between
their own wheelchairs and the test wheelchair in use.  Most of these differences showed
decreased discomfort levels when using the user adjustable features available on the test
wheelchair.  These differences were particularly dramatic as the differences between the features
available on the participants’ own wheelchairs and those available on the test wheelchair differed
(e.g. Participant 3 who had very few adjustments available on his own wheelchair).  For the two
participants who trialed TestChair1 and TestChair2 (participants 1 and 2), both the GDA and
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DIS measures, in contrast to the earlier TIC measure, were able to differentiate the discomfort
differences between these two wheelchairs – which were anecdotally reported by both of these
participants.  However the GDA and DIS measures did not seem to be sensitive enough in many
cases to allow comparison of the two treatment phases using different configurations of seating
(FeatureSet1 and FeatureSet2).  This may be due to the lack of a differential effect of the two
feature sets – i.e. the addition of the pneumatic features did not produce enough of an effect on
discomfort to allow these measures to detect differences between these two intervention phases
(B and C) in most cases.
6.5 CONCLUSION
This study examined the effectiveness of the WcS-DAT and the sitting time outcome measures
for detecting differences in discomfort levels over time, or with the introduction of different
seating equipment.  Also, the research methodology used in this study, single subject design, was
a novel approach to studying discomfort and the effects of a user adjustable seating intervention
in this population.  The effectiveness of the intervention – the user adjustable wheelchair seating
– was also examined to guide future development of this type of equipment to address the issues
around discomfort.
As indicated, the time in wheelchair outcome measure did not perform well as a measure
of wheelchair seating discomfort.  The results based on this measure were inconsistent and
difficult to assess due to the problems with small data sets and the scheduling realities faced by
the participants involved in this study.  This may be an important measure for other individuals
with seating discomfort, but it did not prove itself during this research.  Conversely, the two
scales included in the WcS-DAT performed adequately based on consistency across analysis
methods and for measuring differences in discomfort levels over time and with the introduction
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of the wheelchair seating interventions.  Although these measures had difficulty detecting very
small treatment effects (i.e. the difference between the B and C phase interventions) they easily
detected differences from the baseline seating (the participant’s own wheelchair) to the test
wheelchairs.
Finally, as to the effectiveness of the research design as a whole, the single subject
research design allowed insight into this very difficult wheelchair seating problem.  The 28-day
(sometimes longer) labor intensive data collection methodology placed great demands on the
participants in this study.  There were some inconsistencies with the data collected due to
recording errors or difficulties recording data on the recommended schedule, but overall the data
collected allowed the in-depth investigation of discomfort as a wheelchair seating problem and
the effectiveness of a potential intervention (the user adjustable seating).
Discomfort levels were shown to increase throughout the day – particularly after 6 hours
of continuous sitting.  These data validated the effectiveness of the WcS-DAT tool and
reinforced the need for long duration testing of wheelchair seating products to truly determine
their ability to combat sitting discomfort.  Also, discomfort levels fluctuated from day to day,
indicating a need for multi-day evaluations to truly determine consistency of performance.  The
7-day phases required tremendous dedication from the participants, but resulted in a richness of
data unavailable with shorter testing periods and in some cases (e.g. sitting time measures),
longer phases might have been more desirable.
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The difficulties involved in introducing a novel wheelchair to these participants cannot be
overlooked.  The wheelchair base itself, which was not being studied, may have interfered with
the ability to truly examine the effects of the seating intervention.  The fit and function of the
wheelchair was sub-optimal for many of the participants and interfered with true testing of the
seating intervention being studied.
Recommendations for future study include: 1) studying “stand-alone” seating products
that would be capable of integrating into the participants’ own wheelchairs; 2) reducing the
WcS-DAT scoring to perhaps twice per day – once at 6 hours and once at bed time – due to the
relatively low levels of discomfort reported with shorter sitting durations; 3) reducing the data
collection labor involved on the part of the participants (perhaps by automating more of the data
collection process) and extending the phase lengths to 8 – 10 days per phase to attain greater
stability of trends; and 4) increasing the number and pattern of alternating phases – perhaps only
studying one intervention at a time and using an ABABA design.  These changes will enhance
the ability of the WcS-DAT to evaluate the impact of wheelchair seating on the outcomes of
discomfort.
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7.0 SUMMARY AND RECOMMENDATIONS
7.1 REVIEW OF OBJECTIVES
The main goal of this dissertation research was the development and validation of a tool for
quantifying wheelchair seating discomfort in sensate wheelchair users.  This main goal was
accomplished progressively through attainment of several smaller goals:
1. To use input from wheelchair users who have experienced discomfort to develop
the content of a tool that is useful in allowing individuals who use wheelchairs to
quantify their level of discomfort. (Pilot studies and Phase I)
2. To assess the reliability, concurrent validity and internal item consistency of this
tool to allow it to be a valid research tool for the stated purpose. (Phase II)
3. To assess the effectiveness or sensitivity of this tool for detecting changes in
wheelchair seating discomfort elicited in a longitudinal study using a prototype
user adjustable wheelchair seating system. (Phase III)
To accomplish these goals, three major research studies and two smaller, preliminary
research studies were carried out.  The results from each of these research tasks have been
presented in earlier chapters of this dissertation and discussed within these individual chapters.
This chapter will summarize and discuss all of these research tasks and the overall results and
conclusions of this research as a whole.  Limitations of the research tasks will be discussed as
well as recommendations for future research to expand on that presented in this dissertation.
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7.2 SUMMARY OF FINDINGS
To accomplish the goal of developing a valid and reliable wheelchair seating discomfort
assessment measure, the first step was to perform an extensive review of the literature to
determine what assessment measures already existed that would help guide the development of
the WcS-DAT.  This literature review is presented in full in Chapter 2 of this dissertation.
Results of this review are as follows: (1) as suspected, no validated tool for assessing wheelchair
seating discomfort currently exists; (2) there have been multiple tools developed and validated
for assessing seating discomfort among unimpaired users of office equipment and automobiles,
but these do not directly relate to the unique problems encountered by wheelchair users, (3)
wheelchair users do experience discomfort associated with sitting in their wheelchairs and it is a
significant and negative outcome of this type of assistive technology use, and (4) due to the
potential size of the population of wheelchair users likely to experience problems related to
wheelchair seating discomfort, a tool that will aid in research, clinical outcomes measurement,
and product design and testing would be highly beneficial.
Results from the two pilot studies helped to confirm the significance of the seating
discomfort problem and also helped to guide the development of the WcS-DAT and of the user
adjustable wheelchair seating system used in the Phase III testing process.   In Pilot Study 1 a
questionnaire was used (see Appendix A) to query representatives of the target population
regarding their experiences with wheelchair seating discomfort.  Nine individuals completed this
extensive survey process and data were collected regarding the most important attributes of
wheelchair seating systems, the importance of adjustability of various wheelchair seating
components, and the problems associated with long duration (over 8 hours per day) wheelchair
use.  Several results found in the literature regarding the importance of comfort for wheelchair
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users and the current comfort-related limitations of the available wheelchair seating products
were re-confirmed by the data collected.  The results from this small pilot study supported the
need for a more in-depth investigation of this topic and guided the initial development of the
discomfort assessment tool later developed during Phase I of the larger research study.  In Pilot
Study 2 a prototype of a user adjustable wheelchair seating system was introduced in a
laboratory-based study to assess the initial response to the various adjustable components by a
group of experienced wheelchair users also from the target population.  This limited trial of
many user adjustable components provided valuable information regarding the importance of
adjustability of various features and helped to guide the development of the next prototype test
wheelchair seating system (PTS2).  This interaction with the subjects also added to the general
knowledge of discomfort problems and possible solutions.  Overall the response of these
participants was extremely positive and further encouraged and supported the research proposed
in phases I, II and III of this dissertation.
Phase I of the main research associated with this dissertation involved the use of
qualitative research techniques to obtain necessary information to construct the Wheelchair
Seating Discomfort Assessment Tool (WcS-DAT).  This research phase involved interviews with
experienced wheelchair users who all had problems with seating discomfort.  The interview
questions explored the wheelchair users’ experiences of discomfort and comfort, strategies for
management of discomfort or pain, and differences between comfort and discomfort and pain
and discomfort.  The data from these interviews were coded and analyzed and the analysis was
used to generate the three components of the WcS-DAT.  Part One of the WcS-DAT asks several
questions all related to factors felt to influence the development of discomfort by the wheelchair
users who were interviewed.  This section includes items such as being transferred properly into
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one’s wheelchair, the duration of sitting, distraction in one’s environment, the effects of vibration
caused by traveling over rough terrain in one’s wheelchair, and several other similar items.  Part
two of the WcS-DAT asks the wheelchair user to rate the level of agreement or disagreement
with 13 statements related to comfort and discomfort on a 7 point Likert scale.  All of these
statements were generated directly from the statements offered by the wheelchair users during
the Phase II interview process.  The final part of the WcS-DAT – Part III – allows the wheelchair
users to rate a level of discomfort on a 0 to 10 scale of several body areas and of the body as a
whole.  The necessity of this part of the tool was suggested by the tools reviewed during the
literature review (Corlett & Bishop, 1976; Helander & Zhang, 1997), but also by the participants
in the interview process.  The body area list was generated directly from the data obtained during
the interviews.  Following the construction of this tool, it was distributed to the individuals who
participated in the interview for a “member checking” process.  This was a way to confirm the
face validity of the tool and to assure that it was representative of what the participants felt they
conveyed during the interview process.  All of the participants were pleased with the final tool
and all felt it represented their experiences of wheelchair seating discomfort and would be a good
way to assess wheelchair seating discomfort.  Triangulation with other sources (literature
reviewed and expert clinicians) also confirmed the initial validity of the WcS-DAT.
In Phase II of this research, 30 subjects were recruited to participate in a test-retest
reliability and concurrent validity study of the WcS-DAT.  These subjects were provided with
four copies of the WcS-DAT as well as copies of the Chair Evaluation Checklist (Helander &
Zhang, 1997) and the Short Form of the McGill Pain Questionnaire (Melzack, 1987).  The
subjects completed these assessments in pairs.  The first pair was completed the day of
enrollment in the study – one hour apart from each other.  The second pair was completed one
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week later at approximately the same time of day and also one hour apart.  This time schedule
was designed to provide optimal similarity in wheelchair seating discomfort levels, realizing that
wheelchair seating discomfort is not stable by its nature.  Intraclass Correlation Coefficients
(ICC) were used to assess the reliability of the two discomfort scores derived from the WcS-
DAT data – the General Discomfort Assessment score (GDA) and the Discomfort Intensity
Score (DIS).  The resulting ICC’s ranged from a low of 0.83 to a high of 0.97.  The pre-
determined criteria of acceptability was 0.80, so all of the ICC scores met or exceeded the
established criteria for adequate reliability.  Internal consistency of the items was assessed using
Cronbach’s Alpha scores.  These scores ranged from 0.82 to 0.92 for each of the individual
items.  These values indicated good internal consistency without redundancy of items.  Due to
these results, the decision was made that no changes to the content of the WcS-DAT were
indicated.  Pearson product moment correlations were used to assess concurrent validity of the
WcS-DAT with the other tools used in this assessment process.  Of 52 comparisons used for
determining concurrent validity, 45 of them were significant at the 0.001 level, six were
significant at the 0.01 level and one was significant at the 0.05 level.  These results indicated
good concurrent validity of the WcS-DAT with similar tools that have already been validated
with different subject populations.  However, the resulting correlations were not strong enough
to suggest that the measures used for this concurrent validity assessment would be adequate tools
to assess wheelchair seating discomfort – a slightly different construct.
In phase III of this research, the WcS-DAT was used to assess changing levels of
discomfort in a prospective, longitudinal, single subject design study.  This was a multiple
baseline, alternating treatments design with an ABCA/ACBA format.  The results from this
study were used to analyze the effectiveness of the WcS-DAT in detecting changes elicited by
181
sitting duration and by use of a prototype user adjustable powered wheelchair seating system
designed to reduce wheelchair seating discomfort.  The results, extensively reported in Chapter 6
of this dissertation, illustrate the excellent performance of the two measures – the GDA and the
DIS assessment scales – in quantifying wheelchair seating discomfort for the 6 single subject
trials performed.  These scores were sensitive to changes brought about by increased sitting
duration and also were able to show changes based on the use of novel seating equipment –
regardless of the direction of change.  The two scores had good agreement with each other and
good agreement across analysis methods used.
7.3 LIMITATIONS OF THIS RESEARCH
The research studies reported in this dissertation each have important limitations that affect the
generalizability of the findings.  All of the studies were restricted to a very specific target
population – namely wheelchair users with intact sensory function and severe motor deficits.
This target population was specifically selected due to the belief that the wheelchair users
comprising this group would be at particularly high risk for wheelchair seating discomfort.  This
served two purposes – one was to recruit subjects with particular discomfort related experiences
or expertise, the other is to assure that the findings would benefic those most affected by the
problem.  Diagnostic groups included multiple sclerosis, muscular dystrophy, amyotrophic
lateral sclerosis, and polio or post polio syndrome.  Due to these restrictions, the applicability of
the WcS-DAT in quantifying wheelchair seating discomfort for wheelchair users who are not a
part of this population cannot be predicted.  The first two pilot studies used very small numbers
of subjects – nine for Pilot Study 1 and six for Pilot Study 2.  Even if these self-selected subjects
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were representative of the chosen target population, this small number of subjects may reduce
applicability of these findings to other wheelchair users.  During Phase I testing, the quality of
the data collected may have been affected by the inexperience of the researcher.  Even with the
training and preparation provided by research mentors, the interviews would have been
strengthened by having a more experienced qualitative researcher involved in the process.  All of
the phases involved the use of subjects or participants who were not randomly selected, but
rather were self selected after seeing advertisements for this study or hearing about the study
from another source.  This introduces a selection bias in that there may have been some
characteristic specific to those who volunteered to participate that affected how they reacted to
the intervention.  This does not provide conclusive evidence that these samples were not truly
representative of the target population, but it must be kept in mind that many statistical
techniques used rely on a basic assumption of random subject selection to allow generalization to
the target population as a whole.  This is not as much of a concern for Phases I and III – which
do not rely on statistical methods founded on the principles of random selection, but may
particularly affect Phase II.  Another concern for Phase II and Phase III testing is the testing
effects that may be introduced by completing the same assessment multiple times.  During Phase
II the WcS-DAT is completed on four occasions and the two pair are completed one hour apart.
One of the risks to assessing the true reliability of the tool is that the subjects are merely
remembering and repeating answers rather than re-assessing and providing answers based on
their present experience.  The complexity of the assessments completed would help to minimize
this risk, but it still must be acknowledged.  The repetitive testing involved in Phase III may well
have led to an increased risk of testing effects in which the actual completion of multiple tests
will affect the response being measured in the subjects (i.e. their discomfort levels may be
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heightened or diminished by the act of the reporting itself).  Phases II and III both involve
discomfort testing on multiple occasions, which may affect the way in which the subjects report
or attend to their sitting discomfort just because of the testing.  For the Phase III study – which
was carried out over approximately 28 days of testing per subject, history and maturation may
have affected the results obtained.  Many of the research subjects had progressive neuromuscular
disease processes and they may have actually undergone changed in their medical or functional
conditions (maturation) that would affect their level of seating discomfort.  Also, several of the
subjects underwent changes in their equipment usage or in their home environments or activities
– history effects, that may have affected their discomfort levels separate from the independent
variable.
During Phase III, there may have been a novelty affect associated with the introduction of
a new wheelchair and seating system that the subjects were aware was supposed to alleviate
seating discomfort.  Although the subjects were not specifically informed of this, it was not
possible to totally blind them to the intent.  This may have affected their initial responses to the
test equipment.  It was hoped that the time frame chosen for testing i.e. one week per phase,
would be long enough for this “novelty” affect to wear off – (by allowing a “wash in” period) but
for some of the subjects this may have not been true and their responses to the equipment may
have been based on the fact that it was new or different rather than that it was truly less
uncomfortable.
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7.4 CONTRIBUTIONS OF THIS RESEARCH
The research in this dissertation, presented in the preceding paragraphs, resulted in several
contributions to the field of wheelchair seating research, particularly to that involving wheelchair
seating outcomes or problems associated specifically with seating discomfort among wheelchair
users.  The most prominent contribution is that of the WcS-DAT – a validated tool for
quantifying wheelchair seating discomfort.  This type of tool has never been produced and
validated for use with wheelchair seated individuals and the ability to use this tool for future
research, measurement of clinical outcomes, and development of new wheelchair seating
products is potentially revolutionary.
In addition to this major contribution have been several smaller but not less important
contributions.  The two pilot studies and the Phase I research contributed to our knowledge and
understanding of the problem of discomfort in the target population.  This research also focused
on wheelchair seating discomfort from a consumer’s perspective – this gave the researchers
additional insight that was then shared with the research and clinical practice communities
during conference presentations (Crane & Hobson, 2002; Crane et al., 2003).  Also, in Phase III,
a novel approach to studying wheelchair seat discomfort using a single subject design
methodology was assessed and found to be a highly effective method for investigating
wheelchair seating discomfort and the impact of assistive technology on discomfort.
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7.5 RECOMMENDATIONS FOR FUTURE RESEARCH
The findings from this research, in the context of previous research found in the literature
related to discomfort and wheelchair seating outcomes, suggest several possible areas for future
research.  Validation of the WcS-DAT tool with other populations of wheelchair users would
increase its general usefulness as a clinical outcome and research tool.  Further study of the many
factors associated with wheelchair seating discomfort and possible assistive technology
interventions that might ameliorate this difficult problem would also be highly beneficial.  Using
the WcS-DAT and the Phase III research design methodology, further investigation of the
effectiveness of currently available technologies in preventing or minimizing wheelchair seating
discomfort is also indicated.  This may include investigation of powered seating technologies,
such as powered tilt, powered recline, powered adjustable leg rests and others.  This may be a
highly valuable tool in determining and proving the efficacy of current as well as new
technology interventions.  In addition to the possible research applications, the WcS-DAT was
designed to meet a need for a clinical outcomes measurement tool to assist with therapeutic
decision making and determining the overall effectiveness of the processes and equipment
currently in use in wheelchair seating service delivery settings.  Widespread use of this
discomfort assessment measure will assist clinicians and consumers by providing better evidence
about the relative effectiveness of possible seating interventions in prevention of seating
discomfort.
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APPENDIX A
SEATING COMFORT QUESTIONNAIRE – PILOT STUDY I
Part I.  General Information
1.  Date of this visit: ________/________/_______
month          day           year
2.  Date of Birth: _______/_______/_______
month      day         year
3.  Primary Diagnosis:
___ (1) Amyotrophic Lateral Sclerosis (ALS)
___ (2) Multiple Sclerosis (MS)
___ (3) Muscular Dystrophy (MD)
___ (4) Polio or Post Polio Syndrome(PPS)
___ (5) Other, please specify: ______________________________
4.  Date of onset of this diagnosis: __________/_________
month year
5.  Do you have a secondary diagnosis?
___ (0) no
___ (1) yes --‡ please check all that apply: ___ (1) Osteoarthritis
___ (2) Rheumatoid Arthritis
___ (3) Fibromyalgia
___ (4) Other, please specify:
______________________________
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6.  What is the date of onset of this diagnosis?  ________/_________
     month          year
7.  What is your height? _____inches
8.  What is your weight? _______pounds
9.  Has your weight changed (increased or decreased) by 20 pounds or more over the past year?
___ (0) no
___ (1) yes
10.  Describe your current seating system:
a.  seat cushion type/brand:  _______________________________________
b.  back cushion type/brand: _______________________________________
c.  Is there a tilt in space seating system:
___ (0) no
___ (1) yes  -----‡ is it ___ (2) power
___ (3) manual
d.  Is there a reclining system present:
___ (0) no
___ (1) yes ----‡ is it ___ (2) power
 ___ (3) manual
11.  When did you obtain your current seating system: ________/______
     month       year
12.  What is your current mobility base:
___ (1) manual wheelchair
___ (2) power wheelchair
___ (3) three wheeled power scooter
___ (4) four wheeled power scooter
___ (5) other, please describe: __________________________________
13.  When did you obtain your current mobility base: _________/__________
   month            year
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14. Do you have difficulties with bowel or bladder continence when you are sitting in your
chair?
___ (0) no
___ (1) yes  ‡ does this occur: ___ (1) once a day
___ (2) once a week
___ (3) once a month
___ (4) other, please describe:  ________________
Part II.  Functional level
1.  On an average day, how long do you spend in your seating system? ________hours
2.  What is a typical reason for getting out of your seating system? (check all that apply)
___ (1) discomfort
___ (2) fatigue
___ (3) functional need
___ (4) convenience of family or caregivers
___ (5) home health aide schedule
___ (6) other reason, please specify:  ___________________________
3.  Type of transfer usually used to get in and out of your seating system: (check one)
___ (1) stand and pivot
___ (2) sliding board
___ (3) mechanical lift assisted
___ (4) lifted in/out by another person (or 2)
___ (5) other, please describe: ____________________________________
4.  Amount of assistance usually needed for this transfer: (please check one)
___ (1) no outside assistance, no equipment
___ (2) no outside assistance, equipment needed
___ (3) minimal assistance of one person
___ (4) moderate amount of assistance (I do about 1/2 of the work)
___ (5) maximal amount of assistance of:  one person
___ (6) two people are needed to assist
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5.  Does your ability to transfer with this amount of assistance change:
a.  during the day?
___ (0) no
___ (1) yes
b. from day to day?
___ (0) no
___ (1) yes
6.  Does your ability to transfer depend on the set up of your chair?
___ (0) no
___ (1) yes --‡ does it depend on (check all that apply):
___ (1) the height of the chair seat
___ (2) the “slipperiness” of the seat surface
___ (3) the firmness of the seat
___ (4) the flatness of the seat
___ (5) other, please specify: ______________________________
7.  What types of daily self care tasks are done in your chair? (check all that apply)
___ (1) bathing ___ (5) hair care
___ (2) dressing ___ (6) meal preparation
___ (3) shaving ___ (7) eating
___ (4) brushing teeth/washing face ___ (8) self catheterization
___ (9) other, please specify: __________________________________________
8.  In what environments is your chair used?
___ (1) home
___ (2) school
___ (3) work
___ (4) other, please specify: __________________________________________
9. On an average weekday (Monday through Friday), what percentage of the time you spend
in your chair is spent: (total must be 100%)
At home _______% At school _______% At work ________%
Other environment _______%: please describe environment _________________
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10.   On an average weekend day (Saturday or Sunday), what percentage of the time you
  spend in your chair is spent: (total must be 100%)
At home _______% At school _______% At work ________%
Other environment _______%: please describe environment _________________
Part III. Level of comfort in your current seating system
1.  When you began using a wheelchair for at least 6 hours per day, did you have comfort
problems?
___ (0) no
___ (1) yes
2. Since you obtained your present wheelchair seating system, have you been
experiencing discomfort?
 ___ (0) no
___ (1) yes
3.  In the past month, have you been uncomfortable in your current seating system?
___ (0) no
___ (1)  yes -‡ do you become uncomfortable: (check one)
___ (1) After a few hours
___ (2) every day
___ (3) once a week
___ (4) once a month
4.  Do you ignore your discomfort in order to function at your current level?
___ (0) no
___ (1) yes
5. When you experience discomfort, where on your body is the discomfort experienced?
(please circle all appropriate areas on the “body discomfort map” given to you)
6.  Are you uncomfortable right now?
___ (0) no
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___ (1) yes
7.  How long have you been sitting in your seating system today? _______hours
8.  How do you currently manage discomfort in your seating system?
___ (1) I get out of my seating system
___ (2) I take medications (prescription or non-prescription)
___ (3) I ask someone to re-position me in my seating system
___ (4) I re-position myself in my seating system
___ (5) I have no way to manage discomfort
___ (6) I use some other method, please describe:
________________________________________________________________________
9.  How often do you currently use the following features of your wheelchair seating system to
manage discomfort? (please rate an average day)
Seating system
feature
Not applicable (I don’t
have this feature on my
wheelchair)
Number of
times per
hour
OR
Number of times
per day
Power tilting
system
Power reclining
system
Power seat
elevation system
Other: Please
describe
10.  How do you currently relieve pressure in your seating system?
___ (1) I get out of my seating system
___ (2) I use my tilt in space or recline system (if present)
___ (3) I ask someone to re-position me in my seating system
___ (4) I re-position myself in my seating system
___ (5) I have no way to manage pressure in my current seating system
___ (6) I use some other method to manage pressure, please describe:
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_______________________________________________________________________
11.  How often do you currently use the following features of your wheelchair seating system to
manage pressure? (please rate an average day)
Seating system feature Not applicable Number of times
per hour
OR
Number of
times per day
Power tilting system
Power reclining
system
Power seat elevation
system
Other: Please describe
12.  Is your ability to sit in your seating system (total sitting time) limited by discomfort? 
___ (0) no
___ (1) yes
13.  Is your ability to perform functional activities in your seating system limited by
  discomfort?
___ (0) no
___ (1) yes
14. Please rate the effect that moving over bumpy surfaces in your chair has on your
 comfort?
___ (1) it makes me more uncomfortable
___ (2) it has no effect on my comfort
___ (3) it makes me less uncomfortable
15.  Please rate the effect that just sitting still in your chair has on your comfort?
___ (1) it makes me more uncomfortable
___ (2) it has no effect on my comfort
___ (3) it makes me less uncomfortable
16. Do you have a history of skin breakdown?
___ (0) no
___ (1) yes --‡please describe the following for the most recent episode:
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location:_______________________________
occurrence: ________months ago or _________years ago
17. Has this week been a typical week for you in terms of your level of comfort and your
ability to function?  
___ (0) no
___ (1) yes
Part IV.  Your suggestions for improving seating system comfort
1.  What is the one feature of your current seating system that makes you comfortable?
______________________________________________________________________
2.  What is the one feature of your current seating system that makes you uncomfortable?
______________________________________________________________________
3.  If you could design “the perfect” seating system, what features would you consider
essential in the design?
______________________________________________________________________
4. How important are these features of a seating system to you: (Please rate each of the
following features using a 1-10 scale, 1 being least important and 10 being most
important)
___ a.  Comfort ___ e.  Independent use of all features
___ b.  Safety    ___ f.  ability to adjust multiple features
___ c.  Mobility ___ g.  ability for caregiver to adjust features
___ d.  Ability to perform self care tasks
5.  How important is it for you to be able to adjust or move the following features of your
chair? (Please rate each of the following features using a 1-10 scale, 1 being least
important and 10 being most important)
___ a.  Arm rests ___ e.  Control Mechanism
___ b.  Leg rests ___ f. seat temperature
___ c.  Lateral supports ___ g. seat belt
___ d.  Head support
6.  If the following parts of the chair could be adjusted, would the adjustments need to be
electrically powered or could they be moved manually? (please check one choice in each
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category in the table below)
Chair feature: Manual adjust Power adjust
Arm rests
Leg rests
Lateral supports
Head support
Control
Mechanism
7.  Would it be important for you to be independent in performing this adjustment or could
it be performed by an attendant? (please check one choice in each category in the table
below)
Chair feature: Chair user
adjust
Attendant
adjust
Arm rests
Leg rests
Lateral supports
Head support
Control
Mechanism
8. Please include any other comments regarding the design of a new seating system type below:
________________________________________________________________
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Phase 2 Instructions
Dear Research Subject,
Thank you for participating in the Wheelchair Seat Comfort study for the University of
Pittsburgh.  We appreciate your valuable input into this project.  You are about to begin Phase 2
of this study.  The purpose of this phase is to test the reliability and validity of a newly developed
wheelchair seat discomfort assessment questionnaire.
You have been given a packet of information including the following:
Four copies of the questionnaire to complete – different colors
Four white envelopes (letter size)
One large brown envelope with a return address label and postage
Your copy of the consent form for participating in this study (please keep this)
For this research study, it is important that you follow these instructions carefully.
You are being asked to do the following:
1) Later today, please complete the YELLOW colored questionnaire – this will be #1, note the
date and the time that you completed this questionnaire.  You may have completed this
questionnaire with the researcher, if not, please place it into a white envelope and seal the
envelope.  Then please write the date and time on the white envelope.
2) One hour after you complete the YELLOW questionnaire, please complete the BLUE
questionnaire and mark it #2.  Note the time that you complete this questionnaire.  Please place
the BLUE questionnaire into a white envelope, seal it closed and write the date and time on the
envelope.
3) ONE WEEK LATER please fill out the PURPLE questionnaire at the same time of
day that you filled out the YELLOW questionnaire last week.  This will also be marked #1.
Please place this questionnaire into a white envelope and note the date and time of day you
completed this questionnaire.
4) ONE HOUR AFTER THE PURPLE questionnaire, please complete the GREEN
questionnaire.  Mark this questionnaire #2.  Place it into a white envelope and seal it in.  Please
note the date and time of day on the envelope.
5) Place all FOUR white envelopes into the brown envelope, seal it shut and place it in the US
mail.
Thank you for your participation.  If you have any questions, please do not hesitate to call me.
Barbara Crane
412-383-6583 – work number
Wheelchair Seating Discomfort Assessment Tool (WcS-DAT)
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Introduction and directions:
This questionnaire has been developed as a way of determining the level of discomfort you are
experiencing while you are sitting in your wheelchair.
There are three parts to this questionnaire:
• Part I asks you to provide general information that is important in evaluating seat
discomfort.
• Part II asks you to rate your level of agreement with several statements that relate
to comfort and discomfort.
• Part III asks you to assign a number on a scale from 0 to 10 to describe a
discomfort level for each region of your body.
You are being asked to complete this questionnaire at 4-hour intervals once you are seated in
your wheelchair.  This means that you will complete the first questionnaire of the day 4 hours
after you get into your chair in the morning, and then again every 4 hours after that.  You will
complete your final questionnaire before you get into bed at night, even if it has not been 4 hours
since your last questionnaire.
Each time you complete a questionnaire, you should only consider the 4 hours you have just
experienced – not the entire day.  This means that each questionnaire will represent your feelings
of discomfort over the preceding 4-hour period or since your last questionnaire (even if you did
not spend the total 4 hours in your chair).
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Part I: General Information:
1.  What time did you first transfer into your wheelchair today? __________ am/pm
2.  How much assistance do you need to transfer?
_____ I transfer completely by myself
_____ I require assistance from another person to help me transfer
_____ Another person transfers me, I am unable to help
_____ Another person uses a mechanical lifting device to transfer me
3.  If someone assisted you in transferring, were you positioned properly in you chair after being
transferred?
_____ yes  ______ no
Describe problems if any occurred (anything out of the ordinary):
_______________________________________________________________________
4.  What time is it now?  __________ am/pm
5.  In the last 4 hours, have you asked anyone to help you change your position in your
wheelchair?
_____ yes  ______ no
5a.  If yes, how many times have you asked someone to reposition you? ________
6.  In the last 4 hours, have you changed your own position?
_____ yes  ______ no
6a.  If yes, how many times have you changed your own position? ________
7.  What types of activities have you done in your wheelchair in the last 4 hours?
(check all that apply)
_____ moved around in the house
_____ went outside of the house
______ into the yard (grassy or rough surface)
______ onto a deck or paved driveway
______ traveled on a sidewalk surface
_____ traveled somewhere in a van or car
_____ went to work in my wheelchair
_____ went to school setting in my wheelchair
8.  How many car lengths would you say you drove your wheelchair in the last 4 hours?  ______
(a typical car is 12 feet long)
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Wheelchair Seating Discomfort Assessment Tool
(WCS-DAT)
Think about how you have felt while seated in your wheelchair during the last 4 hours:
Part II:  General Discomfort Assessment
Please rate your answer on the
following scale: (place a mark in the
appropriate box)
Strongly
disagree
Disagree Partly
disagree
Neither agree
nor disagree
Partly
agree
Agree Strongly
agree
While seated in my wheelchair…
I feel poorly positioned
I feel like I have been in one position
for too long
I feel like I need to move or shift my
position
I feel aches, stiffness, or soreness
I feel pressure in some part or parts of
my body
I feel too hot or cold or damp
I seek distraction to relieve
discomfort
I feel uncomfortable
I feel no pain
I feel stable (not sliding or falling)
I feel comfortable
I feel good
I feel able to concentrate on my work
or activities
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Part III: Discomfort Intensity Rating
No        Severe
Discomfort Discomfort
0 1 2 3 4 5 6 7 8 9 10
Using this scale, please RATE and DESCRIBE the amount of discomfort you feel
for each body area listed below.  This rating should reflect the intensity of your
discomfort over the last 4-hour period, for the time you were in your wheelchair:
Body Areas Rating: Please describe the discomfort (for
example: aching, burning,
pressure, instability, or others)
Back
Neck
Buttocks
Legs
Arms
Feet
Hands
Other areas ?
Please list:
Overall Discomfort
Level (General
discomfort level)
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Is this an average day
On a scale of 0 to 10, with a 0 representing “the lowest amount of discomfort I have felt
in the last 3 months” and a 10 representing the “highest amount of discomfort I have felt
in the last 3 months,” what number would best represent your general discomfort level
today?
______  (fill in number 0 to 10)
Using the same scale, what would represent an “average day” for you over the last 3
months?
______  (fill in number 0 to 10)
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(printed on Department of Rehabilitation Science and Technology letterhead)
Dear Participant,
Thank you for helping us with the Dynamic Seating for Comfort wheelchair research
study.  We really appreciate your help with this important project and we hope you enjoy
being involved in this study.
You are being provided with all of the necessary paperwork for participating in this
study.  We have tried to keep the paperwork to a minimum and have made every effort to
provide forms that area easy to understand and require minimal time for completion.
However, we really need you to answer the questions at the proper times each day to
insure that the date you provide can be used.
You will receive one notebook for each week of participation.  Each notebook contains 7
days of paperwork (in sections numbered from 1 to 7).  I will be visiting you at least once
per week and will provide you with the following week’s notebook at this visit.  I will
also plan to contact you once per day by telephone to monitor your progress and answer
any questions, but this does not mean that you need to wait for my call if you have
any questions.
For each day you will complete the following forms:
• A daily log for recording your chair use pattern (white sheet)
• One seat discomfort assessment for every 4-hours that you sit as follows:
o Complete after 4 hours of sitting (blue sheets)
o Complete after 8 hours of sitting (gold sheets)
o Complete if you sit between 8 and 12 hours (green sheets)*
o Complete if you sit between 12 and 16 hours (grey sheets)*
o Complete if you sit between 16 and 20 hours (light yellow sheets)*
• An assessment of how each day compares with your “average day” (pink sheet)
• A page for writing general comments or notes (pink sheet)
• A checklist of the day’s paperwork to be sure you completed it all (pink sheet)
* These are optional – it depends on how long you sit each day
If you have any questions or problems while completing any of the paperwork, please do
not hesitate to call me at my office or to page me.  My office number is 412-383-6583
and my pager number is 1-800-217-5390.  I can always be reached at one of these two
numbers!
Thank you,
Barbara Crane
Research Associate
University of Pittsburgh
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Time
AM: Bed Toilet Shower Wheelchair Other chair (please describe)
5:00 - 5:30
5:30 - 6:00
6:00 - 6:30
6:30 - 7:00
7:00 - 7:30
7:30 - 8:00
8:00 - 8:30
8:30 - 9:00
9:00 - 9:30
9:30 - 10:00
10:00 - 10:30
10:30 - 11:00
11:00 - 11:30
11:30 - Noon
PM:
Noon - 12:30
12:30 - 1:00
1:00 - 1:30
1:30 - 2:00
2:00 - 2:30
2:30 - 3:00
3:00 - 3:30
3:30 - 4:00
4:00 - 4:30
4:30 - 5:00
5:00 - 5:30
5:30 - 6:00
6:00 - 6:30
6:30 - 7:00
7:00 - 7:30
7:30 - 8:00
8:00 - 8:30
8:30 - 9:00
9:00 - 9:30
9:30 - 10:00
10:00 - 10:30
10:30 - 11:00
11:00 - 11:30
11:30 - Midnight
Daily Log of Sitting Time
Please check off the place where you spent the majority of time for each time block:
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Assessment Number 1
Complete after 4 hours of sitting
Introduction and directions:
This questionnaire has been developed as a way of determining the level of discomfort
you experience while you are sitting in your wheelchair.
There are three parts to this questionnaire:
• Part I asks you to provide general information that is important in
evaluating seat discomfort.
• Part II asks you to rate your level of agreement with several statements
about comfort and discomfort.
• Part III asks you to assign a number on a scale from 0 to 10 to describe a
discomfort level for each region of your body.
You are being asked to complete this questionnaire at 4-hour intervals once you are
seated in your wheelchair.  This means that you will complete this first questionnaire of
the day 4 hours after you get into your chair.
Each time you complete a questionnaire, you should answer the
questions based on the 4 hours you have just experienced – not the
entire day.
(Assessment number 1 is included as an example, each assessment contained the
appropriate number and directions depending on when it was scheduled to be completed)
If you are getting out of your wheelchair and
staying out the remainder of the day, please
complete this assessment and then skip to the
pink sheets at the end of this section.
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Part I: General Information:
1.  What time did you first transfer into your wheelchair today? __________
am/pm
2.  How much assistance do you need to transfer?
_____ I transfer completely by myself
_____ I require assistance from another person to help me transfer
_____ Another person transfers me, I am unable to help
_____ Another person uses a mechanical lifting device to transfer me
3.  If someone assisted you in transferring, were you positioned properly in you chair
after being transferred?
_____ yes  ______ no
Describe problems if any occurred (anything out of the ordinary):
_______________________________________________________________________
4.  What time is it now?  __________ am/pm
5.  In the last 4 hours, have you asked anyone to help you change your position in your
wheelchair?
_____ yes  ______ no
5a.  If yes, how many times have you asked someone to reposition you? ________
6.  In the last 4 hours, have you changed your own position?
_____ yes  ______ no
6a.  If yes, how many times have you changed your own position? ________
7.  What types of activities have you done in your wheelchair in the last 4 hours?
(check all that apply)
_____ moved around in the house
_____ went outside of the house
______ into the yard (grassy or rough surface)
______ onto a deck or paved driveway
______ traveled on a sidewalk surface
_____ traveled somewhere in a van or car
_____ went to work in my wheelchair
_____ went to school setting in my wheelchair
8.  How many car lengths would you say you drove your wheelchair in the last 4 hours?
______
(a typical car is 12 feet long)
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Wheelchair Seating Discomfort Assessment Tool
(WCS-DAT)
Think about how you have felt while seated in your wheelchair during the last 4 hours:
Part II:  General Discomfort Assessment
Please rate your answer on the
following scale: (place a mark in the
appropriate box)
Strongly
disagree
Disagree Partly
disagree
Neither agree
nor disagree
Partly
agree
Agree Strongly
agree
While seated in my wheelchair…
…I feel poorly positioned
…I feel like I have been in one
position for too long
…I feel like I need to move or shift
my position
…I feel aches, stiffness, or soreness
…I feel pressure in some part or parts
of my body
…I feel too hot or cold or damp
…I seek distraction to relieve
discomfort
…I feel uncomfortable
…I feel no pain
…I feel stable (not sliding or falling)
…I feel comfortable
…I feel good
…I feel able to concentrate on my
work or activities
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Part III: Discomfort Intensity Rating
On a scale of 0 to 10, 0 being no discomfort and 10 being severe
discomfort, please RATE and DESCRIBE the amount of discomfort you
feel for each body area listed below.
This rating should reflect the intensity of your discomfort over the last
4-hour period, for the time you were in your wheelchair:
Body Areas Rating: Please describe the discomfort (for
example: aching, burning, pressure,
instability, or others)
Back
Neck
Buttocks
Legs
Arms
Feet
Hands
Overall Discomfort
Level (General
discomfort level)
Other areas?
Please list:
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Is this an average day?
On a scale of 0 to 10, where:
0 = “the lowest amount of discomfort I have felt in the last 3
months”;  and
10 = “the highest amount of discomfort I have felt in the last 3
months”
1.  What number would best represent your general
discomfort level today?
______  (fill in number 0 to 10)
2. What number would represent an “average day” for you
during the last 3 months?
______  (fill in number 0 to 10)
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Please review and answer the following questions based
on your use of the PTS2 test wheelchair today:
1.  Do you have any new reddened areas of skin on your buttocks or posterior thighs?
Yes ____*
No  ____
*If yes, call Barbara Crane at 412-383-6583 or page her at 1-800-217-5390 and discontinue use of
the PTS2 wheelchair
2.  Did you experience any difficulties in using the PTS2 wheelchair or seat
controls today?
Yes ____*
No  ____
*If yes, call Barbara Crane at 412-383-6583 or page her at 1-800-217-5390 and
describe the problem below:
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
________________________________________________________________________
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PTS2 WHEELCHAIR USERS GUIDE
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Introduction
The PTS2 wheelchair is a specialized wheelchair developed to evaluate a
dynamic seat for relieving sitting discomfort.  It was developed for the
research study titled “Investigation of Dynamic Seating for Comfort.”
The chair uses technology from the wheelchair and automotive industries.  It
is comprised of a Permobil Chairman power wheelchair base with power tilt,
power recline, power elevating leg rests, and power seat lift functions.
Mounted to the Permobil seat frame is an automobile seat system that has
been customized for this study.  Four air bladders have been inserted inside
the seat cushion, and three air bladders have been inserted inside the back
cushion.
The chair has two control interface devices – one for driving the wheelchair
(joystick) and one for operating the seat functions.  Both control interfaces
are connected to an instrumentation system that controls the operation of the
chair and monitors the usage of each of the features.  The chair runs on
battery power supplied by two12-volt wheelchair batteries.
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The Seat and Back Cushions:
The seat cushion and back cushion of this chair each contain special air
bladders that make it possible to change the firmness of the cushions in
different regions of your body.  This will allow you to adjust the pressure
points exerted by the seat and back, and may help you in making small
postural adjustments or shifts.  The inflation level of the seat and back
bladders is adjusted by pressing the corresponding buttons on the control
panel (see next section on control panel).
This diagram indicates the approximate locations of each of the bladders.
215
Control Panels:
There are two control panels for this chair.  In the picture below, the panel
on the left operates the wheelchair driving functions.  The green button turns
the power for the chair on and off, the round dial to the left of the green
button allows you to adjust the maximum speed of the chair, and the larger
knob below these is the joystick drive control.
The panel on the right operates the inflation and deflation of the individual
air bladders and the wheelchair power seat functions.  The top section of the
control panel represents the wheelchair seat cushion.  Each pair of buttons –
inflates and deflates the corresponding air bladder inside the seat cushion.
The mid section of the control panel represents the wheelchair back cushion
and contains three pair of buttons, these inflate and deflate the air bladders in
the back cushion of the chair.  At the bottom of the panel is the section that
contains all of the power seat functions – these are labeled for ease of use.
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Batteries and Charging
The wheelchair is powered by a pair of normal 12-volt wheelchair batteries.
The batteries are located underneath the seat, inside the black protective case
of the wheelchair base.  There is a charging port on the left hand side of the
chair, just behind the seat.  The batteries for this chair should be charged
every night, even if you do not normally charge your own wheelchair every
night.  This is necessary because this chair uses more power in order to
operate all of the special features.  The wheelchair should run all day on a
full charge.  However, if you notice the green light blinking when the chair
is turned on, you may need to charge it soon.  This blinking green light
indicates a low battery level.
Wheels and Tires
The wheelchair has two larger drive wheels in the front.  These wheels
contain air-filled tire tubes.  If the air in these tires appears to be low, or if
one of these tires develops a flat tire, please call the researchers at the
number provided.  The chair also has two smaller wheels in the rear of the
chair – these are called casters.
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Special equipment
The wheelchair is also equipped with additional instrumentation required to
operate the extra functions and to monitor the usage of the chair.  All of this
special equipment is located in a box mounted on the back of the chair.
Please do not touch this instrumentation.  If you think there is a problem
with it, please contact the research team.
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Air bladder inflation pumps
The seat’s air bladders, operated with the buttons on your control panel, are inflated using
small air pumps attached to the bladders by small tubes.  These pumps are contained
inside the box mounted to the back of the chair (in the picture below they are the red
items inside the yellow box). These pumps make a small amount of noise when they are
pumping air into the bladders.  This is normal.  If you think that the pumps are not
working properly or if you stop hearing noise when you try to inflate the bladders, please
contact the research team.
Protecting the chair from moisture
The control panels and the electronic equipment mounted behind the chair
should be protected from bad weather to the greatest extent possible.  While
many normal wheelchair components are sealed for added protection from
moisture, this chair contains features that do not have this added protection.
If you need to go outside in very wet or rainy weather, please use your
personal wheelchair rather than this test wheelchair.  Please try to avoid
spilling liquids on the control panel that operates the air bladders.  If the
controls are exposed to liquid, they may no longer work properly – that is,
when you push buttons, the bladders or seat functions may fail to operate.  If
this occurs, please contact the researcher team.
Research Team Contact Information
Barbara Crane is the research coordinator for this project.  Please contact her directly if
there are any problems with the wheelchair or if you have any questions about the chair
or the research documents.
Pager Number and Directions: Dial: 1-800-217-5390 – enter your phone number at the
prompt, then wait for it to confirm that the message will be sent before hanging up.
Work Phone: 412-383-6583
Email: bacst62@pitt.edu or cranebar@cs.com
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